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Äußere Haarsinneszellen (ÄHZ) des Corti´schen Organs im Innenohr werden biophysikalisch 
charakterisiert durch den K+ Strom IK,n, dessen molekulare Grundlage der spannungsabhängige 
K+ Kanal KCNQ4 (Kv7.4) ist. IK,n/KCNQ4 dominiert die elektrischen Eigenschaften der ÄHZ 
Zellmembran und ist darüber hinaus essentiell für das Überleben der Zellen. Im knock-out 
Tiermodell führte der Verlust der KCNQ4 Kanalaktivität zum Untergang der ÄHZ und zu Taubheit. 
Dies ist klinisch bedeutend, da im Menschen KCNQ4 Mutationen die Ursache für die erbliche 
Taubheit DFNA2 sind. Der Mechanismus, der zum Haarzelluntergang führt, ist noch unklar, doch 
korreliert das Überleben von ÄHZ direkt mit der Funktion von KCNQ4. Obwohl der durch 
Giftstoffe oder Lärm bewirkte Haarzelluntergang (erworbener Hörverlust) dem KCNQ4-bedingten 
ÄHZ Verlust ähnelt, wurde eine Verbindung zwischen IK,n/KCNQ4 und erworbenem Hörverlust 
bisher noch nicht experimentell erfasst. In der vorliegenden Arbeit habe ich mich mit der 
pathophysiologischen Rolle von IK,n/KCNQ4 in klinisch relevantem Haarzelluntergang beschäftigt, 
der durch Aminoglykosid (AG) Antibiotika hervorgerufen wird. Des Weiteren wurde untersucht, ob 
chemische KCNQ Kanalöffner die Funktion von IK,n trotz pathophysiologisch relevanter Inhibition 
wiederherstellen können, um eventuell Protektion der ÄHZ zu ermöglichen. 
Ich konnte erstmalig zeigen, dass AG Antibiotika schnell in Haarzellen eindringen und IK,n 
inhibieren. Die Inhibition war darauf zurückzuführen, dass AG über elektrostatische 
Wechselwirkungen negativ geladene Phospholipide funktionell depletieren, die für die Funktion 
von IK,n essentiell sind. Verschiedene AG zeigen unterschiedliches ototoxisches Potential: 
Neomycin führt zum Untergang von ÄHZ, während Gentamycin vestibuläre Haarzellen schädigt. 
Das Ausmaß der IK,n Kanalinhibition korrelierte (Neomycin > Gentamycin) mit dem Grad der 
Phospholipid Bindung und mit dem ototoxischen Potential der AG. Dies legt nahe, dass die hohe 
Anfälligkeit der ÄHZ gegenüber Neomycin auf die Inhibition von IK,n zurückzuführen ist. Des 
Weiteren konnte gezeigt werden, dass die Aktivität von IK,n durch chemische KCNQ Kanalöffner 
verstärkt wird. Die AG-induzierte Hemmung von IK,n konnte aufgehoben und die Kanalaktivität 
vollkommen wiederhergestellt werden.  
In heterozygoten DFNA2 Patienten werden IK,n Ströme durch einen dominant-negativen Effekt 
mutierter KCNQ4 Kanaluntereinheiten verringert, was den ÄHZ Untergang bewirkt. Es ist mir im 
heterologen System gelungen, mittels chemischer KCNQ Kanalöffner KCNQ4 von dieser 
dominant-negativen Inhibition zu befreien. Die Ströme in Gegenwart der Kanalöffner waren 
vergleichbar mit Strömen unter Kontrollbedingungen, was gleichbedeutend mit der vollständigen 
Wiederherstellung der Kanalfunktion war. 
Zusammenfassend kann gesagt werden, dass ich in dieser Arbeit erstmals eine Rolle der 
Kaliumleitfähigkeit IK,n in erworbenem Hörverlust demonstrieren konnte. Dies kann die verstärkte 
Anfälligkeit von ÄHZ gegenüber ototoxischen Einflüssen erklären. Darüber hinaus stabilisieren 
chemische Kanalöffner IK,n in Anwesenheit von AG und stellen die Funktion von rekombinanten 
KCNQ4 Kanälen trotz dominant-negativer Inhibition wieder her. Dies könnte Haarzellen vor 
KCNQ4-bedingtem Untergang schützen. Es bleibt allerdings offen, ob die Substanzen den 
Verlust der ÄHZ verzögern und Taubheit abwenden können. 
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Cochlear outer hair cells (OHCs) are characterised by the voltage-dependent K+ conductance IK,n 
that previously was shown to be mediated by KCNQ4 (Kv7) channel subunits. IK,n/KCNQ4 
dominates the electrical properties of the OHC cell membrane and furthermore is essential for 
OHC survival. Genetic deletion of KCNQ4 causes progressive degeneration of OHCs and 
deafness. Similarly, KCNQ4 loss-of-function mutations cause the progressive form of hereditary 
deafness DFNA2. The molecular mechanism leading to OHC degeneration remains elusive, but 
the survival of OHCs has been linked directly to KCNQ4 channel function. Strikingly, the loss of 
OHCs is phenotypically similar to OHC degeneration caused by ototoxic substances and noise 
damage (acquired hearing loss), but a role of IK,n/KCNQ4 in acquired hearing loss has never been 
investigated so far. In the present study I investigated the pathophysiological relevance of IK,n for 
OHC degeneration caused by aminoglycoside (AG) antibiotics. Since KCNQ4 channel function is 
essential for OHC survival, chemical current augmentation may provide a protective strategy 
against KCNQ4-related hearing loss. Thus, I analysed whether chemical KCNQ channel openers 
rescued IK,n currents from pathological inhibition. 
In brief, I found that AGs rapidly entered OHCs and that entry was necessary for IK,n current 
inhibition. The inhibition was caused by functional depletion of phospholipids by the AGs that are 
essential for the function of IK,n/KCNQ4. Various AGs exhibit different ototoxic potential, i.e. 
neomycin causes OHC degeneration whereas gentamicin damages vestibular hair cells. 
Strikingly, the degree of IK,n inhibition (neomycin > gentamicin) correlated with the phospholipid 
binding efficiency and with the ototoxic potential of the respective AG. Given the dependence of 
OHCs on IK,n, the ototoxic potential of AGs thus may be determined by their chemical nature and 
by their inhibitory impact on IK,n. Furthermore, I showed that IK,n was sensitive to current 
augmentation by chemical KCNQ channel openers. A combination of openers rescued IK,n from 
AG-induced inhibition to wild-type levels indicating full restoration of IK,n activity. 
Most DFNA2 patients are heterozygous carriers of KCNQ4 mutations that reduce IK,n through a 
dominant-negative effect. This reduction of IK,n activity causes OHC degeneration. Residual 
currents in the dominant-negative situation were essentially rescued to wild-type levels by the 
application of KCNQ channel openers, at least in a heterologous expression system. The current 
rescue indicated that KCNQ channel openers might be used to stabilise IK,n in heterozygous 
DFNA2 patients. 
In summary, the present work demonstrated for the first time a role of the essential OHC K+ 
conductance IK,n in acquired hearing loss. The dependence of OHCs on IK,n may explain the high 
vulnerability of OHCs towards ototoxic influences. IK,n current augmentation by chemical KCNQ 
openers may be used to stabilise IK,n in OHCs and protect the sensory cells from KCNQ4-related 
degeneration. KCNQ openers rescued IK,n from AG-induced inhibition in OHCs and recombinant 
KCNQ4 from dominant-negative inhibition by mutant subunits. However, it remains elusive 
whether chemical KCNQ agonists alleviate OHC degeneration and protect from hearing loss.  
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1 Introduction 
Hearing is a complex process that involves the transduction of mechanical sound stimuli into 
electrical neuronal signals and the processing of the information in higher auditory brain areas 
(for review see Fettiplace and Hackney, 2006; Schwander et al., 2010). Malfunction at any of 
these hierarchic steps causes hearing impairment and deafness in humans (Smith et al., 
2008). Hearing impairment can only be mitigated by the use of hearing aids or cochlear 
implants, but hereditary hearing loss cannot be averted successfully (Smith et al., 2008). The 
voltage-gated potassium channel KCNQ4 (Kv7.4) constitutes the predominant K+ 
conductance, IK,n, of outer hair cells (OHCs) in the organ of Corti and was shown to be 
mutated in hereditary progressive hearing loss, DFNA2 (deafness-associated autosomal 
dominant locus 2) (Housley and Ashmore, 1992; Kubisch et al., 1999; Kharkovets et al., 
2006). Loss of KCNQ4 channel function causes progressive loss of OHCs and profound 
deafness in affected individuals (Kharkovets et al., 2006; Nie, 2008). OHC degeneration was 
linked to the dysfunction of IK,n/KCNQ4, but the mechanism leading to the loss of the sensory 
cells remain unclear (Kharkovets et al., 2006). Given the necessity of KCNQ4 channel function 
for OHC survival, the potential benefits of KCNQ4 current rescue by chemical channel 
openers are obvious. Interestingly, KCNQ channel agonists are already used successfully 
against KCNQ-linked epilepsies (Wulff et al., 2009), but have never been tested in the 
treatment of KCNQ4-related deafness.  
In this thesis fundamental biophysical and pharmacological properties of IK,n were analysed to 
evaluate the potencies of chemical KCNQ agonists in the treatment of KCNQ4-related hearing 
impairment. In the following section the role of OHCs in the transduction of sound and the 
importance of IK,n for OHCs will be discussed. 
1.1 Auditory Hair Cells Mediate the Transduction of Sound 
The human inner ear detects mechanical displacements below one nanometre (Sellick et al., 
1982), displays an amazing frequency range of perception from 20 Hz to 20 kHz, and 
discriminates frequency differences of only 0.2% (Dallos, 1992; Fettiplace and Hackney, 
2006). This performance is achieved by anatomical and physiological specialisations: First, 
mechanical vibrations are represented on the basilar membrane (BM) as travelling waves with 
local frequency-specific maxima along the cochlear axis. These maxima are facilitated by the 
mechanical properties of the BM that is stiffer with smaller diameter at the base than at the 
apex (Von Békésy, 1960). This produces a frequency map along the cochlea where high 
frequencies are represented at the base and low frequencies at the apex (see Figure 1A). 
Complex sounds are dispersed into distinct frequency components and lead to multiple 
amplitude maxima on the BM (Von Békésy, 1960). Second, the relative movement of the BM 
towards the tectorial membrane and local fluid acceleration displace apical stereocilia of inner 
(IHCs) and outer hair cells (OHCs) which opens or closes mechano-sensitive ion channels 
(mechano-electrical transduction channels, MET) (Schwander et al., 2010). Accordingly, hair 
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cells at different positions along the cochlea are excited by different frequencies, i.e. the 
characteristic frequency of the hair cell (Figure 1A and B). Third, locally activated OHCs 
increase the frequency tuning of the cochlea by active amplification of BM motion (Figure 1B 
and C) (Sellick et al., 1982; Dallos, 1992; Ashmore et al., 2010). 
 
Figure 1: The organ of Corti in the inner ear mediates the transduction of sound. 
A, Schematic representation of the coiled cochlea (top) and for clarity presented as straight 
(bottom). Sound-induced eardrum vibrations produce frequency-specific movements of the 
BM. High frequencies are represented in the cochlear base and low frequencies in the apex. 
The numbers indicate frequency range of the human cochlea (in kHz). 
(Middle ear bones: (I) malleus, (II) incus, (III) stapes; red arrows indicate direction of 
mechanical movement) 
B, Mechanical movements (red arrows) of the BM displace apical stereocilia of hair cells in the 
organ of Corti, which opens or closes mechano-sensitive ion channels.  
C, Cochlear amplification increases frequency discrimination. The green trace shows passive 
BM motion in the dead cochlea. In the living cochlea this movement is increased actively and 
refined by OHCs (red) (see text) (A and B are were adopted and modified from Fettiplace and 
Hackney, 2006). 
 
In the human cochlea sensory hair cells are organised in one row of IHCs and three rows of 
OHCs (Pickles, 1988; Dallos et al., 1996; Schwander et al., 2010). Hair cells are polarised 
epithelial cells with a cylindrical cell body presenting the apical part towards the tectorial 
membrane and the basal (subnuclear) pole towards supporting cells and the tunnel of Corti 
(Dallos et al., 1996). Accordingly, the apical part of hair cells is bathed in endolymph (with high 
K+ and low Na+ concentration) whereas the basal pole is surrounded by perilymph (with low K+ 
and high Na+) (Dallos et al., 1996). The unique feature of the sensory cells is the apical 
mechano-sensitive apparatus with three rows of actin-based stereocilia of increasing length 
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(Lim, 1980). The stereocilia of IHCs and OHCs are made-up by the same molecular 
components and resemble each other in size, geometry and mechanics (Russell et al., 1986b; 
Russell et al., 1986a; Russell et al., 1992), but only the OHC hair bundle is embedded into the 
tectorial membrane (Lim, 1980) (see Figure 1B). Thus, the bundle of OHCs is believed to be 
displaced by movements of the tectorial membrane relative to the BM, whereas the bundle of 
IHCs is displaced by motions of the surrounding fluid induced by BM acceleration (Dallos, 
1986; Fettiplace and Hackney, 2006). Displacement of the stereocilia towards the longest row 
opens (gates) MET channels, whereas deflection into the opposing direction closes the 
channels (Corey and Hudspeth, 1983; Russell and Richardson, 1987). It is believed that MET 
channel gating is mediated via elastic "gating springs", but neither the molecular nature of the 
gating spring nor the molecular components of MET channels have been identified so far 
(Gillespie and Muller, 2009; Schwander et al., 2010). K+-carried currents through the MET 
channels (transduction currents) depolarise IHCs and OHCs. In IHCs depolarisation stimulates 
Ca2+-dependent glutamate release from the basal pole that increases the action potential 
frequency of postsynaptic neurons (Moser et al., 2006; Meyer and Moser, 2010). In contrast, 
voltage changes drive active length changes of the OHC's cell body, which is the mechanism 
underlying cochlear amplification. 
1.2 Outer Hair Cells and the Cochlear Amplifier 
In the dead cochlea the low sensitivity, low frequency selectivity and linear dependence of BM 
movements from stimulus intensity are determined by the mechanical properties of the BM 
and can be explained by passive movement of the involved structures (Figure 1C, green 
trace). (Von Békésy, 1960; Pickles, 1988; Dallos, 1992). The structure of the BM, however, 
does not explain transduction at low stimulus levels, when viscous dampening of the BM and 
additional passive filtering by involved structures should cause total loss of the energy (Von 
Békésy, 1960). In contrast, in the living cochlea even low stimulus levels produce robust BM 
movements that are maximal and sharpest at the characteristic frequency of the respective 
BM portion (Figure 1C, red trace) (Sellick et al., 1982). Such frequency tuning indicates active 
amplification of BM movements. Indeed, OHCs were shown to generate additional mechanical 
output in response to BM displacement which increases BM movement and sharpens cochlear 
frequency selectivity (Ryan and Dallos, 1975; Dallos and Harris, 1978; Dallos, 1992; Fettiplace 
and Hackney, 2006). This active enhancement of BM movements by OHCs is referred to as 
cochlear amplification for which two mechanisms have been proposed: active hair bundle 
movement and somatic electromotility. Hair bundle movements originate from Ca2+-dependent 
MET channel desensitisation that actively moves the hair bundle back to its resting position 
(Fettiplace and Hackney, 2006; Ashmore et al., 2010). Such movement was identified in lower 
vertebrates (e.g. turtle and frog) and may also exist in mammals, but it remains controversial 
whether the generated force is sufficient to contribute to the amplification of BM movements 
(Benser et al., 1996; Martin and Hudspeth, 1999; Ricci et al., 2000; Chan and Hudspeth, 2005; 
I N T R O D U C T I O N  
- 4 - 
Kennedy et al., 2005). The more accepted mechanism of cochlear amplification is length 
changes of the OHC's cell body driven by the membrane potential, also referred to as somatic 
electromotility. Depolarisation (by gating of MET channels) results in contraction and 
hyperpolarisation in elongation of the cells. The length changes are mediated by voltage-
dependent conformational changes of prestin, a protein in the lateral membrane of OHCs 
(Brownell et al., 1985; Ashmore, 1987; Zheng et al., 2000; Fettiplace and Hackney, 2006). 
Since acoustic stimulation changes the membrane potential of OHCs (see 1.2.1), length 
changes follow audio frequencies and produce a "cycle-by-cycle" force on the BM and the 
tectorial membrane driven by depolarisation followed by hyperpolarisation (Dallos et al., 1996; 
Johnson et al., 2011). This mechanical output increases the amplitude of BM movements in 
response to acoustic stimulation and is the cellular mechanism underlying cochlear 
amplification (Liberman et al., 2002; Dallos et al., 2008). 
In summary, OHCs mediate cochlear amplification through two specialisations: First, 
mechanical movement of the BM produces a receptor potential that, second, generates 
mechanical force and enhances BM movement. This requires membrane potential changes as 
well as conformational responses of prestin and consequently somatic length changes of 
OHCs. The electrical properties of OHCs enabling cochlear amplification will be discussed in 
the following section. 
1.2.1 The Electrophysiology of Outer Hair Cells 
The membrane potential of OHCs is determined by depolarising K+ currents through the MET 
channels and by hyperpolarising currents through K+ channels in the hair cell's basolateral 
membrane (in the nuclear region of the cell). At rest (without displacement of the hair bundle) 
approximately 50% of the MET channels are active, setting the membrane potential to around 
-40 mV (Johnson et al., 2011). Additional gating of MET channels causes K+-dependent 
depolarisation, whereas closing of the MET channels hyperpolarises the membrane potential 
(Corey and Hudspeth, 1983; Johnson et al., 2011). Accordingly, mechanical displacement of 
the hair bundle by acoustic stimulation causes sinusoidal variations around the resting 
potential, i.e. an alternating current (AC) receptor potential (Dallos et al., 1996; Hille, 2001). 
The AC receptor potential will be attenuated above a certain stimulus frequency due to low-
pass filtering of biological membranes. In other words, above this cut-off frequency the 
receptor potential cannot follow the stimulus anymore and its amplitude is attenuated (Hille, 
2001). This is relevant for prestin-driven somatic electromotility. Active amplification of BM 
movements via positive feedback requires "cycle-by-cycle" length changes in response to 
alternating depolarisation and hyperpolarisation (Johnson et al., 2011). Thus, OHCs amplify 
BM movement only if they respond to acoustic stimulation with somatic length changes. If the 
stimulus frequency exceeds the cut-off frequency of the OHC, attenuation of the receptor 
potential attenuates prestin-mediated electromotility. This truncates positive feedback and 
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theoretically limits cochlear amplification to the low frequencies where the receptor potential is 
not attenuated, since the stimulus frequency is lower than the cut-off frequency.  
The cut-off frequency of the circuit is determined by the time constant (tau) that describes the 
time needed to recharge a capacitor through a resistor (tau = R x C where R and C are the 
input resistance and membrane capacitance, respectively). Accordingly, the cut-off frequency 
increases with faster time constants of the membrane (Hille, 2001). The input resistance (R) of 
biological membranes depends on the amount of functional ion channels, i.e. the resistance 
decreases with increasing number of activated ion channels. In OHCs voltage-dependent K+ 
channels are located in the basolateral membrane that dominate the OHC-membrane time 
constant and shape the receptor potential (Hille, 2001; Johnson et al., 2011). The K+ channels 
are activated completely at rest (around -40 mV), which lowers the membrane resistance and 
speeds the membrane time constant substantially (Johnson et al., 2011). In fact, in OHCs K+ 
and MET current amplitudes are bigger in the cochlear base than in the apex, resulting in a 
high cut-off frequency in high frequency OHCs (Dallos et al., 1982; Dallos, 1985; Housley and 
Ashmore, 1992; Johnson et al., 2011). Accordingly, complete activation of K+ channels at the 
basolateral OHC membrane enables fast prestin-driven electromotility and cochlear 
amplification even at the highest frequencies in the cochlea. The following chapter describes 
the K+ channels of OHCs. 
1.2.2 IK,n is the Predominant K+ Current of Outer Hair Cells 
The predominant voltage-dependent K+ conductance in OHCs is IK,n that shows an unusually 
negative voltage range of activation. IK,n currents activate at -110 mV and current amplitudes 
saturate around -40 mV. Thus, IK,n is fully activated at the OHC resting membrane potential, 
i.e. IK,n is a physiologically constitutively open current ("background current") (Housley and 
Ashmore, 1992; Mammano and Ashmore, 1996; Nenov et al., 1997; Marcotti and Kros, 1999; 
Johnson et al., 2011). Thus, as IK,n provides the main K+ conductance at all potentials it 
dominates the membrane time constant of OHCs, presumably enabling cochlear amplification 
at high frequencies (see 1.2.1) (Housley and Ashmore, 1992; Johnson et al., 2011). In murine 
OHCs the developmental appearance of IK,n concurs with the onset of somatic electromotility 
around postnatal days eight to ten, implicating the involvement of the conductance in the 
biophysical and structural maturation of OHCs around the onset of hearing (days 10 to 12) 
(Marcotti and Kros, 1999; Oliver and Fakler, 1999).  
Additional basolateral K+ currents in OHCs are IK and SK. IK was identified as large 
conductance voltage- and calcium-activated K+ current (BKCa; Maxi-K) (Housley and 
Ashmore, 1992; Mammano et al., 1995; Mammano and Ashmore, 1996; Ruttiger et al., 2004). 
It resembles a conductance in IHCs and contributes to the fine-tuning of the receptor potential 
(Ruttiger et al., 2004; Thurm et al., 2005; Oliver et al., 2006). OHCs also express small 
conductance calcium-activated K+ channels (SK) at the basal cell pole that mediate fast 
efferent inhibition (Dallos et al., 1996). Acetylcholine increases Ca2+ levels in OHCs via 
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postsynaptic nicotinic acetylcholine receptors. Elevated Ca2+ levels in turn activate SK 
channels that through K+ currents hyperpolarise the hair cell (Elgoyhen et al., 1994; Oliver et 
al., 2000). 
Taken together, the physiology of OHCs largely depends on K+ channels at the basolateral 
membrane. The electrical properties of the OHC membrane are dominated by IK,n that exhibits 
unusual biophysical properties. The following section discusses these characteristics also 
considering the voltage-dependent K+ channel KCNQ4 (Kv7.4) that was shown to constitutes 
IK,n in OHCs (Kharkovets et al., 2006).  
1.2.3 KCNQ4 Mediates IK,n, but Both Channels Show Biophysical Differences 
KCNQ4 (Kv7.4) is a member of the KCNQ family (KCNQ1 - KCNQ5, Kv7) of voltage-
dependent potassium channels and was shown to mediate IK,n (Kharkovets et al., 2006; Holt et 
al., 2007). Whereas other KCNQ isoforms (e.g. KCNQ2/KCNQ3) are expressed throughout 
the nervous system (reviewed in Jentsch, 2000), the expression profile of KCNQ4 seems to be 
restricted to hair cells of the inner ear, neurons of the auditory brainstem, mechano-receptors 
in the skin and vascular smooth muscle cells (Heidenreich et al.; Kharkovets et al., 2000; 
Chambard and Ashmore, 2005; Yeung et al., 2007). KCNQ4 was identified as the molecular 
correlate of IK,n based on various findings: First and most convincing, genetic disruption of 
KCNQ4 eliminates IK,n in OHCs (Kharkovets et al., 2006). Second, co-expression of KCNQ4 
subunits carrying loss-of-function mutations reduces IK,n by a dominant-negative effect, i.e. the 
function of the native channel complex is disrupted by mutant KCNQ4 subunits (Holt et al., 
2007). Third, IK,n is sensitive to specific KCNQ channel inhibitors, XE991 and linopirdine, 
identifying the conductance as carried by KCNQ subunits (Marcotti and Kros, 1999). Fourth, 
KCNQ4 was shown to be expressed in the basolateral membrane of OHCs. In addition, the 
developmental expression of KCNQ4 around
 
days eight to ten matches well with the 
appearance of IK,n (Kubisch et al., 1999; Kharkovets et al., 2000). Taken together, compelling 
evidence points to KCNQ4 as the molecular correlate of IK,n. However, native IK,n shows 
biophysical characteristics that are not reproduced by recombinant KCNQ4 (Housley and 
Ashmore, 1992; Kubisch et al., 1999). Most obviously, IK,n activates at hyperpolarised 
potentials (half-maximal voltages of activation, Vh, -80 mV) compared to recombinant KCNQ4 
(Vh between around -20 mV) (Mammano and Ashmore, 1996; Kubisch et al., 1999; Marcotti 
and Kros, 1999). The gating kinetics of IK,n are substantially faster than of recombinant KCNQ4 
(Housley and Ashmore, 1992; Mammano and Ashmore, 1996). In addition, the 
pharmacological properties of IK,n differ from heterologously expressed KCNQ4. IK,n displays 
higher sensitivity to inhibition by KCNQ antagonists linopirdine and XE991 (Sogaard et al., 
2001; for IHCs see Oliver et al., 2003; Xu et al., 2007). Moreover, IK,n is largely insensitive to 
the K+ channel inhibitor tetraethylammonium (TEA) which potently blocks recombinant KCNQ4 
(Housley and Ashmore, 1992; Marcotti and Kros, 1999; Hadley et al., 2000).  
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The extraordinary biophysical properties of IK,n cannot be explained by KCNQ4 channel 
subunits alone. Since heterologous expression systems normally reproduce biophysical 
properties of ion channels quite well, these findings imply an OHC-specific mechanism 
responsible for the negative voltages of activation of IK,n. Attractive hypothesis arise from the 
presence of hitherto unidentified accessory channel subunits, posttranslational modification or 
a yet unknown mechanism. In any case, an OHC-specific mechanism seems to be the most 
likely explanation, but its molecular mechanism still needs to be elucidated. One possibility 
may be the presence of additional KCNQ subunits (e.g. KCNQ3) in the native channel 
complex. Co-expression of KCNQ4 together with KCNQ3 produced currents with amplitude 
and gating kinetics similar to IK,n, but failed to reproduce the negative voltage range of 
activation (Kubisch et al., 1999; Bal et al., 2008). Also the low TEA sensitivity of IK,n might be 
explained by the co-expression of KCNQ4 with KCNQ subunits with low TEA sensitivity (e.g. 
KCNQ3; Hadley et al., 2000). However, it remains controversial whether KCNQ3 is expressed 
functionally in OHCs (Kubisch et al., 1999; Kharkovets et al., 2000). Another possibility 
emerges from the presence of accessory KCNE β-subunits that have been shown to alter the 
biophysical and pharmacological properties of the KCNQ α-subunit (McCrossan and Abbott, 
2004). All KCNE isoforms were identified in the cochlea and all isoforms seem to co-assemble 
with recombinant KCNQ4 (Strutz-Seebohm et al., 2006). However, none of the KCNE 
isoforms produced biophysical characteristics of KCNQ4 explaining the properties of IK,n 
(Strutz-Seebohm et al., 2006).  
Taken together, an OHC-specific mechanism produces the biophysical properties of IK,n, but 
the molecular nature of this mechanism remains elusive. Since the biophysical and 
pharmacological properties of KCNQ channels depend on the subunit composition of the 
channel tetramer, the pharmacological characterisation of IK,n may help to identify channel 
subunits apart from KCNQ4 in the native channel complex. Thus, one aspect of this thesis 
was the analysis of fundamental biophysical and pharmacological "KCNQ-like" characteristics 
of IK,n and the comparison of these properties to recombinant KCNQ channels. 
1.2.4 IK,n/KCNQ4 is Essential for the Survival of Outer Hair Cells 
It is well established that IK,n/KCNQ4 is essential for the survival of OHCs (Kharkovets et al., 
2000; Winter et al., 2006). Pharmacological inhibition, genetic ablation and loss of KCNQ4 
channel function in human hereditary deafness DFNA2 lead to progressive OHC degeneration 
that starts at the cochlear base and proceeds to the apex (reviewed in Jentsch, 2000; Nouvian 
et al., 2003; Kharkovets et al., 2006; Nie, 2008). Basal OHCs with highest KCNQ4 expression 
and biggest IK,n current amplitudes are most susceptible to degeneration whereas apical 
OHCs with smallest IK,n currents remain unaffected (Housley and Ashmore, 1992; Kubisch et 
al., 1999; Beisel et al., 2000; Nouvian et al., 2003; Kharkovets et al., 2006). The base-to-apex 
loss of OHCs causes progressive hearing impairment that starts at high and proceeds to low 
frequencies (Kharkovets et al., 2006; Smith and Hildebrand, 2008). In affected humans, 
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hearing loss starts in the second or third decade of life and culminates in profound deafness at 
later ages (Nie, 2008; Smith and Hildebrand, 2008). The disease phenotype was recapitulated 
by the KCNQ4 knock-out mouse demonstrating that profound hearing impairment was caused 
by loss of OHCs and absent cochlear amplification (Kharkovets et al., 2006; Smith and 
Hildebrand, 2008). Although KCNQ4 was reported to be expressed also in IHCs (Marcotti et 
al., 2003; Oliver et al., 2003), vestibular type I hair cells (Rusch and Eatock, 1996; Holt et al., 
2007) and neurons of the auditory brainstem (Kubisch et al., 1999; Kharkovets et al., 2000) 
the degree of hearing impairment does not implicate the involvement of IHCs or neuronal 
deficits (Kharkovets et al., 2006). However, profound deafness in elderly DFNA2 patients does 
not totally rule out additional loss of IHCs at later disease stages (Oliver et al., 2003). 
Vestibular defects have not been reported consistently from affected humans or from the 
KCNQ4 knock-out mouse (Kharkovets et al., 2006; Smith and Hildebrand, 2008). Hearing loss 
was attributed to the loss of KCNQ4 channel function, but the molecular mechanism causing 
hair cell degeneration remains elusive. Since KCNQ4 is expressed in the basolateral 
membrane of OHCs, the channel was proposed to serve as the basolateral exit path of K+ ions 
to the tunnel of Corti (see Figure 1B) (Housley and Ashmore, 1992; Jentsch, 2000; Jentsch et 
al., 2000). Thus, IK,n/KCNQ4 may regulate K+ levels in OHCs serving as a key element for the 
recycling of K+ ions back to the endolymph via a system of gap junctions and the stria 
vascularis (Mistrik and Ashmore, 2009). From this follows that loss of KCNQ4 channel function 
disturbs the K+ homeostasis of OHCs together with persistent K+ influx through the MET 
channels. Most probably, sustained K+ overload causes prolonged Ca+2 influx through voltage-
dependent Ca2+ channels and Ca2+-dependent OHC degeneration (Zenner et al., 1994; 
Jentsch, 2000; Jentsch et al., 2000).  
KCNQ4 loss-of-function causes hair cell degeneration and deafness in DFNA2 patients 
(Kubisch et al., 1999; Kharkovets et al., 2006). Several DFNA2-causing KCNQ4 mutations 
have been identified that disturb channel function through disruption of ion permeation or by a 
reduction of channels expressed at the cell surface (summarised in Smith and Hildebrand, 
2008). Accordingly, KCNQ4 mutations reduce IK,n, which initiates OHC degeneration 
(Kharkovets et al., 2006; Holt et al., 2007). A variety of chemical KCNQ channel openers are 
available, and some of these substances are already in clinical use for the treatment of 
neurological disorders (Wulff et al., 2009). Importantly, some KCNQ channel agonists (e.g. 
retigabine, zinc pyrithione) were shown to rescue channel function of epileptogenic KCNQ2 
mutants (Biervert et al., 1998; Schroeder et al., 1998; Xiong et al., 2007; Xiong et al., 2008). In 
analogy, chemical KCNQ openers may rescue IK,n/KCNQ4-mediated currents in DFNA2 
patients offering a protective strategy against OHC degeneration. Despite the obvious benefits 
of such current augmentation, it has never been tested so far whether the substances rescue 
channel function of DFNA2 relevant KCNQ4 mutants or whether IK,n is sensitive to chemical 
current potentiation. Thus, this thesis aims to evaluate the potency of KCNQ channel openers 
in the treatment of KCNQ4-related hearing loss, DFNA2. 
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1.2.5 Other Outer Hair Cell Pathologies May Be Related to KCNQ4 Dysfunction  
Ototoxic agents, noise exposure or aging cause the irreversible loss of OHCs and acquired 
hearing impairment. Basal OHCs are far more vulnerable to degeneration than apical whereas 
IHCs are not affected (Smith et al., 2008). The different hair cell susceptibility cannot be 
explained so far. However, the loss of OHCs correlates directly with the dependence of OHCs 
on IK,n/KCNQ4 (Nouvian et al., 2003; Kharkovets et al., 2006). Although a potential role of 
KCNQ4 in age-related deafness has been proposed previously, the involvement of IK,n/KCNQ4 
in acquired hearing loss has never been investigated (Van Eyken et al., 2006).  
A clinically relevant form of acquired hearing loss is caused by aminoglycosides (AGs): AG-
antibiotics (e.g. neomycin) exhibit high efficiency in the treatment of bacterial infections, but 
their use is limited, since most treated patients develop profound hearing impairment (Forge 
and Schacht, 2000; Rybak and Ramkumar, 2007). Hearing loss is induced by irreversible 
degeneration of OHCs that starts in the cochlear base and proceeds to the apex. Yet, this 
base-to-apex loss of OHCs cannot be explained (Forge and Schacht, 2000). Noteworthy, it 
resembles KCNQ4-related OHC degeneration (Kharkovets et al., 2006). AGs induce hair cell 
death following entry into the cell from the endolymph via a not fully resolved entry pathway, 
possibly via the MET channels (Alharazneh et al., 2011). The mechanisms leading to OHC 
degeneration may involve the disruption of mitochondrial function (Dehne et al., 2002), the 
production of reactive oxygen species (Rybak and Ramkumar, 2007), and the disturbance of 
phosphoinositide (PI) metabolism (Jiang et al., 2006a; Goodyear et al., 2008). AGs have been 
shown to chelate membrane-resident PIs via electrostatic interactions (Gabev et al., 1989). 
This links AG-induced OHC loss to IK,n/KCNQ4, since KCNQ channels essentially require 
membrane-resident phosphatidylinositol-(4,5)-bisphosphate (PI(4,5)P2) for channel activation 
(Li et al., 2005; Suh et al., 2006). Accordingly, reduction of PI(4,5)P2 inhibits the channel (Suh 
and Hille, 2002).  
The dependence of OHC survival on IK,n, the PI(4,5)P2 dependence of KCNQ channels and 
the chelation of PIs by AGs strongly indicate a contribution of AG-induced IK,n/KCNQ4 
inhibition to AG-mediated OHC loss. The role of IK,n in ototoxic hair cell insult has never been 
investigated so far, but IK,n inhibition by AGs may explain the high vulnerability of OHCs. 
Positive evaluation of this hypothesis makes KCNQ4 a promising target in the treatment of 
acquired hearing loss. Accordingly, this thesis evaluates the relevance of IK,n/KCNQ4 inhibition 
for AG ototoxicity and the use of KCNQ channel openers to rescue IK,n function from AG-
induced inhibition.  
AGs bind to PIs, which reduces their availability to ion channels. However, the degree of 
current inhibition depends on the PI affinity and dependence of the respective channel. 
Although the dependence on membrane-resident PI(4,5)P2 is the characteristic feature of the 
KCNQ channel family, the phospholipid requirement for channel activation of IK,n has never 
been investigated so far. The PI dependence of cellular processes has been investigated 
previously using voltage-sensing phosphatases (VSPs) that, in contrast to unspecific PI 
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chelation by AGs, specifically deplete certain PI species (Murata et al., 2005). VSPs are 
modular enzymes that consist of a voltage-sensing domain (VSD) with high homology to 
voltage-dependent ion channels coupled to a phosphatase domain (PD) (Murata et al., 2005). 
Typically VSPs respond to membrane depolarisations with 5-phosphatase activity towards 
PI(4,5)P2 and PI(3,4,5)P3 (Halaszovich et al., 2009). Strikingly, the homology of the PD to the 
3-phosphatase PTEN (phosphatase and tensin homolog deleted from chromosome 10) may 
enable the design of engineered VSPs with altered substrate specificity (Iwasaki et al., 2008; 
Halaszovich et al., 2009). Once transfected into cells these enzymes can be used to analyse 
the PI dependence and affinity of ion channels in straightforward electrophysiological 
experiments. Even though VSPs are available, the difficile handling of OHCs in culture and 
insufficient transfection efficiencies prevented these experiments so far. Thus, technically 
refined tools and experimental settings are needed to analyse the PI dependence of IK,n. 
Detailed knowledge of the PI dependence and specificity of IK,n allows for a more precise 
evaluation of the impact of AGs on the native channel complex in OHCs. Thus, one aspect of 
this thesis is the design and the characterisation of a novel VSP that contains the VSD of 
prototypic Ci-VSP together with the 3-phosphatase PTEN. Native and designed VSP will be 
used in combination to study the PI dependence of IK,n in future studies.  
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2 Aims and Contributions 
2.1 Objectives 
IK,n dominates the electrical properties of cochlear OHCs, enables prestin-mediated cochlear 
amplification and is essential for the survival of OHCs. Nothing is known about the OHC-
specific molecular mechanism that determines the characteristic properties of IK,n. The 
involvement
 
of IK,n/KCNQ4 in acquired hearing loss is likely, but has not been investigated so 
far. The work presented in this thesis aims to analyse the molecular properties of the 
conductance, to evaluate the pathophysiological relevance and mechanisms of IK,n in AG 
ototoxicity and to estimate potential benefits of chemical channel openers in the treatment of 
KCNQ4-related hearing impairment. 
I. The role of IK,n /KCNQ4 in AG-induced hair cell loss 
The PI-dependence of ion channels has been investigated repeatedly by intracellular 
application of AGs that functionally deplete PIs (Gabev et al., 1989; e.g. Schulze et al., 2003). 
In the present work, AGs were used to estimate the PI affinity of IK,n allowing for the 
comparisons with heterologously expressed KCNQ isoforms. Given the clinical relevance of 
AG-mediated hair cell loss (see 1.2.5), in these experiments the physiological role of AG-
induced IK,n inhibition was evaluated. 
II. The sensitivity of IK,n to chemical KCNQ channel openers and their potential for the 
treatment of KCNQ4-related hearing impairment 
Loss of KCNQ4 channel function causes progressive OHC degeneration and hearing loss 
(Nouvian et al., 2003; Kharkovets et al., 2006; Holt et al., 2007). Dysfunction of other KCNQ 
isoforms (e.g. KCNQ2) causes epileptic seizures that are treated successfully with chemical 
KCNQ channel openers (Biervert et al., 1998; Schroeder et al., 1998; Wulff et al., 2009). In 
analogy, IK,n/KCNQ4 current potentiation by the openers may be used as protective strategy 
for DFNA2 patients and against AG-induced hair cell loss (see (I)). The benefits of chemical 
augmentation depend on the sensitivity of IK,n to channel openers. First, IK,n was characterised 
pharmacologically and the sensitivity of IK,n towards chemical KCNQ openers was determined. 
Second, the reconstitution of IK,n from AG-induced inhibition was assessed. Third, rescue of 
DFNA2-causing KCNQ4 mutations by chemical KCNQ openers was investigated (Nie, 2008; 
Smith and Hildebrand, 2008).  
III. Analysis of the KCNQ subunit composition of the native channel complex in OHCs 
The contribution of KCNQ channel subunits apart from KCNQ4 to native IK,n is still 
controversial. The pharmacological properties and biophysical characteristics of KCNQ 
channels depend on the subunit composition of the channel tetramer (Hadley et al., 2000; 
Hernandez et al., 2008; Xiong et al., 2008; Hernandez et al., 2009; Zhang et al., 2011). The 
sensitivity towards chemical current augmentation and the PI-dependence of activation of IK,n 
were analysed and compared to heterologously expressed KCNQ channel subunits to draw 
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conclusions about the subunit composition of the native channel complex. Furthermore, 
recombinant KCNQ4 was established as a sensor for physiologically relevant of PI(4,5)P2 level 
changes. 
IV. Technically-refined tools to investigate PI-dependent processes  
AGs chelate PIs without any preference for a certain PI species. However, the impact of AGs 
on channel function depends on the PI specificity and affinity of the channel. Accordingly, 
knowledge of the PI affinity allows more detailed estimation of AG-induced channel inhibition. 
The PI affinity of ion channels can be determined using stepwise activation of a VSP by 
stepwise depolarisation. Since prototypic VSPs are PI(4,5)P2- and PI(3,4,5)P3-specific 5-
phosphatases, the enzymes can be used to determine the affinity of an ion channel towards 
these PI species. Voltage-controlled PI(3,4,5)P3 3-phosphatases are not yet available, but the 
cytoplasmic 3-phosphatase PTEN shares high sequence homology to the PD of prototypic 
VSPs (Okamura and Dixon, 2011). This homology presumably enables the design of a 
voltage-dependent 3-phosphatase consisting of the VSD of Ci-VSP coupled to PTEN. In the 
work presented, the enzymatic activity and substrate specificity of this chimera were analysed 
and the potential of designed VSPs in the analysis of the PI-dependence of ion channels was 
evaluated. Further studies will make use of this work for detailed analysis of the PI 
dependence of IK,n in OHCs.  
2.2 My Contributions to the Articles Presented 
In this section, I state my contributions to the publications presented in this thesis. 
 
(1) Michael G. Leitner, Christian R. Halaszovich and Dominik Oliver. Aminoglycosides 
inhibit KCNQ4 channels in cochlear outer hair cells via depletion of 
phosphatidylinositol(4,5)bisphosphate. Molecular Pharmacology. 2011 Jan:79(1):51-60 
(Leitner et al., 2011) 
 
I designed the research together with Prof. Dr. Dominik Oliver, performed all 
electrophysiological and imaging experiments including the data analysis and wrote the paper 
together with Prof. Dr. Dominik Oliver.  
 
(2) Michael G. Leitner, Anja Feuer, Olga Ebers, Daniela N. Schreiber, Christian R. 
Halaszovich and Dominik Oliver. Restoration of ion channel function in deafness 
causing KCNQ4 mutations by chemical openers. British Journal of Pharmacology (2012) 
165 2244-2259 (Leitner et al., 2012) 
I conceived the project, performed the electrophysiological experiments with data analysis and 
wrote the paper together with Prof. Dr. Dominik Oliver.  
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(3) Moritz Lindner, Michael G. Leitner, Christian R. Halaszovich, Gerald R. V. 
Hammond and Dominik Oliver. Probing the regulation of TASK potassium channels 
by PI(4,5)P2. Journal of Physiology. 2011 Jul 1; 589 (Pt 13):3149-62 (Lindner et al., 
2011) 
 
This study is part of the doctoral thesis of Moritz Lindner in the group of Prof. Dr. Dominik 
Oliver. I planned, performed and analysed experiments presented in Figure 1 (Receptor-
mediated inhibition of TASK channels and concomitant depletion of PI(4,5)P2) and Figure 2B 
(TASK-currents are insensitive to depletion of PI(4,5)P2 by Ci-VSP).  
 
(4) Jérôme Lacroix, Christian R. Halaszovich, Daniela N. Schreiber, Michael G. Leitner, 
Francisco Bezanilla, Dominik Oliver and Carlos A. Villalba-Galea. Controlling the 
activity of PTEN by membrane potential. Journal of Biological Chemistry. 2011 May 
20; 286(20): 17945-53 (Lacroix et al., 2011) 
 
This project was realised in collaboration with Prof. Dr. Francisco Bezanilla (Chicago, Illinois, 
USA) and Carlos A. Villalba-Galea (Richmond, Virginia, USA). In summary, my contributions 
to this study are experiments and data analysis shown in Figure 2 (Ci-VSPTEN displays 
voltage-activated lipid phosphatase activity; all panels), Figure 5 (Binding of the PBM is 
essential for phosphatase activation by the VSD) and Figure 6A (Experimental control of Ci-
VSPTEN activity in intact cells without use of electrophysiological instrumentation).  
 
 
 
 
 
 
 
 
 
Hiermit bestätige ich die Richtigkeit der unter 2.2 gemachten Angaben bezüglich des 
Eigenanteiles von Michael Leitner an den aufgeführten Publikationen. 
  
Marburg, März 2012 
 
 
 
           Michael Leitner                                                               Prof. Dr. Dominik Oliver 
        (Autor)                                                                                  (Betreuer) 
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3 Results 
3.1 The Outer Hair Cell K+ Current IK,n Requires PI(4,5)P2 for Activation  
The PI dependence of ion channels has been investigated repeatedly by intracellular application 
of AGs. The positively charged substances bind to the polyanionic PIs, thereby functionally 
depleting PIs and reducing their availability to the ion channel (Gabev et al., 1989; Oliver et al., 
2004). In these experiments AGs were applied via a whole cell patch pipette and IK,n or 
recombinant KCNQ4 were recorded (Leitner et al., 2011). Introduction of AGs into OHCs 
inhibited IK,n. The time course of inhibition was rapid suggesting direct action of the chelators on 
the channels rather than inhibition via intracellular messenger systems (Leitner et al., 2011; 
Figure 1). The degree of current inhibition correlated with the amount of positive charges in the 
descending order of neomycin > gentamicin > kanamycin. Intracellular neomycin dose-
dependently inhibited IK,n, whereas ampicillin, a structurally not related antibiotic, was ineffective. 
These findings indicated that IK,n inhibition depended on the positive charges of the substances. 
Analogous experiments with KCNQ4 heterologously expressed in Chinese hamster ovary (CHO) 
cells revealed that the same substances also robustly inhibited recombinant KCNQ4 (Leitner et 
al., 2011; Figure 2). The rank order of KCNQ4 current inhibition was similar to native IK,n, albeit 
current inhibition by the chelators was more pronounced compared to IK,n. These findings 
indicated higher sensitivity to AG-mediated inhibition of heterologously expressed KCNQ4. Given 
the well known binding of AGs to phospholipids and the dependence of KCNQ channel activation 
on PI(4,5)P2, these findings strongly suggested inhibition of IK,n/KCNQ4 via the depletion of PIs 
(Gabev et al., 1989; Suh and Hille, 2002). I monitored the availability of free PIs upon intracellular 
dialysis of neomycin and kanamycin using the PI(4,5)P2 sensor tubby-Cterm-GFP and total 
internal reflection fluorescence (TIRF) microscopy (Halaszovich et al., 2009; Leitner et al., 2011; 
Figure 3). In brief, the membrane-association of tubby-Cterm is a direct measure for membrane-
resident PI(4,5)P2. Since in TIRF microscopy only membrane-bound fluorophores are excited, the 
fluorescence intensity of GFP-labelled tubby-Cterm directly reports on the amount of PI(4,5)P2 at 
the membrane (Santagata et al., 2001; Halaszovich et al., 2009). Introduction of neomycin or 
kanamycin via the patch pipette into CHO cells expressing tubby-Cterm-GFP caused rapid 
decline of membrane-associated fluorescence indicating the functional depletion of PI(4,5)P2 
(Leitner et al., 2011; Figure 3). The degree of PI(4,5)P2 chelation was stronger for neomycin 
than for kanamycin, i.e. neomycin with more positive charges bound PI(4,5)P2 more efficiently 
than kanamycin. Of special note, these findings are in agreement with stronger current inhibition 
of IK,n and recombinant KCNQ4 by neomycin than by kanamycin. In addition, the time course of 
PI(4,5)P2 depletion matched the electrophysiological experiments (compare to Leitner et al., 
2011 Figure 1 and 2). To see whether KCNQ4 current reduction by AGs depended on the 
availability of free PI(4,5)P2 I increased basal PI(4,5)P2 levels in CHO cells by over-expression of 
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a PI(4)-5-kinase (e.g. Li et al., 2005). In these cells KCNQ4 current inhibition was significantly 
reduced compared to control cells (Leitner et al., 2011, Figure 3).  
Taken together, these findings strongly suggested inhibition of IK,n and recombinant KCNQ4 by 
functional sequestration of PI(4,5)P2 through AGs. Additionally, I demonstrated the PI-
dependence of IK,n, which indicated a role of IK,n current inhibition in AG ototoxicity. Furthermore, I 
was able to show that KCNQ4 currents can be used along with fluorescent PI sensors to monitor 
PI(4,5)P2 changes in living cells (Lindner et al., 2011). 
3.2 Inhibition of IK,n by Aminoglycosides is Pathophysiologically Relevant 
Given the inhibition of IK,n by AGs and the degeneration of OHCs caused by KCNQ4 dysfunction, 
I investigated the relevance of IK,n in AG ototoxicity (Kharkovets et al., 2006; Rybak and 
Ramkumar, 2007). In the experiments presented in 3.1 AGs were introduced into the cell. 
However, ototoxic degeneration of OHCs occurs subsequent to entry of AGs into hair cells from 
the endolymph (Forge and Schacht, 2000; Marcotti et al., 2005; Dai et al., 2006; Wang and 
Steyger, 2009). Thus, I examined whether AG entry into OHCs was sufficient to cause relevant 
IK,n current inhibition (Leitner et al., 2011; Figure 4). I applied AGs from the extracellular side 
and recorded IK,n currents in OHCs. When applied from the extracellular side, AGs inhibited IK,n 
with the same rank order of current inhibition as upon intracellular application (neomycin > 
kanamycin) (compare to Leitner et al., 2011; Figure 1). Noteworthy, the potency of the 
substances matched the clinical ototoxic potential with neomycin having the most detrimental 
impact on OHCs (Forge and Schacht, 2000). Extracellularly applied AGs robustly depolarised 
OHCs highlighting the physiological relevance of AG-induced IK,n inhibition (Leitner et al., 2011; 
Figure 6) . Analogous experiments in CHO cells showed that AGs did not inhibit recombinant 
KCNQ4 when applied from the extracellular side (Leitner et al., 2011; Figure 6). These findings 
strongly suggested OHC specific inhibition of IK,n. Since AGs were shown to enter hair cells 
specifically, we hypothesised that AGs rapidly entered OHCs and inhibited IK,n via intracellular 
depletion of PI(4,5)P2. To see whether the AG entry was reasonably fast to explain IK,n inhibition, I 
investigated the entry of AGs into hair cells with fluorescently labelled neomycin and confocal 
microscopy. Indeed, confocal imaging with neomycin conjugated to Texas Red revealed fast 
accumulation of AGs in hair cells as detected by rapid increase of cellular fluorescence (Leitner 
et al., 2011; Figure 5). AGs specifically entered hair cells and the time course was rapid enough 
to explain IK,n inhibition (Leitner et al., 2011; Figure 5). In contrast, CHO cells did not take up 
AGs in agreement with absent current inhibition of recombinant KCNQ4 by AGs applied from the 
extracellular side (Leitner et al., 2011; Supplemental Figure 2). 
Taken together, I demonstrated rapid entry of AGs into OHCs from the extracellular 
(endolymphatic) side and AG-induced inhibition of IK,n via functional depletion of PI(4,5)P2. These 
findings strongly suggest a role of IK,n inhibition in AG ototoxicity. 
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3.3 IK,n is Sensitive to Chemical KCNQ Openers 
Loss of KCNQ4 channel function causes OHC degeneration and deafness (Kharkovets et al., 
2006). Since OHC survival was directly attributed to IK,n/KCNQ4 function, it can be hypothesised 
that augmentation of IK,n by previously described channel openers may alleviate or even avert this 
pathology. However, the benefit depends on the sensitivity of native IK,n to the channel openers. 
Thus, I characterised the sensitivity of recombinant KCNQ4 and IK,n towards KCNQ agonists 
(Leitner et al., 2011; Leitner et al., 2012). The substances robustly potentiated recombinant 
KCNQ4 currents and shifted the voltage-dependence of activation to hyperpolarised voltages 
(Leitner et al., 2012; Figure 1). The rank order of current potentiation was flupirtine < retigabine 
< BMS-204352 < zinc pyrithione << zinc pyrithione/retigabine (ZnP/Ret) in line with reports from 
other KCNQ isoforms (Tatulian et al., 2001; Xiong et al., 2007; Xiong et al., 2008). The 
combination of ZnP/Ret was most effective and shifted the voltage dependence of activation of 
heterologously expressed KCNQ4 by -40 mV (Leitner et al., 2012; Supplemental Figure 1). 
Similarly, KCNQ openers robustly augmented IK,n in OHCs and shifted the voltage-dependence of 
activation to hyperpolarised voltages (Leitner et al., 2012; Figure 7). The rank order of current 
enhancement was similar, but current potentiation was less pronounced for IK,n than for 
recombinant KCNQ4 (Leitner et al., 2012, Figures 1 and 7). Of special interest, retigabine that is 
clinically used as antiepileptic drug also increased IK,n (Leitner et al., 2012, Figure 7).  
In conclusion, IK,n was sensitive to current potentiation by chemical KCNQ openers, albeit the 
degree of current potentiation was lower than for recombinant KCNQ4. The sensitivity of IK,n to 
KCNQ channel openers, especially to retigabine, may be used to rescue IK,n in case of KCNQ4 
dysfunction.  
3.4 KCNQ Channel Openers Rescue IK,n from AG-induced Inhibition and 
Reconstitute Channel Function of Deafness-Causing KCNQ4 Mutants 
Next I tested whether KCNQ channel agonists rescued IK,n from pathophysiologically relevant loss 
of function. I started with AG-induced inhibition of IK,n (Leitner et al., 2011). In brief, neomycin 
inhibited IK,n and substantially depolarised OHCs (Leitner et al., 2011; Figures 6 and 7). 
ZnP/Ret rescued IK,n and fully reversed AG-induced depolarisation to control levels before AG 
application (Leitner et al., 2011; Figure 7). IK,n current amplitudes and the membrane potential of 
the cells treated with ZnP/Ret in presence of AGs were indistinguishable from normal control 
cells. These findings showed that KCNQ agonists could be used to stabilise the KCNQ 
conductance in OHCs despite the presence of AGs. KCNQ channel openers thus might offer a 
protective strategy against AG-mediated OHC degeneration through augmentation of IK,n (Leitner 
et al., 2011; Figure 7). 
Several KCNQ4 loss-of-function mutations have been shown to cause hereditary hearing loss in 
humans (Nie, 2008; Smith and Hildebrand, 2008; Kim et al., 2011). I tested whether KCNQ 
openers rescued channel function of DNFA2 relevant KCNQ4 mutations (Leitner et al., 2012). I 
over-expressed mutant KCNQ4 subunits in CHO cells and performed whole cell patch clamp 
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experiments. Recombinant KCNQ4 channels carrying a mutation in the pore region could not be 
rescued by KCNQ agonists, which suggested total loss of function in these mutants (Leitner et 
al., 2012; Figure 3). A mutation localised close to the C-terminus of KCNQ4 produced small 
currents under control conditions. Application of ZnP/Ret uncovered voltage-dependent KCNQ4 
currents mediated by the mutant subunits. The ZnP/Ret-induced currents through the mutant 
channels were slightly smaller than KCNQ wild-type (wt) control currents, i.e. the mutant was 
rescued partially to wt levels (Leitner et al., 2012; Figure 4). Most affected individuals are 
heterozygous carriers of KCNQ4 mutations, which reduces IK,n by a dominant-negative effect, i.e. 
a single mutant subunit disrupts the function of the tetrameric channel (Kubisch et al., 1999; Holt 
et al., 2007; Kim et al., 2011). Accordingly, heterozygous patients produce the same amount of wt 
and mutant KCNQ4 subunits, which leaves behind only 6.25% functional homomeric wt channels 
at the cell surface. This reduction of functional channels causes the decrease of overall currents. 
Co-expression of recombinant wt KCNQ4 with mutants in CHO cells reproduced the dominant-
negative situation (Leitner et al., 2012; Figure 5). Whole cell currents were strongly reduced as 
predicted from co-assembly of wt and mutant subunits and disruption of channel function by the 
mutants. Strikingly, application of ZnP/Ret rescued the minute residual currents to wt levels, i.e. 
currents were indistinguishable from KCNQ4 control currents (Leitner et al., 2012; Figure 5). 
This demonstrates full rescue of KCNQ4 currents from dominant-negative inhibition by KCNQ 
channel openers. In the dominant-negative situation, the channel population at the cell membrane 
comprises homomeric wt channels, homomeric mutant channels and heteromeric channels of 
both, wt and mutant subunits. At this point, it was not clear whether also otherwise dysfunctional 
heteromeric channels and with homomeric mutant channels contributed to ZnP/Ret-mediated 
current rescue. We constructed concatamers of wt and mutant channel subunits to obtain 
homogenous channel populations in the cell membrane and tested whether KCNQ openers 
rescued the function of the resulting channels. Using the protein concatamers, I showed that 
channel function of tetramers containing mutant subunits was not restored by the channel 
openers. Current rescue resulted solely from potentiation of currents through remaining 
homomeric wt channels. However, this current potentiation was sufficient to account for the 
complete rescue of KCNQ4 from dominant-negative inhibition (Leitner et al., 2012; Figure 6).  
Taken together, these findings showed that KCNQ channel openers rescued KCNQ4 from 
dominant-negative inhibition. Since native IK,n (see 3.3) was robustly augmented by KCNQ 
channel agonists as well, these substances may be used to stabilise the conductance in OHCs. 
This may postpone profound hearing loss or even protect OHCs from degeneration in DFNA2 
patients. 
3.5 The Biophysical Properties and the Molecular Nature of IK,n 
The subunit composition determines the biophysical and pharmacological properties of tetrameric 
KCNQ channels (Hadley et al., 2000; Hernandez et al., 2009). Accordingly, it may be possible to 
draw conclusions on the subunit composition from the biophysical properties. In brief, I found that 
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IK,n was inhibited by depletion of PIs via introduction of AGs. This is expected, since PI(4,5)P2-
dependent KCNQ4 subunits contribute to the native channel complex (Leitner et al., 2011). 
However, the IC50 for neomycin of IK,n was significantly higher than for recombinant KCNQ4 (IK,n 
0.59 mM; KCNQ4 0.13 mM), indicating lower sensitivity to neomycin-induced current inhibition for 
IK,n than of recombinant KCNQ4. Since current inhibition was caused by PI depletion (see 3.1), 
the degree of current decrease allowed to estimate the PI affinity of the respective channel. 
Accordingly, these results indicated higher PI affinity of IK,n than of recombinant KCNQ4 (Leitner 
et al., 2011; Figures 1 and 2). Equal neomycin concentrations (500 µM) inside the patch pipette 
inhibited recombinant KCNQ4 more pronounced (approximately 80% inhibition) than IK,n, (30% 
inhibition) albeit the time course of current inhibition was similar. Noteworthy, currents through 
recombinant KCNQ3 with high PI(4,5)P2 affinity were reduced by only 10% upon dialysis of the 
cells with 500 µM neomycin (Hernandez et al., 2009; Leitner et al., 2011; Figures 1, 2 and 3). 
These differences strongly suggested intermediate PI affinity of IK,n between recombinant KCNQ4 
and KCNQ3. Similarly, co-expression of KCNQ2 with low PI(4,5)P2 affinity and KCNQ3 resulted 
in heteromeric channels with intermediate PI(4,5)P2 affinity in previous reports (Hernandez et al., 
2009). In analogy, my findings suggested the contribution of additional subunits with high PI 
affinity to IK,n in OHCs. Additionally, these experiments established recombinant KCNQ4 as a 
perfect read-out for physiologically relevant PI(4,5)P2 changes. This makes KCNQ4 a bona fide 
PI(4,5)P2 sensor that can be used to study the PI dependence of cellular processes (Lindner et 
al., 2011). 
Also the pharmacological profile of IK,n suggested the presence of additional subunits in OHCs. 
Current potentiation by KCNQ openers was less pronounced for IK,n than for recombinant KCNQ4 
(Leitner et al., 2012; Figure 1 and 7). Similarly, also the agonist-mediated shift of the voltages of 
activation to hyperpolarised potentials was smaller for the native channel complex. Since KCNQ3 
shows lowest sensitivities towards chemical current potentiation of all KCNQ isoforms, co-
expression of KCNQ3 may be responsible for the special pharmacological profile of IK,n. Thus, I 
co-expressed KCNQ4 together with KCNQ3 and analysed the sensitivity towards chemical 
current potentiation of heteromeric channels (Leitner et al., 2012; Supplemental Figure 5). As 
previously reported, current amplitudes through heteromeric channels were increased and 
activation kinetics were accelerated compared to homomeric KCNQ4 wt channels (Kubisch et al., 
1999). However, the voltage-dependence of the heteromers was not altered (Leitner et al., 2012; 
Supplemental Figure 5). Also the sensitivities towards chemical KCNQ channel openers was not 
different from KCNQ4 wt channels, indicating that co-assembly of KCNQ4 together with KCNQ3 
does not explain the unusual pharmacological properties of IK,n (Leitner et al., 2012).  
Taken together, although the PI sensitivity of IK,n suggested the co-expression of KCNQ3 
subunits, the pharmacological properties of IK,n argued against the presence of KCNQ3 subunits 
in OHCs. Thus, the molecular nature of IK,n remains unknown. 
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3.6 Development of Novel Tools to Experimentally Alter PI Levels in Living Cells 
Ciona intestinalis VSP (Ci-VSP) is a voltage-sensing phosphatase that exhibits PI(3,4,5)P3 and 
PI(4,5)P2 5-phosphatase activity upon membrane depolarisation (Murata et al., 2005; Iwasaki et 
al., 2008; Halaszovich et al., 2009). The PD of Ci-VSP shows high homology to the tumour 
suppressor PTEN, a 3-phosphatase (Maehama and Dixon, 1998; Okamura and Dixon, 2011). We 
constructed a chimera of PTEN coupled to the voltage sensor of Ci-VSP, termed Ci-VSPTEN. 
The substrate specificity of the chimera was characterised in whole cell voltage clamp 
experiments together with TIRF microscopy utilising fluorescent PI sensors (Lacroix et al., 2011). 
I found PI(3,4,5)P3 and PI(3,4)P2 3-phosphatase activity of Ci-VSPTEN fully reproducing the 
substrate specificity of wt PTEN (Lacroix et al., 2011; Figure 1). Voltage-dependent enzymatic 
activity was conferred by a phosphoinositide binding motif in the linker between the VSD and PD, 
as shown by mutations inside the motif that functionally uncoupled the VSD from phosphatase 
activity (Lacroix et al., 2011; Figure 5).  
Taken together, we engineered a novel voltage-dependent 3-phosphatase by conferring voltage-
sensitivity to an otherwise cytoplasmic enzyme. These findings promise future design of voltage-
dependent phosphatases with desired substrate specificity. VSPs can be used to elucidate the PI 
dependence of ion channels in their native environment. Thus, future studies will utilise designed 
and native VSPs to analyse the PI-dependence of IK,n/KCNQ4 channel gating in OHCs. 
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4 Discussion 
4.1 Biophysical and Pharmacological Differences of IK,n and Recombinant KCNQ4: 
Implications for the Molecular Identity of IK,n 
Strong evidence indicates that KCNQ4 channel subunits mediate IK,n in OHCs (Kharkovets et al., 
2006). However, native and recombinant currents show different biophysical characteristics. Most 
obviously IK,n, activates at more negative potentials than recombinant KCNQ4, the activation 
kinetics of IK,n are faster and IK,n displays less sensitivity to chemical current inhibition (Mammano 
and Ashmore, 1996; Kubisch et al., 1999; Marcotti and Kros, 1999). The molecular explanation 
for these unique properties remains elusive. Here, I extend the knowledge to the PI dependence 
and to the sensitivity towards current augmentation by chemical KCNQ openers (Leitner et al., 
2011; Leitner et al., 2012). 
Intracellular application of AGs inhibited IK,n and heterologous KCNQ4 currents by depletion of 
PI(4,5)P2 (Leitner et al., 2011). The sensitivity of IK,n to AG-induced current inhibition was 
intermediate between recombinant KCNQ4 and KCNQ3. These findings suggested intermediate 
PI(4,5)P2 dependence of IK,n between KCNQ4 with low affinity and KCNQ3 with high affinity (Li et 
al., 2005). Since co-assembly of KCNQ channel subunits with low and high PI(4,5)P2 affinity (e.g. 
KCNQ2/3) produced tetrameric channels with intermediate affinity (Hernandez et al., 2008; 
Hernandez et al., 2009), the PI affinity of IK,n suggests the co-assembly of KCNQ4 with KCNQ3 or 
another yet unknown K+ channel subunit with high PI(4,5)P2 affinity. Indeed, KCNQ3 has been 
identified on transcript level in OHCs and has been reported to co-assemble with KCNQ4, but 
evidence for functional KCNQ3 protein is still missing (Kubisch et al., 1999; Beisel et al., 2000; 
Kharkovets et al., 2000; Kharkovets et al., 2006). Although KCNQ3/KCNQ4 may explain the 
PI(4,5)P2 dependence of IK,n, such heteromers failed to reproduce the voltages of activation of IK,n 
(Kubisch et al., 1999; Leitner et al., 2012). Further work may include the specific knock-down of 
KCNQ3 channel subunits in OHCs to elucidate the presence of functional KCNQ3 in the native 
hair cell channel complex. 
My findings also showed that the pharmacological profile of IK,n differs from recombinant KCNQ4 
(Leitner et al, 2012). Thus, current potentiation and the activation shift to hyperpolarised voltages 
by ZnP/Ret were less pronounced for IK,n than for heterologously expressed KCNQ4 (Leitner et 
al., 2012). Most strikingly, BMS-204352 failed to augment IK,n despite robust increase of currents 
through recombinant KCNQ4. The reason for the lower sensitivity of IK,n may be one of the 
following: First, OHC-specific mechanisms produce an IK,n channel complex by posttranslational 
modification or special subunit composition that is less sensitive to current augmentation by 
KCNQ openers than homomeric KCNQ4. The OHC-specific mechanism and KCNQ channel 
openers may change the biophysical properties of KCNQ4 via a similar molecular mechanism, 
which occludes further current potentiation by the openers. It has been reported that the zinc 
pyrithione sensitivity of KCNQ1 in complex with the accessory β-subunit KCNE1 was strongly 
reduced, since the molecular determinant of current potentiation was already occupied by the β-
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subunit (Gao et al., 2008). Similarly, in OHCs the sensitivity of IK,n may be reduced by additional 
yet not identified interaction partners (Kubisch et al., 1999; Kharkovets et al., 2006). Since 
KCNQ3 shows lowest sensitivity towards chemical current potentiation, co-assembly of KCNQ3 
with KCNQ4 may also explain the low sensitivity of IK,n. However, KCNQ3/4 heterotetramers 
failed to reproduce the sensitivity of IK,n again indicating that KCNQ3 may rather not be present in 
OHCs (Leitner et al., 2012). Second, one explanation for the different sensitivities may be derived 
from the molecular mechanism of current augmentation by the openers. KCNQ agonists have 
been shown to increase KCNQ-mediated currents via an increase of the channel open probability 
(Xiong et al., 2007). The low open probability of recombinant KCNQ4 under control conditions 
thus allows for the dramatic current potentiation by the openers (Tatulian et al., 2001; Xiong et al., 
2008). Indeed, KCNQ4 in presence of ZnP/Ret closely resembles native IK,n (Leitner et al., 2012). 
This strongly suggests high resting open probability of IK,n that limits maximal possible current 
potentiation by the openers. However, the open probability of IK,n at saturating voltages is not 
known, but once elucidated it will allow the evaluation of the maximal current augmentation that 
can be achieved by KCNQ openers.  
Taken together, my findings add to the biophysical differences of IK,n and KCNQ4. These findings 
showed that "KCNQ-like" features such as the PI dependence and chemical current 
augmentation of IK,n are markedly different from recombinant KCNQ4, but the OHC-specific 
mechanism remains elusive and requires further work. An interesting aspect is whether this 
mechanism is specific for KCNQ4, i.e. OHC-specific interaction partners specifically alter the 
voltage range of activation of KCNQ4 in OHCs. Further work will thus focus on the presence of 
specific interaction KCNQ4 partners in OHCs (see 4.4: Outlook).  
Since IK,n exhibits larger current amplitudes and markedly different voltage sensitivity, it is likely 
that the pore structure of IK,n is altered compared to KCNQ4. Tetraethylammonium (TEA) potently 
inhibits K+ channels via subunit specific binding to the pore domain of the tetrameric channel. 
Accordingly, TEA and chemically related substances were used to test the pore structure of K+ 
channels repeatedly (e.g. Piechotta et al., 2011). Strikingly, decreased TEA sensitivity of IK,n was 
reported compared to recombinant KCNQ4 (Marcotti and Kros, 1999), strongly suggesting altered 
architecture of the channel's pore in OHCs. Since in the tetrameric channel all subunits contribute 
to the structure of the pore, lower TEA sensitivity of IK,n thus suggests the presence of additional 
K+ channel subunits in the native channel complex. Accordingly, future studies will investigate the 
TEA sensitivity of IK,n. 
4.2 The Role of IK,n Inhibition in AG-induced Hair Cell Loss 
I showed for the first time that AG antibiotics rapidly entered into hair cells from the extracellular, 
endolymphatic side and inhibited the predominant K+ conductance in OHCs (Leitner et al., 2011). 
Given robust depolarisation caused by this inhibition and the established importance of IK,n for the 
survival of OHCs, it seems likely that AG-induced inhibition of IK,n contributes to AG-induced OHC 
degeneration (Nouvian et al., 2003; Kharkovets et al., 2006). This idea is well supported by the 
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fact that hair cells exhibit the same vulnerability towards AGs as to KCNQ4 dysfunction, 
highlighted by the phenotypical similarities of AG-induced OHC degeneration with KCNQ4-related 
hair cell loss (Kharkovets et al., 2006; Rybak and Ramkumar, 2007). Among different hair cell 
types in the inner ear IK,n/KCNQ4 provides the predominant K+ conductance only in OHCs and 
this cell type is most susceptible to AG-induced degeneration (Housley and Ashmore, 1992; 
Forge and Schacht, 2000; Kharkovets et al., 2006). Loss of KCNQ4 channel function causes 
specific OHC degeneration, whereas IHCs and vestibular hair cells remain widely unaffected 
(Kharkovets et al., 2006). Moreover, the varying vulnerability of OHCs along the cochlear axis 
also matches well with the appearance of KCNQ4 with higher current densities and expression 
levels in basal, highly susceptible OHCs than in apical OHCs (Beisel et al., 2000; Beisel et al., 
2005; Kharkovets et al., 2006). Since the involvement of reactive oxygen species or mitochondrial 
dysfunction in AG-induced hair cell loss is well established (Jiang et al., 2006b; Rybak and 
Ramkumar, 2007), we do not believe that the mechanism presented here is the major cause for 
hair cell loss. However, it is plausible that AG-induced IK,n inhibition contributes to hair cell 
degeneration. We hypothesise that the dependence of OHC survival from KCNQ4 and the 
inhibition of the conductance by AGs may explain the high susceptibility of OHCs towards 
ototoxic insult (Leitner et al., 2011). Additionally, our findings may explain differences in the 
ototoxic potential of various AGs. Neomycin is more ototoxic for hair cells in the organ of Corti 
than kanamycin, whereas gentamicin mainly affects vestibular hair cells (Forge and Schacht, 
2000). Indeed, the detrimental potential correlated well with the PI chelating efficiency of each AG 
and the potency of IK,n current inhibition (Leitner et al., 2011). Thus, the chemical nature of the 
substance and the resulting degree of IK,n current inhibition may determine the ototoxic potential 
of AGs. However, the mechanisms leading to hair cell degeneration may be different for OHCs 
and vestibular hair cells, without the involvement of the KCNQ conductance in the vestibular 
system. 
4.3 Potential Use of KCNQ Openers to Protect from KCNQ4-related Hearing Loss 
Since KCNQ4 channel dysfunction causes OHC degeneration, rescue of IK,n by chemical openers 
may protect from OHC loss and thus from deafness (Kharkovets et al., 2006). We showed that 
IK,n was sensitive to chemical augmentation by KCNQ agonists (Leitner et al., 2012). Finally, the 
most important question remains: Can KCNQ channel openers protect OHCs from KCNQ4-
related degeneration?  
KCNQ4 knock-out mice suffer from progressive degeneration of OHCs and thus progressive 
hearing loss, suggesting a similar phenotype in DFNA2 patients with KCNQ4 loss-of-function 
mutations (Kharkovets et al., 2006). Interestingly, small residual IK,n currents in a dominant-
negative mouse model with a heterozygous KCNQ4 mutation were sufficient to delay hair cell 
degeneration and hearing loss significantly (Kharkovets et al., 2006). Thus, it is likely that even 
moderate current potentiation by chemical channel openers alleviates KCNQ4-related OHC 
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degeneration. However, the benefits of IK,n potentiation may be different for patients treated with 
AGs or humans carrying a DFNA2 mutation. 
Due to slow turn-over AGs accumulate in hair cells which initiates OHC degeneration even 
months after the treatment with the drugs (Forge and Schacht, 2000; Rybak and Ramkumar, 
2007). Thus, the critical period for OHCs comprises the time during the treatment with the drugs 
and some months afterwards. Accordingly, stabilisation of IK,n may be needed during this time 
only. Since retigabine is already in clinical use and no side-effects have been reported, such 
treatment does not bear any risk for the patient. Thus, we propose concomitant treatment of 
retigabine with AGs over the critical period until hair cells are cleared from the AGs. This may 
serve as a protective strategy to alleviate OHC degeneration AGs by activation of IK,n. Similarly, 
the up-regulation of neuronal K+ channels is believed to alleviate neuronal damage under 
pathological conditions (Czuczwar et al., 2011). Of course, such treatment needs to be tested in 
adequate cell culture and animal models first, but we think that it may provide a yet unknown 
protective strategy against KCNQ-related OHC degeneration (see 4.4). 
In DFNA2-affected humans the situation is somewhat different. To our knowledge, most DFNA2 
patients are heterozygous carriers of KCNQ4 mutations (Smith and Hildebrand, 2008). In these 
patients IK,n currents are reduced by a dominant-negative effect, which drastically decreases the 
amount of functional channels at the membrane (Kubisch et al., 1999; Holt et al., 2007). For 
recombinant KCNQ4 we essentially rescued the remaining currents back to control levels, and we 
expect current potentiation of remaining channels also in OHCs (Leitner et al., 2012). We believe 
that even slight IK,n current increase by chemical openers may significantly postpone hearing loss 
in DFNA2 patients. However, such treatment may require life-long treatment with KCNQ openers 
(e.g. retigabine) and it is not yet known to what extend the substances prevent KCNQ4-related 
OHC degeneration.  
4.4 Outlook 
The work presented here offers new insight into the physiology and pathophysiology of the 
predominant K+ conductance of OHCs, IK,n. My findings raise a couple of interesting questions: 
The first concerns the actual PI(4,5)P2 dependence of the native conductance. So far, we only 
estimated the PI dependence of IK,n by intracellular dialysis of AGs that globally deplete cellular 
PIs. Graded PI depletion using voltage-dependent phosphatases with specific PI phosphatase 
activity should allow for a substantially improved determination of the PI affinity of the channel 
(Halaszovich et al., 2009). Such experiments require the over-expression of voltage-dependent 
phosphatases (e.g. Ci-VSP, Ci-VSPTEN) in OHCs. Low transfection efficiency can be overcome 
with viral transduction that already has been used successfully on OHCs (Holt et al., 2007; 
Schaechinger et al., 2011). Accordingly, future work may include the design of viral constructs 
and the production of virus particles for the transduction of OHCs with genetically-encoded PI-
manipulating enzymes and subsequent electrophysiological recordings from infected OHCs.  
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Second, as shown for other members of the KCNQ channel family, IK,n may be modulated by 
synaptic input (e.g. from the olivo-cochlear cholinergic system) (Brown and Adams, 1980; Wang 
et al., 1998; Shapiro et al., 2000; Suh and Hille, 2002). This may include IK,n current inhibition 
through G-protein coupled receptors and phospholipase C-mediated PI(4,5)P2 depletion. 
Muscarinic receptors have been shown to be expressed in OHCs (Khan et al., 2002), but the 
efferent modulation of IK,n has never been investigated. This work will substantially improve the 
understanding of the physiological regulation of IK,n in OHCs 
Third, it remains elusive whether KCNQ agonists rescue OHCs from KCNQ4-related 
degeneration also in vivo. We showed that KCNQ agonists rescued KCNQ4 from dominant-
negative inhibition by mutant subunits at least in an expression system (Leitner et al., 2012). 
Although these results seemed promising, evidence for in vivo protection of OHCs is still missing. 
Future work will investigate whether chemical KCNQ openers alleviate hearing loss in a 
dominant-negative KCNQ4 mouse model and whether the substances rescue OHCs isolated 
from these and from KCNQ4 knock-out mice (Kharkovets et al., 2006). Additionally, it will be 
interesting to see whether KCNQ agonists reduce OHC degeneration in cultured organs of Corti 
treated with AG antibiotics. 
Fourth, the molecular nature of IK,n still needs to be determined. Because other KCNQ isoforms 
differ from KCNQ4 in terms of sequence homology and possible interaction partners, it is likely 
that the OHC-specific environment does not affect these subunits. Thus, a promising strategy to 
identify OHC-specific interaction partners might be the transfection of KCNQ subunits into OHCs 
of KCNQ4 knock-out mice. This will produce currents either resembling IK,n or heterologously 
expressed KCNQ channels. Transfection of chimeric proteins of KCNQ4 with different parts of a 
KCNQ subunit that is not affected by the OHC environment may identify amino acid sequences 
necessary for the restoration of IK,n. These protein stretches will be used to identify interaction 
partners of KCNQ4 in OHCs. In any case, further work is needed to unravel the OHC-specific 
mechanism that determines the biophysical properties of IK,n.  
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ABSTRACT
Aminoglycoside antibiotics (AGs) are severely ototoxic. AGs
cause degeneration of outer hair cells (OHCs), leading to profound
and irreversible hearing loss. The underlying mechanisms are not
fully understood. OHC survival critically depends on a specific K
conductance (IK,n) mediated by KCNQ4 (Kv7.4) channels. Dys-
function or genetic ablation of KCNQ4 results in OHC degenera-
tion and deafness in mouse and humans. As a common hallmark
of all KCNQ isoforms, channel activity requires phos-
phatidylinositol(4,5)bisphosphate [PI(4,5)P2]. Because AGs are
known to reduce PI(4,5)P2 availability by sequestration, inhibition
of KCNQ4 may be involved in the action of AGs on OHCs. Using
whole-cell patch-clamp recordings from rat OHCs, we found that
intracellularly applied AGs inhibit IK,n. The inhibition results from
PI(4,5)P2 depletion indicated by fluorescence imaging of cellular
PI(4,5)P2 and the dependence of inhibition on PI(4,5)P2 availability
and on PI(4,5)P2 affinity of recombinant KCNQ channels. Likewise,
extracellularly applied AGs inhibited IK,n and caused substantial
depolarization of OHCs, after rapid accumulation in OHCs via a
hair cell-specific apical entry pathway. The potency for PI(4,5)P2
sequestration, strength of IK,n inhibition, and resulting depolariza-
tion correlated with the known ototoxic potential of the different
AGs. Thus, the inhibition of IK,n via PI(4,5)P2 depletion and the
resulting depolarization may contribute to AG-induced OHC de-
generation. The KCNQ channel openers retigabine and zinc pyri-
thione rescued KCNQ4/IK,n activity from AG-induced inhibition.
Pharmacological enhancement of KCNQ4 may thus offer a pro-
tective strategy against AG-induced ototoxicity and possibly other
ototoxic insults.
Introduction
Aminoglycoside antibiotics (AGs) are highly efficient in the
treatment of infections caused by Gram-negative bacteria,
but clinical use is restricted by severe ototoxic side effects
(Forge and Schacht, 2000; Rybak and Ramkumar, 2007). The
hearing loss induced by clinical doses of AGs results from
degeneration of OHCs and is therefore profound and irre-
versible. Inner hair cells (IHCs) show little vulnerability to
AGs, and susceptibility of OHCs shows a marked cochlear
base-to-apex gradient. Basal, high-frequency OHCs are most
sensitive, which leads to initial high-frequency hearing loss
that proceeds to lower frequencies with continued adminis-
tration of AGs (Fausti et al., 1984). AG-induced ablation of
OHCs is also widely used to study hair cell regeneration in
animal models. However, the underlying mechanisms are not
fully understood, and the basis of the differential suscepti-
bility of hair cells remains elusive.
Hair cell damage occurs after the uptake of AGs from the
endolymph via endocytosis or mechanoelectrical transduction
(MET) channels (Hashino and Shero, 1995; Marcotti et al.,
2005). After entry, AGs seem to initiate multiple pathways,
leading to necrotic or apoptotic cell death. These pathways may
involve caspase-dependent and -independent signals (Jiang et
al., 2006a), formation of reactive oxygen species (Rybak and
Ramkumar, 2007), mitochondrial dysfunction (Dehne et al.,
2002), and disruption of phosphoinositide homeostasis (Jiang et
al., 2006b; Goodyear et al., 2008). In addition, it is known that
AGs interact with phosphoinositides via strong electrostatic
interactions and can thereby functionally deplete these phos-
pholipids (Gabev et al., 1989).
OHC function is directly linked to phosphoinositide metab-
olism, because the major K current of OHCs, IK,n, is medi-
ated by KCNQ4 (Kv7.4) channels (Kubisch et al., 1999;
Kharkovets et al., 2000, 2006). Activity of all KCNQ isoforms,
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including KCNQ4, essentially depends on PI(4,5)P2 (Li et al.,
2005; Suh et al., 2006). Strikingly, IK,n/KCNQ4 activity is
essential for OHC survival. Pharmacological block and ge-
netic ablation of KCNQ4 result in OHC degeneration and
hearing loss (Nouvian et al., 2003; Kharkovets et al., 2006).
Remarkably, this degeneration totally resembles AG-induced
outer hair cell loss, starting at the cochlear basis and pro-
ceeding to the apex. Mutations of KCNQ4 underlie the hu-
man hereditary deafness, DFNA2, further highlighting the
importance of KCNQ4 for hair cell maintenance (Kubisch et
al., 1999; Kharkovets et al., 2000).
Bringing together the knowledge on KCNQ channel regu-
lation, interaction of AGs with phosphoinositides, and depen-
dence of OHC survival on KCNQ4 leads to the idea that IK,n
may be a primary molecular target of ototoxic AGs. Given the
important implications for the etiology of AG-induced hair
cell loss, we analyzed the effect of AGs on OHC currents and
recombinant KCNQ4. We find that both are inhibited by
intracellular AGs. Imaging of PI(4,5)P2 concentrations, ex-
perimental manipulation of PI(4,5)P2 levels, and differential
responses of KCNQ isoforms with different PI(4,5)P2 affini-
ties indicate that this inhibition results from depletion of free
PI(4,5)P2. Moreover, entry of AGs into OHCs through stereo-
ciliary MET channels is sufficient to substantially block IK,n
and to depolarize the hair cell. Thus, inhibition of IK,n may
contribute to AG ototoxicity.
Materials and Methods
Acute Organ of Corti Preparation. Animals were kept accord-
ing to German law and institutional guidelines at the Philipps Uni-
versity (Marburg, Germany). Apical cochlear turns of Wistar rats
(12–20 days after birth) were isolated as described previously (Oliver
et al., 2000). The preparation was placed in a recording chamber and
continuously perfused with standard extracellular solution contain-
ing 144 mM NaCl, 5.8 mM KCl, 1.3 mM CaCl2, 0.9 mM MgCl2, 0.7
mM NaH2PO4, 10 mM HEPES, and 5.6 mM D-glucose, pH 7.4 (ad-
justed with NaOH), 305 to 310 mOsmol/kg. Experiments were per-
formed within 3 h after the preparation.
Cell Culture and Transfection. Chinese hamster ovary (CHO)
cells were platted on glass coverslips and transfected with jetPEI
(Polyplus Transfection, Illkirch, France). The following expression
vectors were used: pEGFP-C1-KCNQ4 (NM_004700.2); pBK-
CMV-KCNQ3 (NM_004519.2) (plus pEGFP for identification of
transfected cells); and pEGFP-C1-tubby-Cterm (NP_068685.1,
amino acids 243–505) pRFP-C1-PI(4)P-5 kinase (NM_008846.1). Ex-
periments were performed 24 to 48 h after transfection.
Electrophysiological Recordings from OHCs and CHO
Cells. Whole-cell recordings were done with an Axopatch 200B am-
plifier (Molecular Devices, Sunnyvale, CA) in voltage-clamp or cur-
rent-clamp mode. Data were sampled with an ITC-18 interface
(HEKA, Lambrecht/Pfalz, Germany) controlled by PatchMaster soft-
ware (HEKA). Currents were low pass-filtered at 2 kHz and sampled
at 5 kHz. Patch pipettes were pulled from quartz glass to an open
pipette resistance of 1.5 to 3 M when filled with intracellular
solution containing 135 mMKCl, 2.41 mMCaCl2 (free Ca
2, 0.1 M),
3.5 mM MgCl2, 5 mM HEPES, 5 mM EGTA, and 2.5 mM Na2ATP,
pH 7.3 (adjusted with KOH), 290 to 295 mOsmol/kg. In some exper-
iments, neomycin trisulfate, kanamycin disulfate, G418 (Geneticin)
disulfate, or poly(D-lysine) hydrobromide (molecular weight, 1000–
4000) (all from Sigma-Aldrich, Munich, Germany) was added to the
intracellular solution at the concentrations indicated under Results.
Series resistance (RS) was less than 10 M, and RS compensation
(80–90%) was applied. For perforated patch-clamp experiments, pi-
pettes were pulled from borosilicate glass to an open pipette resis-
tance of 1.5 to 3 M. Pipettes were tip-filled with standard intracel-
lular solution and then back-filled with the same solution containing
120 g/ml Nystatin (Sigma-Aldrich). RS was less than 22M, and RS
compensation (75%–80%) was applied.
Experiments were performed on OHCs of the third row. Access
to the basolateral membrane was achieved by gently removing
adjacent supporting cells with a suction pipette. Only OHCs with
visually intact stereocilia and a membrane potential more nega-
tive than 69 mV were used. Neomycin trisulfate, kanamycin
disulfate, 10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone di-
hydrochloride (XE991), zinc-pyrithione (all purchased from Sig-
ma-Aldrich), and retigabine (kindly provided by Neurosearch,
Ballerup, Denmark) were added to the extracellular solution at
the concentrations indicated under Results and applied locally via
a glass capillary. All experiments were performed at room tem-
perature. Membrane potentials shown are not corrected for liquid
junction potential (4 mV).
Total Internal Reflection Imaging. Total internal reflection
(TIRF) microscopy was performed as described previously
(Halaszovich et al., 2009). In brief, experiments were performed
using a BX51WI upright microscope (Olympus, Hamburg, Germany)
equippedwith a TIRF condensor (numerical aperture of 1.45; Olympus)
and a 488 nm laser (20 mW; Picarro, Sunnyvale, CA). Fluorescence
was imaged by a LUMPlanFI/IR 40X/0.8 water immersion objective
(Olympus). Fluorescence was acquired with an IMAGO-QE cooled
charge-coupled device camera controlled by TILLvisION software
(TILL Photonics, Gra¨felfing, Germany). CHO cells transiently ex-
pressing Tubby-Cterm-GFP (Santagata et al., 2001; Halaszovich et
al., 2009) were simultaneously imaged and voltage-clamped. Exper-
iments were included for analysis when the access resistance was
less than 5 M to ensure consistent and rapid dialysis of AGs. F/F0
traces were calculated from the background-corrected TIRF signal
(F) and initial fluorescence intensity (F0), averaged over the footprint
of the patch-clamped cell excluding cell margins to avoid movement
artifacts.
Aminoglycoside Labeling and Confocal Microscopy. Gen-
tamicin and neomycin (both from Sigma-Aldrich) were conjugated
with Texas Red (TR) according to published protocols (Sandoval et
al., 1998). In brief, gentamicin sulfate or neomycin trisulfate (both
50 mg/ml in 100 mM K2CO3, pH 8.5) were agitated with Texas
Red-X succinimidyl ester (TR; Invitrogen, Carlsbad, CA) at a
molar ratio of 330:1 for 36 h at 4°C (final AG concentration, 50
mM; final TR, concentration 0.150 mM). As a control, TR was
diluted in 100 mM K2CO3, pH 8.5, and processed accordingly. The
obtained gentamicin-Texas Red (GTTR) and neomycin-Texas Red
(NTR) conjugates were diluted (1:50) to final concentrations of 1
mM with standard extracellular solution. Control TR solution was
diluted accordingly to obtain equal concentrations of the fluores-
cent dye in control experiments (1:50). For some experiments,
NTR was diluted in extracellular solution containing 144 mM KCl,
5.8 mM NaCl, 1.3 mM CaCl2, 0.9 mM MgCl2, 0.7 mM NaH2PO4, 10
mM HEPES, and 5.6 mM D-glucose, pH 7.4 (adjusted with NaOH),
305 to 310 mOsmol/kg.
Confocal live-cell imaging was performed with an upright LSM
710 Axio Examiner.Z1 microscope equipped with a W Plan/Apochro-
mat 20/1.0 DIC M27 75-mm water immersion objective (Carl Zeiss
GmbH, Jena, Germany). Texas Red was excited at 561 nm with a
diode-pumped solid-state laser (Carl Zeiss), and fluorescence
emission was sampled at 565 to 609 nm. All preparations were
imaged with the same laser power and gain settings. Fluorescence
was averaged from regions of interest at various levels of OHCs,
background-corrected, and is presented normalized to the initial
background fluorescence F0 at the beginning of an experiment.
Data Analysis and Statistics. Electrophysiological data were
analyzed using PatchMaster (HEKA) and IGOR Pro (Wavemetrics,
Lake Oswego, OR). Recombinant KCNQ current amplitudes were
derived from monoexponential fits to current activation at 0 mV. IK,n
was activated at a holding potential of 60 mV, and the current was
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quantified as the XE991-sensitive tail current amplitude from this
holding potential at 130 mV and corrected for leak current remain-
ing after channel deactivation. Different voltage protocols were used
for recombinant KCNQ4 and IK,n to account for the large difference
in their activation voltage ranges (Kubisch et al., 1999; Marcotti and
Kros, 1999).
Fluorescence time series were analyzed using TILLvisION (TILL
Photonics), Zen 2009 (Carl Zeiss), ImageJ (http://rsbweb.nih.gov/ij/),
and Igor Pro (Wavemetrics).
Statistical analysis was performed with (paired) t test, and signif-
icance was assigned at P  0.05. Data are presented as mean 
S.E.M., with n representing the number of independent experiments
(individual cells).
Results
Inhibition of IK,n and KCNQ4 by Intracellular Ami-
noglycosides. Because hair cell degeneration occurs after
the entrance and cytoplasmic accumulation of AGs (Hiel et
al., 1993; Hashino and Shero, 1995), we first analyzed the
effects of intracellular AGs on IK,n by introducing AGs
through the patch pipette. IK,n current amplitude was mea-
sured as the deactivating tail current at 130 mV sensitive
to the KCNQ channel blocker XE991 (Fig. 1A), showing that
the used voltage protocol is qualified to monitor the KCNQ
conductance in OHCs.
After the establishment of the whole-cell configuration,
KCNQ4-mediated currents rapidly decreased by approxi-
mately 60% of initial amplitude, when the prototypical AG,
neomycin (1 mM) was included in the pipette solution (Fig. 1,
B and C). In contrast, only minor channel rundown was
observed in the absence of neomycin (Fig. 1D). These results
indicate the inhibition of IK,n by neomycin entering the cell.
As shown in Fig. 1F, patching OHCs with various neomycin
concentrations yielded dose-dependent inhibition of IK,n with
a half-blocking concentration of 0.59 mM. XE991-insensitive
K currents in OHCs that are not carried by KCNQ channels
were not affected by neomycin (Supplemental Fig. S1).
Other AG antibiotics were also tested for their effect on
IK,n. Both G418 (an AG that is similar in structure to genta-
micin) and kanamycin inhibited IK,n, albeit with lower po-
tency than neomycin (35 and 30% at 1 mM, respectively; Fig.
1, E and G). Poly(D-lysine) (200 g/ml), another polycationic
molecule, which is structurally unrelated to AGs, strongly
inhibited IK,n when applied via the pipette (Fig. 1G). In
contrast, ampicillin, a structurally unrelated antibiotic that
lacks net positive charge, had no effect on IK,n. These findings
suggest that the polycationic nature of AGs is essential for
the inhibiting effect on IK,n. The rapid time course of inhibi-
tion suggested an immediate action of AGs on the channels
rather than involvement of intracellular signaling pathways
that have been implicated in AG action.
We therefore examined the interaction of AGs with
KCNQ4 in a simple recombinant system. Whole-cell voltage-
clamp experiments were done on CHO cells heterologously
expressing KCNQ4. The introduction of neomycin via the
patch pipette robustly inhibited KCNQ4 currents (Fig. 2, B
and E). Sensitivity toward neomycin was somewhat higher
than observed in hair cells, yielding a half-inhibiting concen-
tration of 0.13 mM (Fig. 2D). Similar to native IK,n, G418,
Fig. 1. Intracellular aminoglycoside antibiotics inhibit IK,n.
A, IK,n, measured from rat OHCs as the deactivating in-
ward tail current upon hyperpolarization (voltage com-
mand as indicated). Complete block by application of
XE991 identifies this current as being carried by KCNQ
channels. B, time course of current amplitude after estab-
lishment of whole-cell configuration in the absence (black)
and presence (red) of neomycin in the pipette solution.
Traces are representative recordings obtained from two
different OHCs. Currents are presented normalized to the
amplitude immediately after patch rupture (I0). C, D, and
E, representative currents immediately (black) and 10 min
after (colored) patch rupture obtained with pipette solu-
tions containing neomycin (C), no aminoglycosides (control;
D) or kanamycin (E). Scale bars apply to A, C, D, and E. F,
dose-dependent inhibition of IK,n by intracellular neomycin
measured as in C. Continuous line shows a fit with the Hill
equation, yielding an IC50 of 0.59 mM and a Hill coefficient
of 1.3. G, steady-state inhibition of IK,n by various antibi-
otics and polycations. Neo, neomycin; Gen, G418; Kana,
kanamycin; poly-K, poly(D-lysine); Amp, ampicillin. Num-
bers of experiments are indicated. ; P  0.01; , P 
0.001.
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kanamycin, and poly(D-lysine) also inhibited recombinant
KCNQ4, whereas ampicillin was ineffective (Fig. 2E). The
order of sensitivities toward these polycations was the same
obtained from hair cells, suggesting the same mechanism of
inhibition for IK,n and recombinant KCNQ4.
Aminoglycosides Interfere with the Availability of
PI(4,5)P2 to Channels. It is well established that neomycin
and poly(D-lysine) bind PI(4,5)P2 via electrostatic interaction
with the anionic head groups (Gabev et al., 1989), thereby
effectively chelating these lipids. Because activity of all
KCNQ channels requires binding of PI(4,5)P2, inhibition of
IK,n may result from reduced availability of PI(4,5)P2 to the
channels. Indeed, sequestration by polycations has been used
previously to define the role of phosphoinositides in the reg-
ulation of ion channels (Oliver et al., 2004; Suh and Hille,
2007).
To address the involvement of PI(4,5)P2 in AG-induced
inhibition of IK,n/KCNQ4, we first examined the ability of
AGs to effectively deplete free PI(4,5)P2 under our experi-
mental conditions. To this end, we used a genetically encoded
sensor for PI(4,5)P2, the GFP-fused C terminus of the tubby
protein (tubby-Cterm) (Santagata et al., 2001; Halaszovich et
al., 2009). The degree of binding of this protein domain to the
plasma membrane is a direct measure for the concentration of
free PI(4,5)P2. We measured membrane association of Tubby-
Cterm using total internal reflection (TIRF) microscopy as de-
scribed previously (Halaszovich et al., 2009). In brief, TIRF was
used to selectively excite GFP bound to the plasma membrane,
such that the obtained fluorescence signal directly reported the
amount of membrane-associated PI(4,5)P2 sensor and thus the
concentration of free PI(4,5)P2. As before, cells were dialyzed
with either neomycin or kanamycin via a patch pipette (1 mM
each). Upon the introduction of neomycin into the cell, the TIRF
signal rapidly decreased to 26% of the initial signal amplitude,
reporting full dislocation of Tubby from the membrane
(Halaszovich et al., 2009) and thus depletion of free PI(4,5)P2
(Fig. 3, A and B). In contrast, without neomycin in the pipette
(control, Fig. 3, A and B) only an initial minor reduction of
membrane fluorescence was observed, probably because of
washout and bleaching of the fluorescent probe upon rupture of
the membrane patch. Kanamycin also reduced free PI(4,5)P2
concentration (to 70%), as indicated by a decrease of membrane
fluorescence exceeding control recordings (Fig. 3, A and B).
However, the change of the TIRF signal and thus reduction
of PI(4,5)P2 concentration was significantly smaller than
that observed with the same concentration of neomycin (Fig.
Fig. 2. Inhibition of recombinant KCNQ4 channels by intracellular ami-
noglycosides. A, representative whole-cell currents recorded from a CHO
cell transiently expressing homomeric KCNQ4 channels, immediately
(top trace) and 10 min after establishment of whole-cell configuration.
Voltage protocol was performed as indicated in inset. B and C, recordings
as in A with neomycin (B) or kanamycin (C) included in the patch pipette
solution. Steady-state currents after dialysis of aminoglycosides into the
cell are indicated in color. D, dose-dependent inhibition of KCNQ4 by
intracellular neomycin measured as in B. Steady-state currents were
normalized to current amplitude immediately after patch rupture (I0) for
each cell. Fit of the Hill equation to the data set (continuous line) yields
IC50 of 0.13 mM and Hill coefficient of 1.8. E, summarized steady-state
inhibition of KCNQ4 by the various antibiotics and polycations indicated.
, P  0.001.
Fig. 3. Aminoglycosides decrease free PI(4,5)P2 in
the plasma membrane. A, combined TIRF imaging
and patch-clamp experiments on CHO cells trans-
fected with the PI(4,5)P2 sensor domain Tubby-
Cterm. Fluorescence intensity (TIRF F/F0) signifies
the degree of membrane association of the sensor,
and is shown normalized to signal intensity (F0)
before establishing whole-cell configuration (patch
rupture). Note that inclusion of neomycin and kana-
mycin in the patch pipette displaced the PI(4,5)P2
sensor from the membrane. Representative TIRF
images of Tubby-Cterm are shown at three time
points with neomycin applied via the patch pipette
(inset; scale bar, 20 m). B, averaged relative
changes in TIRF signals upon introduction of ami-
noglycosides into CHO cells. C, coexpression of a
constitutively active PI(4)P-5 kinase significantly
attenuated neomycin-induced KCNQ4 current inhi-
bition in CHO cells. Voltage-clamp experiments
were performed as in Fig. 2. D and E, differential
inhibition of homomeric KCNQ4 and KCNQ3 chan-
nels by aminoglycosides. D, whole-cell currents dur-
ing introduction of 500 M neomycin through the
patch pipette were measured and normalized as in
Fig. 2. E, steady-state inhibition of KCNQ4, charac-
terized by low PI(4,5)P2 affinity, is significantly
stronger than inhibition of KCNQ3, exhibiting high
PI(4,5)P2 affinity. ; P  0.01; , P  0.001.
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3B). Thus, the efficacy of both AGs for shielding PI(4,5)P2
corresponds to the potency of KCNQ4 channel inhibition,
consistent with the idea that inhibition results from deple-
tion of PI(4,5)P2.
If so, the degree of channel inhibition by AGs should de-
pend on the PI(4,5)P2 concentration in the plasma mem-
brane. We therefore increased PI(4,5)P2 levels in CHO cells
by coexpression of a PI(4)P-5 kinase (e.g., Li et al., 2005; Suh
and Hille, 2007). In these cells, the degree of KCNQ4 current
inhibition by neomycin (100 M) was significantly reduced
compared with control cells (Fig. 3C).
The different KCNQ channel subtypes show marked dif-
ferences in their apparent PI(4,5)P2 binding affinities. Thus,
homomeric KCNQ3 channels display a more than 50-fold
higher apparent affinity compared with KCNQ4, rendering
KCNQ4 more sensitive to PI(4,5)P2 depletion than KCNQ3
(Li et al., 2005; Hernandez et al., 2009). We therefore com-
pared the sensitivity of both channels to neomycin inhibition.
As shown in Fig. 3, D and E, neomycin inhibition matched
the channels’ PI(4,5)P2 affinity: KCNQ4 currents decreased
to 14.9  4.0% (n  6) upon diffusion of 500 M neomycin
into the cells, whereas KCNQ3 currents were only slightly
affected (reduction to 80.6  10.6%, n  6). Taken together,
these findings strongly indicate that AGs inhibit KCNQ4
channels via the sequestration of PI(4,5)P2 in the plasma
membrane.
Extracellular Aminoglycosides Inhibit IK,n in OHCs
but Not KCNQ4 in CHO Cells. In the above experiments,
we directly delivered AGs into the OHC’s cytoplasm. How-
ever, in an ototoxic insult, AGs reach the hair cells from the
endolymph (Hashino and Shero, 1995; Wang and Steyger,
2009). We thus tested whether entry of AGs from the extra-
cellular space is sufficient to induce substantial inhibition
of IK,n.
Extracellular application of neomycin (1 mM) onto OHCs
robustly inhibited IK,n to 65.8  1.6% (n  12) of preappli-
cation current amplitude. Representative current traces,
time course of current inhibition, and mean inhibition are
shown in Fig. 4, A, B, and C, respectively.
In contrast, application of kanamycin (1 mM) only slightly
diminished IK,n current amplitudes (to 87.0  2.0%, n  9).
However, this reduction was not significantly different from
the slight current rundown observed in control experiments
(to 93.4  1.1%, n  8) (Fig. 4, B and C). The current
inhibition induced by the application of neomycin was not
fully reversible, consistent with the uptake into the OHC and
intracellular retention after extracellular wash-off (Fig. 4A).
Because intracellular accumulation of AGs may be limited
under whole-cell conditions by diffusional loss into the patch
pipette, we performed additional recordings in the perforated
patch configuration, preventing any washout of neomycin.
Under perforated-patch conditions, application of neomycin
Fig. 4. Inhibition of IK,n in OHCs by extracellular amino-
glycosides. A, representative current traces of IK,n before
(left), during (middle), and after the extracellular applica-
tion of neomycin (right). B, averaged time course of current
amplitudes upon application of neomycin (1 mM, red) and
kanamycin (1 mM, blue) onto OHCs, obtained as shown in
A. C, summary of steady-state inhibition by extracellular
aminoglycosides measured either in whole-cell or perforat-
ed-patch configuration. Note that inhibition by neomycin
was significantly increased in the perforated-patch config-
uration compared with whole-cell. D, E, and F, effect of
extracellular aminoglycosides on recombinant KCNQ4
channels expressed in CHO cells. D, representative whole-
cell current traces before, during, and after application of
neomycin. E, time course of currents upon application of
neomycin. F, summary of relative steady state current am-
plitudes. Measurements were done in whole-cell configura-
tion. , P  0.05; , P  0.001.
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induced a stronger inhibition of IK,n to 54.9  3.7% (n  6)
compared with whole-cell recordings (P  0.02), as shown in
Fig. 4C. This finding is consistent with a higher degree of
intracellular accumulation of the AG and thus supports an
intracellular action of AGs on IK,n.
To further scrutinize this conclusion, we also examined the
effect of neomycin applied onto recombinant KCNQ4 chan-
nels in CHO cells, which lack the specific AG entry pathways
of hair cells (Supplemental Fig. S2). Application of neomycin
(1 mM) only slightly reduced KCNQ4 currents in a partially
reversible manner (Fig. 4, D–F). Combined with the earlier
finding of a substantially higher sensitivity of recombinant
KCNQ4 to intracellular application of AGs, this result con-
firmed that AGs inhibit KCNQ4 only after uptake into the
cell and do not considerably block channels from the extra-
cellular side.
In summary, these results suggest that AGs inhibit KCNQ4-
mediated IK,n after uptake and possibly accumulation via a hair
cell-specific specific entry pathway.
Aminoglycoside Uptake into OHCs Is Fast. Although
inhibition of IK,n by intracellular AGs is entirely consistent
with the previously described entry of AGs into OHCs, the
fast time course of current inhibition seemed surprising.
Imaging studies are consistent with fast entry of AGs (Tiede
et al., 2009); however, to our knowledge, the kinetics of AG
entry have not been examined in detail at the relevant time
scale.
Uptake of AGs into hair cells has been monitored previ-
ously using fluorescent Texas Red-derivatives of gentamicin
(GTTR) (Dai et al., 2006). We used this approach to quanti-
tatively record the entry of neomycin into OHCs in acutely
isolated organs of Corti by confocal microscopy. Incubation
with NTR or GTTR (1 mM each) for 5 min produced robust
fluorescence inside OHCs and IHC but not in supporting cells
and surrounding tissue (Fig. 5, A and B). Incubation with
Texas Red alone did not increase hair cell fluorescence (Fig.
5C), confirming that the observed accumulation results from
hair cell-specific entry of AGs but not from an unspecific
permeation of the fluorescent group.
As shown in Fig. 5D, time-resolved imaging revealed the
rapid accumulation of intracellular NTR in OHCs. Fluores-
cence increase was fastest and most pronounced in confocal
sections through the hair bundles (time constant obtained
from monoexponential fit to fluorescence increase, 69 s) and
somewhat slower in optical sections through the medial and
basal (subnuclear) regions of hair cells (281 and 241 s, re-
spectively). These findings point to AG entry into OHCs at
the level of the stereocilia and subsequent intracellular dif-
fusion to the OHC’s base, where IK,n/KCNQ4 is located
(Kharkovets et al., 2000).
AGs may enter via the hair cell’s MET channels located at
the stereociliary tips (Marcotti et al., 2005). Consequently,
apical membrane potential must contribute to the driving
force for permeation, with hyperpolarization increasing the
rate of entry of these cationic molecules. We addressed volt-
age-dependence of AG uptake by applying NTR while depo-
larizing or hyperpolarizing the cells with high or low extra-
cellular K concentrations, respectively (Fig. 5, E and F).
When NTR was applied to OHCs depolarized by 144 mM
extracellular K, cellular fluorescence increased slowly (rel-
ative increase in the subnuclear region of OHCs, 0.02 s1).
Subsequent hyperpolarization upon washout of extracellular
Fig. 5. Confocal imaging reveals rapid and voltage-dependent entry of
aminoglycosides into OHCs. A, representative differential interference
contrast (left) and confocal fluorescence (right) images of an isolated
organ of Corti from rat, after incubation with fluorescently labeled
neomycin (NTR; 1 mM) for 5 min (at room temperature). Note the
selective uptake of NTR into OHCs and inner hair cells (). The oblique
orientation of the preparation allows visualization of labeled OHC hair
bundles (filled arrow) and cell bodies (open arrow) (scale bars, 100
m). B, images as in A after application of fluorescently labeled
gentamicin (GTTR; 1 mM). C, no increase of cellular fluorescence was
detected upon application of Texas Red not conjugated to aminoglyco-
sides (TR; same TR concentration as in A and B). D, time course of
entry of NTR (1 mM) into OHCs. Fluorescence intensities were sam-
pled from confocal optical sections through hair bundles, apical region
(level of the cuticular plate), middle, and subnuclear regions of OHCs.
Application of TR did not produce any detectable increase in fluores-
cence (bottom trace). Numbers of individual OHCs analyzed are indi-
cated (from five independent preparations). E, voltage dependence of
NTR entry. Increase of OHC fluorescence during application of NTR (1
mM) was slow in depolarizing extracellular medium (144 mM KCl) and
accelerated upon exchange by repolarizing medium (5.6 mM KCl).
Note that the onset of increased entry is delayed because of the time
needed for full solution exchange in the recording chamber. F, quan-
tification of NTR uptake kinetics. Relative increase was derived from
linear fits to the fluorescence traces from single OHCs (n  51–91,
from four independent preparations). Asterisks indicate significantly
faster fluorescence increase at 5.6 mM K compared with 144 mM K.
, P  0.001.
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K resulted in acceleration of fluorescence buildup (relative
increase, 0.14 s1), indicating a strongly increased rate of
aminoglycoside entry. Note that the onset of accelerated en-
try upon hyperpolarization is delayed because of the time
needed for full exchange of the solutions inside the recording
chamber (Fig. 5E).
In conclusion, AGs rapidly enter OHCs in a voltage-depen-
dent manner, indicating permeation through MET channels.
Moreover, the kinetics of AG entry into OHCs are consistent
with the rapid inhibition of IK,n observed under similar ex-
perimental conditions.
AG-Induced Inhibition of IK,n Depolarizes OHCs.
Loss of functional KCNQ4, and therefore IK,n, results in OHC
loss. The mechanisms that couple reduced IK,n to hair cell
degeneration are not fully understood, but it seems likely
that depolarization and subsequent Ca2 overload play a
major role (Oliver et al., 2003; Kharkovets et al., 2006),
because IK,n is the principal determinant of membrane po-
tential of OHCs (Marcotti and Kros, 1999; Kharkovets et al.,
2006). Therefore, we next monitored membrane potential to
investigate the immediate consequences of AG-mediated in-
hibition of IK,n (Fig. 6).
Under control conditions, membrane potentials of OHCs
were constant during whole-cell recordings (VM change,
0.4  0.2 mV at 10 min after establishing the whole-cell
configuration; n  8). In contrast, neomycin (1 mM) depolar-
ized OHCs both when introduced via the patch pipette (by
7.0  2.4 mV; n  6) and when applied from the extracel-
lular side (5.5  1.0 mV; n  14). Fully blocking IK,n
resulted in even stronger depolarization of OHCs by 26.8 
3.4 mV (n  4), as assessed by application of the KCNQ-
specific antagonist XE991 (10 M). Kanamycin and G418
had a small, albeit not significant, depolarizing effect when
applied through the pipette, and ampicillin was entirely in-
effective. Given the presumed relevance of depolarization in
OHC degeneration upon dysfunction of KCNQ4, these find-
ings point to IK,n inhibition as a mechanism contributing to
AG ototoxicity.
Rescue of IK,n from Inhibition by Chemical KCNQ
Channel Openers. If inhibition of IK,n contributes to hair
cell loss, the reversal of current block by recently discovered
activators of KCNQ channels (Wulff et al., 2009) might pro-
vide protection against AG ototoxicity. Therefore, we exam-
ined whether KCNQ channel openers could be used to rescue
the IK,n conductance inhibited by AGs. We tested the channel
openers retigabine (Rundfeldt and Netzer, 2000) and zinc
pyrithione (ZnP) (Xiong et al., 2007). Both compounds
slightly enhanced IK,n in the presence of intracellular neo-
mycin (500 M) at concentrations of up to 10 M (Supple-
mental Fig. S3). However, combined application of retigabine
and ZnP (10 M each) robustly enhanced IK,n amplitudes
(Fig. 7A).
Fig. 6.Neomycin depolarizes OHCs. A, representative recordings of OHC
membrane potential in current clamp mode. Patch pipettes contained
either standard intracellular solution (control) or additional 1 mM neo-
mycin. The establishment of whole-cell configuration at t  0. B, sum-
mary of membrane potential changes, recorded as in A upon application
of XE991, aminoglycosides or ampicillin, either via the patch pipette or by
application through the extracellular solution as indicated. Note robust
depolarization by intracellular and extracellular neomycin. , P  0.05;
; P  0.01; , P  0.001.
Fig. 7. Rescue of IK,n currents by chemical channel openers. A, represen-
tative IK,n tail currents recorded from an OHC immediately after patch
rupture (black; control), after dialysis of neomycin from the patch pipette
into the cell (red), and during additional extracellular application of zinc
pyrithione (ZnP) and retigabine (10 M each; blue) (scale bars represent
200 pA and 50 ms). B, averaged current amplitudes, obtained as in A at
a membrane potential of 70 mV. Note the full reversal of neomycin-
induced IK,n inhibition by ZnP plus retigabine. C, mean I-V curves for IK,n,
obtained from tail currents at 130 mV and plotted as a function of
prepulse voltage. Experimental conditions correspond to A and B (n  6).
D, OHC membrane potentials measured with a pipette containing 0.5
mM neomycin shortly after establishment of whole-cell conditions, after
neomycin diffusion into the cell and during additional extracellular ap-
plication of ZnP plus retigabine (10 M each). Gray symbols signify the
recordings from individual OHCs and average potentials for each condi-
tion are shown in black. Note the reversal of aminoglycoside-induced
depolarization by the channel openers. , P  0.001.
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At a physiological membrane potential of 70 mV, the
channel activators fully recovered IK,n current to the control
amplitude before dialysis of neomycin into the OHCs (Fig. 7,
B and C). Accordingly, AG-induced depolarization was
largely reversed by the application of the channel openers
(Fig. 7D). The effects on current amplitude and membrane
potential resulted exclusively from the openers’ action on
IK,n, because increase of OHC currents was fully occluded in
the presence of the specific KCNQ channel blocker XE991
(Supplemental Fig. S4). Current enhancement by the chan-
nel openers resulted from an increase in saturating IK,n con-
ductance and from a pronounced leftward shift of the activa-
tion curve (Fig. 7D and Supplemental Fig. S5). Thus,
application of retigabine plus ZnP induced an over-recovery
of IK,n at potentials more negative than 70 mV (Fig. 7C). In
conclusion, these results show that chemical KCNQ openers
can reverse the inhibition of IK,n by AGs and stabilize the
OHC membrane potential despite AG entry.
Discussion
Inhibition of KCNQ4-Mediated IK,n via PI(4,5)P2 Se-
questration. Here, we show for the first time that AGs have
an immediate inhibiting effect on the major K conductance
of OHCs, IK,n. Moreover, we demonstrate that the mecha-
nism underlying current deactivation is the decrease of free
plasma membrane PI(4,5)P2 as a result of sequestration by
AGs. This conclusion is consistent with a recent report show-
ing that intracellular polycations, including neomycin, can
inhibit heteromeric KCNQ2/3 channels by electrostatic inter-
action with PI(4,5)P2 (Suh and Hille, 2007). Adding to the
previous work, our data strongly support this mechanism of
IK,n inhibition by directly demonstrating that AGs efficiently
bind to membrane PI(4,5)P2 using a fluorescent PI(4,5)P2
sensor, Tubby (Santagata et al., 2001). The potency of differ-
ent AGs to inhibit KCNQ4 correlates with the strength of
PI(4,5)P2 binding, derived from their efficacy in displacing
Tubby. Moreover, the susceptibility to AG-induced block of
different KCNQ channel isoforms is in agreement with their
distinct PI(4,5)P2 affinities as determined previously using
independent methods (Li et al., 2005; Hernandez et al.,
2009). IK,n seemed moderately less sensitive to the depletion
of PI(4,5)P2 induced by intracellularly applied AGs compared
with recombinant KCNQ4. Different possible explanations
may be considered. First, diffusional access of AGs to the
PI(4,5)P2 pool associated with the channels may be restricted
(e.g., by subsurface cisternae, lamellar membrane sheets
that are tightly stacked below the lateral plasma membrane).
However, the localization of KCNQ4 has only little overlap
with the membrane regions associated with cisternae
(Kharkovets et al., 2000). Second, OHCs may possess higher
basal PI(4,5)P2 concentrations than mammalian culture cells
such as CHO cells. Finally, the PI(4,5)P2 affinity of native
IK,n channels may differ from recombinant KCNQ4. Pro-
nounced differences between IK,n and recombinant channels
have been noted previously. In particular, native channels
are characterized by a strikingly more negative activation
range and faster kinetics (Kubisch et al., 1999; Marcotti and
Kros, 1999). The present data extend these differences,
suggesting a functional adjustment of KCNQ4 in OHCs
(e.g., by post-translational modification or accessory chan-
nel subunits).
Mechanism of AG Entry into Hair Cells. Inhibition of
IK,n by extracellular neomycin indicated rapid uptake into
the OHC cytosol, supporting the existence of a hair cell-
specific entry pathway for AGs. Uptake of AGs into hair cells
has been determined as the first step leading to the ototoxic
action of AGs (Forge and Schacht, 2000), and two different
mechanisms for entry of AGs into hair cells have been sug-
gested: endocytotic uptake at the apical surface (de Groot et
al., 1990; Hashino and Shero, 1995), or permeation through
the MET channels located in the stereocilia (Marcotti et al.,
2005).
Our data strongly support entry through MET channels:
the rapid inhibition of IK,n and the rapid uptake of fluores-
cent NTR are difficult to reconcile with endocytosis. More-
over, PI(4,5)P2 sequestration requires cytosolic localization of
free AGs immediately after uptake, whereas endocytosis
would deliver AGs into the lumen of organelles. Accordingly,
the increase of fluorescence was first detected in the hair
bundle, followed by slower accumulation of NTR in the apical
pole of the OHC. This indicates that the hair bundle, but not
the apical surface, is the site of AG entry. Finally, the ob-
served voltage dependence of entry is consistent with electri-
cally driven permeation.
The mode of AG entry has important implications for the
intracellular concentration that can be reached at a given
extracellular concentration. We show here that some 100 M
intracellular neomycin is required to substantially inhibit
IK,n. A comparable degree of inhibition resulted from the
application of 1 mM extracellular neomycin. However, sys-
temic administration of AGs yields lower endolymphatic con-
centrations in the micromolar range (de Groot et al., 1990;
Marcotti et al., 2005). Can this result in relevant reduction
of IK,n?
In vivo, membrane potential and endocochlear potential
provide a 150-mV electrical driving force for cation entry
into the hair cell, which allows for the generation of huge
concentration gradients. Maximum intracellular concentra-
tion is reached at electrochemical equilibrium, which is quan-
titatively described by the Nernst equation. For a tetravalent
cation such as neomycin (valence 4.5 at pH 7), the calculated
potential intracellular concentration would exceed extracel-
lular concentration by approximately 1010 at an electrical
driving force of 150 mV. Using the dihydrostreptomycin
entry rate estimated by Marcotti et al. (2005) of 0.05 fmol/h
at an extracellular concentration of 1 M, intracellular con-
centrations of several hundred micromoles may be reached
within hours. Thus, even micromolar endolymphatic concen-
trations can produce intracellular concentrations that result
in massive inhibition of IK,n. It is noteworthy that, because of
the endocochlear potential, the electrical driving force is
much larger in vivo than in the patch-clamp and imaging
experiments presented here, allowing for higher cytoplasmic
accumulation. Yet, cytoplasmic accumulation can be appre-
ciated from NTR uptake, in which intracellular NTR fluores-
cence rapidly exceeds extracellular fluorescence.
Inhibition of IK,n and AG Ototoxicity. Strikingly, the
interaction of AGs with phosphoinositides as a potential
mechanism underlying AG-induced hair cell loss was recog-
nized approximately three decades ago (Lodhi et al., 1980).
Our data now identify KCNQ4, the channel that mediates
IK,n, as a molecular target affected by AG-phosphoinositide
interaction. Other channels present in OHCs were not af-
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fected by aminoglycosides (Supplemental Fig. S1), or their
loss does not affect OHC survival (Vetter et al., 1999; Murthy
et al., 2009). Because it is well documented that IK,n is
essential for the survival of OHCs (Nouvian et al., 2003;
Kharkovets et al., 2006), it seems likely that AG-induced
inhibition of this current contributes to ototoxicity.
This idea is supported by a conspicuous correlation be-
tween the ototoxic potency of AG antibiotics and their effi-
cacy in inhibiting IK,n. Thus, neomycin exhibits higher co-
chleotoxicity than gentamicin and kanamycin in vivo and in
vitro (Lodhi et al., 1980). Likewise, vulnerability to AGs of
the different hair cell types correlates well with the expres-
sion of KCNQ4 and the requirement of KCNQ4 for cell sur-
vival. Most obviously, the highest susceptibility to damage by
AGs is found in OHCs, in which KCNQ4/IK,n provides essen-
tially all of the resting K conductance (Marcotti and Kros,
1999; Kharkovets et al., 2006). Moreover, the higher vulner-
ability of basal OHCs that results in the characteristic high-
frequency hearing loss upon administration of AGs (Fausti et
al., 1984), corresponds to a base-to-apex gradient of KCNQ4
expression (Kharkovets et al., 2000) and IK,n conductance
(Mammano and Ashmore, 1996). We have shown previously
that IHC express KCNQ4, in which it contributes to setting
the membrane potential (Oliver et al., 2003). However, IHC
function and survival do not obviously depend on this current
(Nouvian et al., 2003; Kharkovets et al., 2006). In agreement
with this difference to OHCs, IHCs are little, if at all, affected
by AGs (Forge and Schacht, 2000).
A similar correlation is found for vestibular hair cells.
Here, KCNQ4 is specifically expressed in type I but not in
type II cells (Kharkovets et al., 2000). In analogy to cochlear
hair cells, KCNQ4-expressing type I cells are more suscepti-
ble to AG-induced hair cell death (Forge and Schacht, 2000).
It remains to be shown whether KCNQ-mediated currents in
vestibular type I hair cells are inhibited by AGs and whether
KCNQ4 is required for their survival.
Despite these considerations, it seems unlikely that inhi-
bition of IK,n is the unique or predominant cause of AG-
induced hair cell loss. Detailed analyses have demonstrated
that multiple intracellular signaling pathways mediate OHC
death by necrotic and/or apoptotic mechanisms (Jiang et al.,
2006a). Considerable evidence, both from in vitro and in vivo
experiments, points to the generation of reactive oxygen spe-
cies as a major mechanism leading to AG-induced hair cell
loss (Forge and Schacht, 2000). Additional mechanisms such
as phospholipid scrambling triggered by interaction of AGs
with phosphoinositides (Goodyear et al., 2008) may contrib-
ute as well. At present, it is not known how impairment of
KCNQ4-mediated currents leads to OHC loss. However, cel-
lular depolarization may be critical, possibly by initiating
voltage-dependent Ca2 influx (Oliver et al., 2003; Khark-
ovets et al., 2006). Excessive intracellular Ca2 is involved in
triggering several signals that promote cell death (Stefanis,
2005). It is noteworthy that such Ca2-sensitive signals have
been implicated in AG-induced hair cell death, including the
activation of calpain and subsequent release of cathepsins
(Jiang et al., 2006a). Moreover, increased intracellular Ca2
can contribute to mitochondrial dysfunction, which is impli-
cated in hair cell degeneration (Dehne et al., 2002).
In conclusion, AG-induced depolarization may add to and
act cooperatively with previously identified mechanisms of
hair cell death. We propose that the dependence of outer hair
cells on KCNQ-mediated conductances may be an important
determinant of their vulnerability to AGs.
Rescue of IK,n by KCNQ Channel Openers. Given that
insufficient KCNQ4 activity leads to the degeneration of
OHCs (Nouvian et al., 2003; Kharkovets et al., 2006), strat-
egies for the prevention of current inhibition might have
important therapeutic potential. Here, we demonstrate that
the chemical KCNQ openers retigabine and zinc pyrithione
enhance IK,n in OHCs and fully reverse inhibition by AGs.
Retigabine is being evaluated for use as an anticonvulsant
drug in clinical trials (Wulff et al., 2009). In addition, poten-
tial clinical applications of retigabine and other recently
identified KCNQ channel activators include treatment of
pain and neuropsychiatric conditions (Wulff et al., 2009). Our
data suggest that KCNQ activators may be evaluated for
antagonism of AG ototoxicity. Despite the requirement of
relatively high concentrations of channel activators (10 M)
for IK,n rescue, the recent discovery and ongoing development
of further KCNQ openers (Wulff et al., 2009) seems promis-
ing with respect to compounds with improved potency for IK,n
enhancement. Moreover, the combinatorial action of different
channel openers may increase their therapeutic potential in
inner ear disease. Additive current enhancement by retigabine
and zinc pyrithione was described previously for recombinant
neuronal KCNQ2 channels (Xiong et al., 2008). The combina-
torial effect seems to result from simultaneous binding to dis-
tinct binding sites, and distinct molecular determinants for the
action of each channel opener have been identified (Xiong et al.,
2008). Because the determinant amino acid residues are fully
conserved between KCNQ2 and KCNQ4, we presume that
binding sites and mechanism of action on IK,n are the same as
identified previously for KCNQ2 channels.
We note that KCNQ4 openers might be useful in further
conditions leading to hearing loss as a result of OHC degen-
eration. It will be interesting to see whether the openers can
rescue the phenotype of human KCNQ4 mutations underly-
ing DFNA2, similar to the rescue of epileptogenic mutations
of KCNQ2 (Xiong et al., 2007). Moreover, correlations be-
tween KCNQ4 gene polymorphisms and both age-related and
noise-induced hearing loss have been found (Van Eyken et
al., 2006), suggesting that rather subtle changes in KCNQ4
expression or function may contribute to deafness. Thus,
these frequent conditions might benefit from drugs modulat-
ing KCNQ4-mediated currents. In summary, the present
data suggest that the spectrum of potential therapeutic use
of KCNQ channel activators may include hearing loss.
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BACKGROUND AND PURPOSE
DFNA2 is a frequent hereditary hearing disorder caused by loss-of-function mutations in the voltage-gated potassium channel
KCNQ4 (Kv7.4). KCNQ4 mediates the predominant K+ conductance, IK,n, of auditory outer hair cells (OHCs), and loss of
KCNQ4 function leads to degeneration of OHCs resulting in progressive hearing loss. Here we explore the possible recovery
of channel activity of mutant KCNQ4 induced by synthetic KCNQ channel openers.
EXPERIMENTAL APPROACH
Whole cell patch clamp recordings were performed on CHO cells transiently expressing KCNQ4 wild-type (wt) and
DFNA2-relevant mutants, and from acutely isolated OHCs.
KEY RESULTS
Various known KCNQ channel openers robustly enhanced KCNQ4 currents. The strongest potentiation was observed with a
combination of zinc pyrithione plus retigabine. A similar albeit less pronounced current enhancement was observed with
native IK,n currents in rat OHCs. DFNA2 mutations located in the channel’s pore region abolished channel function and these
mutant channels were completely unresponsive to channel openers. However, the function of a DFNA2 mutation located in
the proximal C-terminus was restored by the combined application of both openers. Co-expression of wt and KCNQ4 pore
mutants suppressed currents to barely detectable levels. In this dominant-negative situation, channel openers essentially
restored currents back to wt levels, most probably through strong activation of only the small fraction of homomeric wt
channels.
CONCLUSIONS AND IMPLICATIONS
Our data suggest that by stabilizing the KCNQ4-mediated conductance in OHCs, chemical channel openers can protect
against OHC degeneration and progression of hearing loss in DFNA2.
Abbreviations
BFNC, benign familial neonatal convulsion; DFNA2, deafness autosomal dominant locus 2; OHC, outer hair cell; wt,
wild-type; ZnP, zinc pyrithione; ZnP/Ret, zinc pyrithione plus retigabine
Introduction
Loss-of-function mutations in the voltage-gated potassium
channel KCNQ4 (Kv7.4) cause a non-syndromic, progressive
form of hereditary deafness, deafness autosomal dominant
locus 2 (DFNA2) (Kubisch et al., 1999; Beisel et al., 2000;
Kharkovets et al., 2000; 2006). DFNA2 is characterized by
symmetric hearing loss that is progressive at all frequencies
(Jentsch, 2000; Nie, 2008). Hearing impairment is moderate
at young ages, but most affected individuals develop severe-
to-profound high-frequency hearing loss by the age of 70
(Smith and Hildebrand, 2008). KCNQ4 is strongly expressed
in sensory outer hair cells (OHCs) in the organ of Corti, where
it mediates the predominant K+ conductance, IK,n (Mammano
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and Ashmore, 1996; Kubisch et al., 1999; Marcotti and Kros,
1999; Kharkovets et al., 2006; Holt et al., 2007). KCNQ4 has
an essential role for OHC function, as pharmacological inhi-
bition, genetic ablation and loss of function by dominant-
negative mutations lead to progressive loss of OHCs and
subsequent hearing loss in animal models, recapitulating the
human DFNA2 phenotype (Kubisch et al., 1999; Nouvian
et al., 2003; Kharkovets et al., 2006). KCNQ4 is also expressed
in inner hair cells (Oliver et al., 2003) and in neurons in the
central auditory system (Kharkovets et al., 2000; Beisel et al.,
2005), but the physiological relevance in these cells is not
known. To date, eight distinct KCNQ4 point mutations gen-
erating non-functional channel subunits, two mutations pro-
ducing truncated protein (Coucke et al., 1999; Kamada et al.,
2006) and a six-amino acid deletion in the linker between the
fourth and fifth transmembrane segment (Baek et al., 2011)
have been identified in DFNA2-affected humans. Most point
mutations were located within the channel’s pore region,
where mutations inhibit channel function presumably by
disrupting ion permeation (Coucke et al., 1999; Kubisch et al.,
1999; Talebizadeh et al., 1999; Van Hauwe et al., 2000; Akita
et al., 2001; Van Camp et al., 2002; Topsakal et al., 2005) or by
reducing channel surface expression (Mencia et al., 2008; Kim
et al., 2011). A mutation in a putative splicing site in the third
transmembrane region was hypothesized to produce a non-
functional KCNQ4 isoform specifically in OHCs (Su et al.,
2007; Kim et al., 2011), and a mutation in the proximal
C-terminus renders channels non-functional (Coucke et al.,
1999; Kim et al., 2011), possibly by disrupting channel
gating. Voltage-gated potassium channels are homo- or het-
eromeric assemblies of four pore-forming subunits. Therefore,
mutations in one single subunit can disrupt channel function
of the tetramer in a dominant-negative manner (Biervert
et al., 1998; Charlier et al., 1998; Schroeder et al., 1998; Singh
et al., 1998). Accordingly, DFNA2-causing mutations are
thought to reduce native IK,n via dominant-negative suppres-
sion of channel function in individuals heterozygous for the
mutation (Kubisch et al., 1999; Holt et al., 2007). A variety of
potassium channel openers has been identified over the last
years that strongly and specifically potentiate currents
through KCNQ channels (Wulff et al., 2009). Some of these
KCNQ openers are already in use or in clinical trials for the
treatment of various neurological disorders (Wulff et al.,
2009). Interestingly, the KCNQ openers, retigabine and zinc
pyrithione (ZnP), were recently shown to restore the channel
function of epileptogenic KCNQ2-mutants (Xiong et al.,
2007; 2008). These channel subunits mediate the neuronal
M-currents (Wang et al., 1998; Shapiro et al., 2000) and loss-
of-function mutations cause a specific form of neonatal epi-
lepsy [benign familial neonatal convulsion (BFNC)] (Biervert
et al., 1998; Charlier et al., 1998; Schroeder et al., 1998; Singh
et al., 1998). In analogy, if KCNQ openers restored channel
function in DFNA2-relevant KCNQ4 mutants, these agonists
may have therapeutic potential to protect against OHC
degeneration and hearing loss.
Here we investigated the effects of synthetic KCNQ
openers on native IK,n and heterologously expressed KCNQ4
and found enhancement of both currents. Channel function
of the DFNA2-causing mutation that is located close to
the sixth transmembrane segment, G321S, was partially
restored by a combination of zinc-pyrithione and retigabine
(ZnP/Ret). Moreover these KCNQ openers rescued KCNQ4
from dominant-negative inhibition by DFNA2-mutations.
Channel activity was recovered substantially to wild-type
(wt) levels by activation of residual homomeric wt channels.
Taken together, our data suggest that channel activators have
the potential to stabilize the essential KCNQ4-mediated con-
ductance in OHCs in DFNA2.
Methods
Cell culture, transfection and mutagenesis
CHO cells were maintained in MEM Alpha Medium (Invitro-
gen GmbH, Darmstadt, Germany) supplemented with 10%
fetal calf serum and 1% penicillin/streptomycin (both Invit-
rogen). For experiments cells were plated on glass cover slips
(Carl Roth, Karlsruhe, Germany) and transfected with jetPEI
transfection reagent (Polyplus Transfection, Illkirch, France).
Experiments on transfected cells were performed 24 h to 48 h
post-transfection. The expression vectors used were pEGFP-
C1-KCNQ4 and pRFP-C1-KCNQ4 (NM_004700.2), and pBK-
CMV-KCNQ3 (NM_004519.2). The expressed channels are
referred to as KCNQ4 wt and KCNQ3 wt (Kv7.4 and Kv7.3,
respectively) according to the Guide to Receptors and Chan-
nels (Alexander et al., 2009). Based on pEGFP-C1-KCNQ4 six
DFNA2-relevant point mutations were generated by site-
directed mutagenesis using the QuickChangeII XL Site-
Directed mutagenesis kit (Stratagene, Santa Clara, CA, USA),
and mutagenesis was verified by sequencing (SEQLAB-
Sequence Laboratories Göttingen GmbH, Göttingen,
Germany). KCNQ4 wt and mutations were co-expressed to
examine the action of channel openers in a setting corre-
sponding to heterozygote DNFA2 carriers. In these experi-
ments wt and mutant plasmids were transfected at various
ratios as indicated while keeping the total amount of DNA
constant. To verify co-expression of wt and mutated protein,
wt KCNQ4-mRFP was co-expressed with the GFP-fused
mutant. The expected fraction of homomeric wt channels
was calculated for each proportion assuming random assem-
bly of channel tetramers.
Tandem concatamers consisting of KCNQ4 wt subunits or
of one wt and one mutant subunit (W276S, G285S or G321S)
were generated by fusing the subunits N-terminus to
C-terminus. Molecular cloning of the concatamers was based
on KCNQ4 in the pBK-CMV-rev vector. An AgeI cutting site
was introduced 3′ of the KCNQ4 insert and the stop codon
was removed by mutagenesis. The resulting construct was
digested with AgeI and NheI, yielding a 2367 bp fragment
encoding KCNQ4 that was subsequently subcloned into the
KCNQ4-pEGFP-C1 plasmid to create the wt concatamer
plasmid. For concatamers containing one of the mutations
(W276S, G285S orG321S) we used the same cloning strategy
with source vectors that carried one of the mutations.
Mutagenesis and cloning were verified by sequencing.
Organ of Corti preparation
All experiments utilizing animal tissue were performed
according to German law and to institutional guidelines at
the Philipps-University Marburg. Organs of Corti of Wistar
rats (12–20 days after birth) were acutely isolated as previ-
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ously reported (Oliver et al., 2000). Briefly, animals were
anaesthetized using Isofluran (Baxter Deutschland GmbH,
Unterschleißheim, Germany) and killed by decapitation. The
cochlea was dissected, separated from modiolus, stria vascu-
laris and and tectorial membrane and then was continuously
perfused with standard extracellular solution containing
(mM) 144 NaCl, 5.8 KCl, 1.3 CaCl2, 0.9 MgCl2, 0.7 NaH2PO4,
10 HEPES and 5.6 D-glucose, pH 7.4 (with NaOH), 305–
310 mOsm·kg-1. Experiments were performed within 3 h after
the preparation at room temperature (22–25°C).
Electrophysiological recordings
Patch clamp recordings were performed in the whole cell
configuration with an Axopatch 200B amplifier (Molecular
Devices, Union City, CA, USA). Data were sampled with an
ITC-18 interface (HEKA Elektronik, Lambrecht, Germany)
controlled by PatchMaster software (HEKA) via a Macintosh
PowerPC (Apple Inc, Cupertino, CA, USA). Some experiments
were performed using an EPC10-USB patch clamp amplifier
(HEKA). Currents were low-pass filtered at 2 kHz and sampled
at 5 kHz, and whole cell capacitance was compensated in
whole-cell configuration. Patch pipettes were pulled from
borosilicate glass (Sutter Instrument Company, Novato, CA,
USA) to an open pipette resistance of 1.5–3 MW after back-
filling with intracellular solution containing (mM) 135 KCl,
2.4 CaCl2 (0.1 mM free Ca2+), 3.5 MgCl2, 5 HEPES, 5 EGTA, 2.5
Na2ATP, pH 7.3 (with KOH), 290–295 mOsm·kg-1. Series resis-
tance (Rs) typically was below 8 MW and Rs compensation
(80–90%) was applied throughout the recordings. Experi-
ments were performed on OHCs of the third row of apical
cochlear turns, and recordings were only included in analysis
if the membrane potential was more hyperpolarized than
-69 mV. Access to the basolateral membrane of OHCs was
achieved by gently removing surrounding tissue with a
suction pipette. In CHO cells robust expression of wt and/or
mutant KCNQ4 was verified by GFP and/or RFP fluorescence,
and only one CHO cell was investigated per cover slip. All
experiments were performed at room temperature (22–25°C).
Membrane potentials shown are not corrected for liquid junc-
tion potentials (approximately 4 mV).
Chemicals
Retigabine {[N-(2-amino-4-(4-fluorobenzylamino)-phenyl)
carbamic acid ethyl ester]}, flupirtine {N-[2-amino-6-
((4-fluorophenyl)methyl)amino)-3-pyridinyl]carbamic acid},
BMS-204352 {maxipost; [(S)-3-(5-chloro-2-methoxyphenyl)-
3-fluoro-6- (trifluoromethyl) -1,3-dihydro-2Hindole-2-one]}
(all kindly provided by Neurosearch, Ballerup, Denmark), ZnP
(Sigma-Aldrich, Munich, Germany) and XE991 [10,10-bis
(4-pyridinylmethyl)-9(10H)-anthracenone dihydrochloride]
(Tocris Bioscience, Bristol, UK) were applied from the extra-
cellular side via a glass capillary at the concentrations indi-
cated in results.
Data analysis and statistics
Data were analysed with PatchMaster (HEKA) and IGOR Pro
(Wavemetrics, Lake Oswego, OR, USA). Steady-state KCNQ4
currents were quantified as the outward current 1200 ms after
a voltage pulse (as indicated) from the holding potential
(-60 mV). Data are presented normalized to membrane
capacitance as the measure for membrane area, yielding
current densities (pA/pF). Membrane capacitance was deter-
mined with the CM compensation circuitry of the patch
clamp amplifier. Drug-induced changes in current amplitudes
were calculated by normalizing to the current amplitude at
the beginning of each experiment prior to application of the
respective channel opener (I/Icontrol). Concentration-response
relations were derived from normalized KCNQ4 steady-state
currents at 0 mV at various drug concentrations. Responses
were fitted with a Hill equation with I/Ib = Ib + (Imax - Ib)/(1 +
( )EC S nH50/[ ] ), where I is the normalized current, Ib and Imax
denote the minimal and maximal currents at low and high
drug concentrations, EC50 is the concentration at the half
maximal effect, [S] is the drug concentration and nH is the Hill
coefficient. Voltage-dependence of channel activation was
derived from tail current amplitudes using the voltage proto-
cols given in the figures. Current-voltage curves were derived
from tail currents and were fitted with a two-state Boltzmann
function with I = Imin + (Imax-Imin)/{1 + exp[(V-Vh)/s]}, where I is
current, V is the membrane voltage, Vh is the voltage at half
maximal activation, and s describes the steepness of the
curve. Results are shown as conductance-voltage curves,
obtained by normalizing to (Imax-Imin), obtained from fits to
the data of the individual experiments. To account for bio-
physical differences between heterologous KCNQ4 and
native IK,n (i.e. hyperpolarized voltages of activation for IK,n),
different voltage protocols were used for OHCs and CHO cells
(Kubisch et al., 1999; Marcotti and Kros, 1999; Oliver et al.,
2003). Thus, IK,n current amplitudes were measured as the tail
currents at -120 mV following pre-pulses to voltages between
-160 and +40 mV (increments of 10 mV), and heterologous
KCNQ4 tail currents were recorded at 0 mV from pre-pulses
between -100 and +50 mV.
Statistical analysis was performed with (paired) t-test and
Dunnett test for multi-comparison, and significance was
assigned at P  0.05 (*P  0.05, **P  0.01, ***P  0.001).
Data are presented as mean  SEM, with n representing the
number of independent experiments (individual cells).
Results
Potentiation of heterologous KCNQ4 by
channel openers
The effects of channel openers on heterologously expressed
KCNQ channels have been investigated previously. However,
the efficacy of current potentiation differs between channel
openers and depends on the KCNQ isoform (Schroder et al.,
2001; Tatulian et al., 2001; Xiong et al., 2007). To identify the
most potent activator of KCNQ4, we systematically com-
pared the potencies of openers that have been described
previously, namely flupirtine, retigabine, BMS-204352 and
ZnP.
At concentrations of 10 mM, all openers except flupirtine
strongly increased steady-state KCNQ4 currents (at 0 mV) 4-
to 12-fold (Figure 1A,B; Supporting Information Figure S1). In
these experiments the rank order of current potentiation was:
flupirtine < retigabine < BMS-204352 < ZnP < ZnP/Ret.
Despite different degrees of current augmentation, heterolo-
gous KCNQ4 showed comparable sensitivities for flupirtine
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Figure 1
Potentiation of heterologous KCNQ4 currents by channel openers. (A) Representative recordings from CHO cells transiently transfected with wt
KCNQ4 under control conditions and after application of flupirtine, retigabine, BMS-204352, zinc pyrithione (ZnP) or a combination of zinc
pyrithione and retigabine (ZnP/Ret) (10 mM each, voltage command as indicated). Dashed lines indicate zero currents, and scale bar applies to all
recordings. (B) Summary of steady-state currents at 0 mV normalized to plasma membrane area (membrane capacitance), obtained from recordings
as presented in (A). Concentration of all openers was 10 mM. (C) KCNQ4 current potentiation by KCNQ openers was voltage-dependent.
Steady-state currents at different holding potentials were normalized to currents obtained before the application of KCNQ channel openers. KCNQ4
current increase was more pronounced at hyperpolarized voltages, and saturated at approximately 10 mV for all openers. (D) Voltage- dependence
of KCNQ4 currents with and without KCNQ channel openers. Conductance-voltage relations were derived from tail current recordings as shown in
Supporting Information Figure S2 and normalized to maximum currents derived from Boltzmann fits to the data. Continuous lines indicate a
Boltzmann fit to the averaged data. Fits to current-voltage relation of individual measurements yielded Vh -21.8  2.0 mV for controls, -31.7 
2.7 mV with retigabine, -33.4  2.9 mV with ZnP, and -64.0  2.5 mV with ZnP/Ret (all openers at 10 mM). Current-voltage relationships for
BMS-204352 and flupirtine are shown in Supporting Information Figure S1. (E) Summary of the shifts of the half-maximal voltage of activation (DVh)
induced by application of KCNQ openers, calculated from recordings as in (D). Flupirtine, retigabine and BMS-204352 exhibited modest shifts
(approximately -10 to -20 mV), ZnP (-26.7  3.3 mV) and ZnP/Ret (-47.8  2.9 mV) extremely shifted voltages of activation to hyperpolarized
potentials. (Numbers of cells for all panels were 11 flupirtine, 11 retigabine, 12 BMS-204352, 11 ZnP and 8 ZnP/Ret)
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(EC50 = 2.9 mM), retigabine (EC50 = 3.7 mM), BMS-204352
(EC50 = 3.5 mM), and for ZnP (EC50 = 6.8 mM) (Supporting
Information Figure S1). Thus, 10 mM produced saturating or
nearly saturating effects for all openers and this concentra-
tion was therefore used in the further studies. Figure 1C
shows that current potentiation was stronger at hyper-
polarized voltages, with highest current gain observed with
ZnP/Ret. The voltage-dependence of current enhancement
resulted from a shift of the voltage-dependence of activation
to hyperpolarized potentials for all openers, as reported pre-
viously (Figure 1D) (Schroder et al., 2001; Tatulian et al.,
2001; Xiong et al., 2007). Taken together these results show
that combined application of ZnP/Ret produced the strongest
amplification of KCNQ4 currents. By enhancing steady-state
conductance at 0 mV by a factor of approximately 11
(Figure 1B,C), and by shifting the voltage of half-maximal
activation from -21.8  2.0 mV to -64.0  2.5 mV
(Figure 1D,E), ZnP/Ret-mediated current potentiation
amounted to more than 200-fold at -40 mV (Figure 1C).
These results are consistent with a previous report, showing
strong and additive enhancement of KCNQ currents by ZnP
and retigabine via distinct molecular interaction sites in the
channel protein (Xiong et al., 2008). In fact, the shift in
voltage sensitivity by ZnP/Ret produced currents that closely
resembled the native IK,n currents from OHCs, which are
characterized by their unique negative activation range (Sup-
porting Information Figure S2) (Mammano and Ashmore,
1996; Marcotti and Kros, 1999; Oliver et al., 2003).
KCNQ4 mutations in the pore region cannot
be restored by ZnP/Ret
We next explored whether channel openers might be able to
rescue channel function of the various KCNQ4 loss-of-
function mutants that cause DFNA2 (Figure 2). To this end,
we used the combination of ZnP and retigabine that exhib-
ited the highest efficacy in potentiation of the wt channel.
Figure 3 summarizes the effects of ZnP/Ret (10 mM both)
on KCNQ4 channels carrying mutations within or close to
the pore. None of the mutant channels produced detectable
currents when expressed in CHO cells, consistent with previ-
ous reports (Kubisch et al., 1999; Holt et al., 2007; Baek et al.,
2011; Kim et al., 2011). Application of the channel opener
combination did not uncover detectable currents for W276S,
L281S and G285S (Figure 3A–E, G). In cells transfected with
the G296S mutant subunits ZnP/Ret produced small outward
currents (approximately 1 pA/pF at 0 mV) that were clearly
identified as KCNQ-mediated currents, since they were abol-
ished by the KCNQ antagonist XE991 (10 mM; Figure 3D,G).
However, equivalent currents were also found in non-
transfected cells (Figure 3E, G) and thus most likely arise from
a minuscule expression of endogenous channels that is
uncovered by the KCNQ openers. Apparently, expression of
the pore mutants (W276S, L281S and G285S) suppressed
endogenous currents by the dominant-negative effect
described previously (Kubisch et al., 1999; Holt et al., 2007).
In contrast to these mutations, channel dysfunction of G296S
Figure 2
Topology of DFNA2-relevant mutations in the KCNQ4 channel protein. Point mutations described as causative for DFNA2 are presented in red
and the K+ channel pore motif glycine–tyrosine–glycine (GYG) is depicted in green.
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appeared not to interfere with the function of the endog-
enous channels, in line with a recent report of defective
membrane targeting of this mutation (Mencia et al., 2008). It
should be noted that the currents recorded from non-
transfected CHO cells or cells transfected with G296S were
extremely small when compared with wt KCNQ4 currents
(Figure 3D–G).
Taken together, these experiments show that homomeric
KCNQ4 channels composed of subunits carrying a mutation
in or close to the pore region cannot be rescued by applica-
tion of the most potent KCNQ openers tested in this study,
ZnP/Ret.
Partial restoration of channel function of a
mutation in the proximal C-terminus
Two DFNA2mutations have been identified within or close to
transmembrane regions distinct from the pore structure
(F182L and G321S, respectively; see Figure 2) (Coucke et al.,
N
N
C
Figure 3
KCNQ4 mutations in the pore region cannot be rescued by ZnP/Ret. (A–E) Representative currents measured from cells expressing the DFNA2
mutations W276S (A), L281S (B), G285S (C) and G296S (D), and from non-transfected CHO cells (E) in the presence of ZnP/Ret (10 mM each).
Scale bars apply to (A–E). Voltage protocol as indicated in (A). (F) wt KCNQ4 currents in the presence of ZnP/Ret. Voltage protocol as indicated
in (A). Note the different current scaling. (G) Summarized steady-state current densities at 0 mV obtained from experiments as in (A–F), under
control conditions, with ZnP/Ret and during subsequent application of the KCNQ antagonist XE991. None of the mutations produced substantial
currents either in the absence or presence of ZnP/Ret. Application of the openers revealed small currents in non-transfected cells and in cells
transfected with G296S that most likely arose from endogenous expression of KCNQ-like channels in CHO cells (see text). Note the compressed
axis scaling for wt currents.
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1999; Su et al., 2007). We reasoned that these mutant chan-
nels may be more promising targets for functional restoration
by channel openers.
The G312S mutation is located at the interface of S6 and
the cytoplasmic C-terminus, which we refer to as the proxi-
mal C-terminus (see Figure 2) (Coucke et al., 1999). Consis-
tent with a recent report (Kim et al., 2011), homomeric
KCNQ4-G321S did not produce clearly detectable voltage-
dependent currents under control conditions (Figure 4A,C).
However, a standing outward current at 0 mV was apparent
that was significantly larger than in non-transfected cells
(1.5  0.6 pA/pF, n = 14; Figure 4A,C and D). Application of
Figure 4
Partial rescue of a KCNQ4 mutation in the proximal C-terminus by ZnP/Ret. (A, B) Representative recordings from the same CHO cell transfected
with KCNQ4-G321S under control conditions (A) and in the presence of ZnP/Ret (10 mM both) (B). Voltage protocol as in Figure 3. (C) Time
course of current potentiation by application of ZnP/Ret in cells transfected with KCNQ4-G321S (n = 14) and in non-transfected CHO cells
(n = 5). Steady-state currents were measured at 0 mV. (D) Average current densities obtained from the experiments shown in (C). Potentiated
currents were fully blocked by XE991 (10 mM, n = 14). (E) Voltage-dependence of G321S-mediated currents in the presence of ZnP/Ret.
Conductance-voltage relations were derived from tail current recordings as shown in (B) and derived from Boltzmann fits to the data (see Figure 1
and Supporting Information Figure S2). Continuous line indicates a Boltzmann fit to the averaged data. Fits to current-voltage relation of individual
measurements yielded Vh = -36.0  4.3 mV and k = -14.8  1.2 mV (n = 8). Currents without channel openers were too small to determine
voltage-dependence.
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ZnP/Ret (10 mM both) elicited substantial voltage-activated
outward currents of 14.4  5.1 pA/pF (at 0 mV; n = 14;
Figure 4B–E). These currents were significantly larger than the
endogenous KCNQ-like currents induced by ZnP/Ret in non-
transfected CHO cells (Figure 4C) and were blocked by XE991
(Figure 4D), unequivocally identifying them as carried by
KCNQ4-G321S. These G321S-mediated currents activated at
somewhat more hyperpolarized voltages than KCNQ4 wt cur-
rents under control conditions (Vh = -36.0  4.3 mV, slope =
-14.8  1.2 mV, n = 8, P  0.01; Figure 4E). ZnP/Ret poten-
tiated G321S-mediated currents 15- to 20-fold, yielding a
conductance that was about 40% of wt currents in the
absence of channel openers (also see Figure 3G). Yet, the
ZnP/Ret-augmented G321S conductance was sufficient to
hyperpolarize CHO cells from a membrane potential of -25.4
 0.7 mV to -50.3  4.0 mV (n = 8; P  0.001), which is
indistinguishable from the membrane potential of cells
expressing wt KCNQ4 (-48.5  2.3 mV, n = 12; P = 0.50).
Taken together, the current amplitudes, voltage-dependence,
and subsequent hyperpolarization of CHO cells demonstrate
the partial restoration of G321S channel function by ZnP/Ret.
We also examined F182L, a DFNA2 mutation located in
the third transmembrane domain of KCNQ4 (Su et al., 2007).
In line with recent findings (Kim et al., 2011), current ampli-
tudes and voltage-dependence of this mutation were indis-
tinguishable from wt KCNQ4. Similar to wt, application of
ZnP/Ret (10 mM) shifted the voltage range of activation to
hyperpolarized voltages and potentiated F182L currents (Sup-
porting Information Figure S3). Apparently, in the case of the
F182L mutant impaired channel conductance is not the cause
for deafness. We therefore did not investigate this mutation
further.
ZnP/Ret rescues KCNQ4 from dominant-
negative suppression by DFNA2 mutations
DFNA2 is a dominantly inherited disease, i.e. a single mutant
KCNQ4 allele is sufficient to severely affect function of the
channel. On the molecular level, the dominant nature of
these loss-of-function mutations can be explained by the
tetrameric structure of the channels. Thus, channel function
may be disrupted by a single mutant subunit per tetrameric
channel complex. If wt and mutant subunits are synthesized
at the same level and assemble in a stochastic manner, this
leaves only one functional (i.e. homomeric wt) channel out
of 16 (6.25%), yielding a strong dominant-negative effect of
the mutation. Indeed, stoichimetric co-expression of KCNQ4
with DFNA2 mutants resulted in strong suppression of
channel activity (Kubisch et al., 1999; Holt et al., 2007), sup-
porting this model. Moreover, in a mouse model heterozy-
gous for the DFNA2 mutation (G285S) the native KCNQ4
equivalent in OHCs, IK,n, was strongly diminished in a
manner compatible with this dominant-negative action
(Kharkovets et al., 2006). We therefore tested for effects of
channel openers on KCNQ4 currents suppressed by
dominant-negative inhibition. To this end, wt KCNQ4 was
co-expressed with subunits carrying mutations in the selec-
tivity filter motif, GYG (G285S), near the channel pore
(W276S), or in the proximal C-terminus (G321S) (Figure 2).
As reported previously (Kubisch et al., 1999; Holt et al.,
2007; Baek et al., 2011; Kim et al., 2011), co-expression of
mutant subunits with wt KCNQ4 strongly reduced current
amplitudes compared with wt currents alone (Figure 5A–C).
Supporting Information Figure S4 confirms that this current
reduction was not simply due to the lower amount of wt
DNA used for transfection in these experiments, as wt
current amplitudes were unaffected by decreasing the
amount of DNA amount to the same level used in
co-transfection experiments. Thus, the current reduction
resulted from a dominant-negative interaction of the mutant
channel subunits with the wt subunits. Co-expression of wt
KCNQ4 with the pore mutants (1:1) reduced current densi-
ties at 0 mV to 2.4  0.3% (wt/G285S; 1.0  0.1 pA/pF,
n = 6) and 5.7  1.7% (wt/W276S; 2.3  0.5 pA/pF, n = 8) of
wt currents (obtained from the same batches of cells, Sup-
porting Information Figure S4) (Figure 5A–C, lower panel).
This is roughly compatible with the 6% (1/16) of functional
homomeric wt channels expected to result from the assem-
bly of co-synthesized wt and mutant subunits, assuming that
co-assembly into tetrameric channels is stochastic and that a
single mutated subunit is sufficient to abolish ion conduc-
tance of a channel (Kubisch et al., 1999; Holt et al., 2007). As
shown in Figure 5A and B, application of ZnP/Ret (10 mM
each) strongly potentiated these residual currents to 18.9 
6.8 pA/pF (wt/G285S; n = 6) and 28.5  4.7 pA/pF (wt/
W276S; n = 8). These potentiated current amplitudes were
statistically indistinguishable from wt control currents in the
absence of channel openers (43.5  7.8 pA/pF, n = 5, Sup-
porting Information Figure S4 for the same batch of cells),
indicating full compensation for dominant-negative suppres-
sion of channel function by ZnP/Ret. Similar to the pore
mutants, co-expression of the G321S mutant suppressed wt
KCNQ4 currents (to 5.3  2.1 pA/pF at 0 mV, 12.2  2.7% of
wt; n = 7; Figure 5C, top and lower panel). Interestingly, the
remaining current was larger than the 6.3% of wt currents
expected from disrupted channel function by a single
mutant subunit. ZnP/Ret robustly increased these currents to
75.2  16.5 pA/pF (n = 7; Figure 5, C lower panel), which was
even larger than wt control currents in the absence of
channel openers. In addition to the strong enhancement of
maximum current amplitude, restored currents from cells
co-expressing mutant and wt channels exhibited negatively
shifted activation ranges, similar to ZnP/Ret-potentiated wt
currents (Figure 5D,E).
How do openers rescue current amplitudes
from dominant-negative suppression?
The channel population under conditions of dominant-
negative suppression by DFNA2 mutants consists of homo-
meric mutant channels, homomeric wt channels and
heteromeric channels containing both wt and mutant sub-
units. As shown above, ZnP/Ret strongly activates the homo-
meric wt channels and potentiates homomeric G321S
channels but has no effect on homomeric pore mutant chan-
nels (G285S and W276S; Figures 2 and 3). However, at this
point it is not clear if the current potentiation, in the
dominant-negative situation may also comprise the restora-
tion of activity of otherwise dysfunctional heteromeric
wt/mutant channels.
To address this issue we first consider the degree of current
enhancement. ZnP/Ret increased currents from cells
co-expressing wt and pore mutant channels by factors of
17.3  4.5 (n = 6; wt/G285S) and 15.1  2.8 (n = 8;
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wt/W276S). This is similar to the 11-fold increase in current
densities obtained with wt channels (11.4  2.0-fold; n = 11;
see Figure 1). Therefore, the restored current may be
explained solely by potentiation of the residual homomeric
wt channels without the need to invoke a functional resto-
ration of channels containing one or more mutant subunits.
However, since the above values of current enhancement
may be spurious due to the minute residual current
amplitudes in the absence of openers, we aimed at a more
robust and quantitative examination of the degree of
current enhancement. To this end, we titrated the relation
between homomeric and heteromeric channel tetramers by
Figure 5
ZnP/Ret rescues KCNQ4 currents from dominant-negative inhibition. (A–C) Representative recordings from cells co-transfected with wt KCNQ4
and the DFNA2 mutants indicated. Current amplitudes were strongly suppressed by co-expression of the mutant channel subunits (upper panels).
Application of ZnP/Ret (10 mM both) strongly increased currents for all three mutants (middle panel; same cells). Voltage protocol as presented
in Figure 3. Lower panels summarize current densities (at 0 mV) before and during application of ZnP/Ret and after application of XE991 (10 mM).
(D) Voltage-dependence of ZnP/Ret-induced currents in cells co-transfected with KCNQ4 wt and G285S or W276S, obtained from experiments
as in (A and B): Vh = -49.1  4.0 mV, n = 6 (wt/G285S); Vh = -46.8  3.4 mV, n = 8 (wt/W276S). Under control conditions, currents were too
small to reliably determine current-voltage relations. Conductance-voltage curves from wt KCNQ4 without and with ZnP/Ret (Vh = -64.0 
2.5 mV) are shown for comparison. (E) Conductance-voltage relations were determined from cells co-expressing wt KCNQ4 and G321S as in (C)
before (Vh = -22.2  1.2 mV) and during application of ZnP/Ret (Vh = -43.5  1.2, n = 7).
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systematically varying the ratio of wt and W276S plasmids
transfected into the cells.
As shown in Figure 6A, variation of the wt-to-mutant
ratio from 9:1 to 1:1 resulted in an incremental suppression
of whole-cell currents. For each plasmid ratio, the remaining
current under control conditions (normalized to the current
from cells expressing only wt homomers; Figure 6A, open
columns) matched well with the predicted fraction of homo-
meric wt channels (Figure 6A, red axis), assuming random
assembly of channel subunits and a linear relation between
concentration of plasmid and synthesis of the respective
subunit (9:1 81.4  12.6%; 4:1 38.1  5.4%; 2:1 26.9  5.4%;
1:1 5.7  1.7%). This finding strongly supports the previous
notion that only homomeric wt channels are functional
under these conditions, i.e. a single mutant subunit close to
the pore region is sufficient to render the tetrameric channel
non-functional (Kubisch et al., 1999; Holt et al., 2007). Simi-
larly, the ZnP/Ret-potentiated current also agreed closely with
the predicted fraction of homomeric wt channels for each
subunit ratio (Figure 6A, grey columns) (9:1 72.1  9.3%; 4:1
45.5  6.6%; 2:1 29.2  7.0; 1:1 7.6  1.3).
These results suggest that in the dominant-negative situ-
ation both control and opener-enhanced currents are medi-
ated exclusively by the residual homomeric wt channels,
since the fraction of currents did not increase upon applica-
tion of the channel opener. Consequently, all channels con-
taining at least one pore mutant subunit are non-conducting
and cannot be rescued by the channel openers. The rescue of
dominant-negative suppression by pore mutants therefore
occurs through exclusive activation of the small fraction of
homomeric wt channels.
Notably, the proximal C-terminal mutant, G321S, showed
a different behaviour. In cells co-expressing wt and G321S
(1:1), currents in the presence and absence of ZnP/Ret were
larger than the predicted fraction of homomeric wt channels
(Figure 6A). This suggests that in the case of G321S, channels
containing mutant subunits may be functional under control
conditions and furthermore can be activated by ZnP/Ret.
These findings are fully consistent with the current recovered
in homomeric G321S channels (Figure 4) (control 1:1 12.2 
2.7%; ZnP/Ret 21.0  3.2).
Finally, we directly tested the sensitivity of heteromeric
wt : mutant channels to the channel openers. Homogeneous
populations of heteromeric channels were achieved by gen-
eration of concatamer of a wt and a mutant subunit, which
were expected to assemble into tetramers containing two wt
and two mutant subunits (Figure 6B). Channels assembled
from wt : wt concatamer exhibited currents indistinguishable
from monomeric wt channels, and were potentiated by ZnP/
Ret to the same degree (10.3  2.4, n = 11; Figure 6B) as wt
KCNQ4 assembled from monomeric subunits. Expression of
wt:W276S or wt:G285S concatamer did not produce detect-
able currents. Moreover, application of ZnP/Ret did not
produce currents beyond those seen in non-transfected cells,
indicating that these channels containing pore mutant sub-
P
Figure 6
For pore mutants, extrication from dominant-negative inhibition is
mediated by activation of residual wt channels. (A) Co-expression of
KCNQ4 wt with mutant subunits reduced whole cell currents by
dominant-negative inhibition. Currents were recorded from CHO
cells co-transfected at the indicated ratios of wt to mutant plasmid.
Current densities recorded under control conditions are presented
normalized to wt control current densities recorded from control
cells transfected with wt plasmid only. Currents measured with ZnP/
Ret are normalized to wt current densities in the presence of the
same openers. For each subunit co-expression ratio of wt and the
pore mutant W276S, the level of control and potentiated currents
matched the predicted fraction of residual homomeric wt channels
(red dashed lines), indicating that only homomeric wt channels
contributed to the currents under all conditions. In contrast, for
co-expression of wt subunits with G321S (1:1), current levels nor-
malized to pure wt currents exceeded the predicted fraction of
homomeric wt channels (calculated fractions: 9:1 65.6%; 4:1 41.0%;
2:1 19.9%; 1:1 6.3%). (B) Current densities of KCNQ4 channels
assembled from tandem concatamers in the absence and presence of
KCNQ channel openers. Insets indicate the subunit stoichiometry of
channels assembled from the respective concatameric constructs.

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units cannot be activated by the channel agonists. In contrast,
wt:G321S concatamer showed small currents under control
conditions, and application of ZnP/Ret uncovered robust
KCNQcurrents. Thus heteromeric channels containingG321S
subunits are not fully dysfunctional and can be restored, at
least partially, by KCNQ channel openers (Figure 6B).
In conclusion, these data show that KCNQ channel
openers can rescue the whole-cell KCNQ4 conductance from
suppression by dominant-negative mutant subunits. For
pore mutants, the recovery exclusively relies on the activa-
tion of residual homomeric wt channels. For the pro-
ximal C-terminal mutation, potentiation probably involves
channels of all wt : mutant proportions and accordingly is
stronger.
Chemical KCNQ openers potentiate native IK,n
in OHCs
In DFNA2, OHC degeneration and deafness in heterozygots
results from the substantial suppression of the native
KCNQ4-mediated current, IK,n by a dominant-negative action
of the mutant subunits (Kubisch et al., 1999; Kharkovets
et al., 2000; 2006; Holt et al., 2007). Our findings suggest that
KCNQ channel openers, by removing this suppression, are a
promising strategy for the stabilization of IK,n in DFNA2. Since
native IK,n and recombinant KCNQ4 showmarked biophysical
differences (Mammano and Ashmore, 1996; Kubisch et al.,
1999; Marcotti and Kros, 1999; Kharkovets et al., 2006) (see
Supporting Information Figure S2), we next examined the
effects of KCNQ openers on IK,n.
Figure 7 summarizes the potentiation of native IK,n by
retigabine (10 and 100 mM), BMS-204352, ZnP and ZnP/Ret
(all applied at 10 mM). We quantified tail currents at -120 mV
from voltage-steps ranging from -160 to -20 mV before and
during application of KCNQ openers to measure pure IK,n
currents not contaminated by other OHC currents that acti-
vate at more positive potentials (Figure 7A-D) (Mammano
and Ashmore, 1996; Kubisch et al., 1999; Marcotti and Kros,
1999; Oliver et al., 2003), as demonstrated recently (Leitner
et al., 2011). Under control conditions IK,n currents were acti-
vated at around -110 mV with Vh of -75.7  1.3 mV (n = 26;
Figure 7A,E). Application of chemical openers robustly aug-
mented current amplitudes and shifted voltage-dependence
to hyperpolarized potentials (Figure 7C). Figure 7D shows
relative current increase upon application of chemical KCNQ
openers. Retigabine and ZnP/Ret (all 10 mM) robustly
increased IK,n currents 1.4-fold (at -60 mV) to 2.2-fold (at
-110 mV) with no relevant differences at physiological mem-
brane potentials between the substances tested. Both sub-
stances quite specifically augmented IK,n without involvement
of other OHC potassium currents, since XE991-insensitive
currents were not affected by the openers, as we recently
reported (Leitner et al., 2011). Interestingly, BMS-204352 was
barely effective, especially at membrane potentials around
-70 mV, despite its high efficacy at potentiating KCNQ4-
mediated currents in CHO cells. Since BMS-204352 failed to
potentiate IK,n and thus is unlikely to be useful in the case of
DFNA2, we did not further investigate the effects of this
substance on native OHCs.
As for heterologous KCNQ4 channels, KCNQ openers
shifted voltage-dependence of IK,n to hyperpolarized poten-
tials (Figure 7E,F). These shifts were comparable for retigabine
at 10 and 100 mM to Vh of -86.0  3.3 mV (n = 9) and -92.1
 2.0 mV (n = 8), respectively, and for ZnP/Ret (both 10 mM)
to -92.5  3.29 mV (n = 11). In contrast, ZnP and BMS-
204352 produced rather modest shifts of Vh to -79.7 
4.4 mV (n = 6) and -82.0  3.5 mV (n = 8), respectively. These
data show that 10 mM retigabine is a saturating concentra-
tion, yielding comparable sensitivities for this chemical
opener for IK,n as for heterologous KCNQ4. Additionally, the
recordings suggest equal sensitivity of IK,n for ZnP and retiga-
bine, without additional current potentiation by the combi-
nation of the two substances (see also Figure 1) (Xiong et al.,
2008). This is also represented by the average shifts of Vh by
the openers: Application of retigabine resulted in Vh shifts of
-14.0  1.7 mV (n = 8) and -15.4  0.9 mV (n = 8) at 10 and
100 mM, respectively. Similarly, ZnP/Ret shifted Vh by -17.2 
1.9 mV (n = 11) (Figure 7F), which was not higher than the
effect of retigabine alone. This is in strong contrast to heter-
ologous KCNQ4, and suggests retigabine has equivalent
effects on OHCs to ZnP/Ret. Thus, retigabine may be used to
stabilize the KCNQ conductance in OHCs, similar to ZnP/Ret
for heterologous KCNQ4.
Discussion
Here we showed for the first time that synthetic channel
openers can functionally rescue KCNQ4-mediated currents
from deafness-causing mutations. While homomeric pore
mutant channels remained non-functional even in the com-
bined presence of ZnP/Ret, these openers were able to activate
channels carrying the DFNA2-related mutation, G321S,
located in the proximal C-terminus. Moreover, ZnP/Ret
rescued KCNQ4 currents from dominant-negative suppres-
sion by co-expressed mutant channel subunits irrespective of
the specific mutant, that is, both with pore mutants and the
mutant located in the proximal C-terminus. For the pore
mutants the restored function resulted exclusively from
potentiation of the small population of channels assembled
from wt channel subunits. Current enhancement in the case
of G321S also involved activation of channels containing
mutant subunits.
Implications of the rescue of DFNA2 mutants
In DFNA2, patients suffer from slowly progressing hearing
loss that amounts to severe to profound deafness (Kharkovets
et al., 2006; Smith and Hildebrand, 2008). As KCNQ4 medi-
ates the predominant K+ conductance of OHCs, IK,n, DFNA2
most likely results from OHC dysfunction. Indeed, a mouse
model for KCNQ4 shows progressive OHC degeneration and
hearing loss (Kharkovets et al., 2006). KCNQ4 is also
expressed in inner hair cells, where it mediates an IK,n-like
conductance (Kharkovets et al., 2000; Oliver et al., 2003). Yet,
this inner hair cell current seems to be less critical, since IHC
function was not impaired in the KCNQ4 knock-out mouse
model (Kharkovets et al., 2006). Apart from sensory hair cells,
KCNQ4 is also expressed in various neurons along the central
auditory pathway (Kharkovets et al., 2000; Beisel et al., 2005);
however, it is currently not known whether neuronal defects
contribute to the pathology of DFNA2. Given the importance
of KCNQ4 for the maintenance of hearing, the restoration of
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channel function by chemical channel openers immediately
suggests that these compounds may be of clinical use to
stabilize the KCNQ conductance and prevent or retard OHC
loss. It is worth noting that since DNFA2 is a dominant
deafness, most patients present with a heterozygous geno-
type. Pathology therefore usually results from dominant-
negative suppression of channel function by the mutant
channel subunits transcribed from the mutated allele
(Kubisch et al., 1999; Holt et al., 2007; Smith and Hildebrand,
2008). Here we demonstrated essentially full restoration of
currents in this situation, at least in a heterologous expres-
sion system. Thus, enhancement of KCNQ4-mediated cur-
rents by channel openers might be a therapeutic option for
most DFNA2 patients irrespective of the particular mutation
in the KCNQ4 gene.
Native IK,n currents were potentiated by chemical openers
similar to heterologously expressed KCNQ4, but current gain
was substantially smaller. Since the action of the openers
includes a substantial shift in the activation voltage range to
more hyperpolarized potentials, the degree of current poten-
tiation that can be reached in vivo must also depend on the
membrane potential (VM) of OHCs. The VM of OHCs in vivo is
not known precisely. While it has been reported as about
-80 mV (Mammano and Ashmore, 1996; Marcotti and Kros,
Figure 7
Native IK,n in OHCs is sensitive to chemical KCNQ openers. (A, B) Representative recordings of IK,n currents from an OHC before (A) and during
application of ZnP/Ret (10 mM each) (B). Scale bars and voltage protocol apply to (A) and (B). (C) Summary of tail current densities recorded as
in (A, B) in presence of retigabine and ZnP/Ret (all 10 mM). Retigabine and ZnP/Ret increased IK,n current amplitudes and shifted voltages of
activation to hyperpolarized voltages. (D) Potentiation of IK,n by KCNQ openers (all 10 mM). The relative current potentiation at different holding
potentials is presented, calculated from tail currents as in (A–C). (E) Hyperpolarizing shifts in the voltage-dependence of IK,n currents induced by
chemical openers. Voltage-dependence was derived from tail currents as in (C), normalized to the maximal current and fitted to a Boltzmann
function. Under control conditions Vh was -75.7  1.3 mV (n = 26), and was shifted to -82.0  3.5 mV by BMS-204352 (10 mM; n = 8), to
-86.0  3.3 mV by 10 mM retigabine (n = 9), to -92.1  2.0 mV by 100 mM retigabine (n = 8), to -79.7  4.4 mV by ZnP (10 mM; n = 6), and
to -92.5  3.29 mV by ZnP/Ret (10 mM; n = 11). (F) Averaged shifts of half-maximal voltages of activation (DVh) upon application of the various
KCNQ openers obtained from the data shown in (E).
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1999), which is close to the half-activating voltage of IK,n, VM
might be much more depolarized in vivo due to the large
depolarizing transducer conductance that is lost with the
usual recording conditions in vitro (He et al., 2004; Johnson
et al., 2011). The lower efficacy of openers on the native
channel may impose a limitation to any therapeutic use of
channel openers, unless activators with higher potency are
found. However, it should be noted that in human DFNA2,
hearing loss is slowly progressive (Smith and Hildebrand,
2008) and its progressive nature was recapitulated in a mouse
model. Hearing loss in mice heterozygous for the dominant-
negative pore mutation G285S progressed significantly slower
than after full deletion of KCNQ4 (Kharkovets et al., 2006).
Thus, even the minute current levels retained under
dominant-negative suppression of KCNQ-mediated currents
are obviously sufficient to substantially delay hair cell degen-
eration. Hence, even a moderate enhancement of native IK,n,
as observed with the channel openers, may provide signifi-
cant protection against hair cell loss in DFNA2. We expect
that chemical KCNQ openers enhance the current of residual
wt channels in the dominant-negative mouse model (Khark-
ovets et al., 2006) as also seen for native IK,n in OHCs.
However, if this current increase is sufficient to delay the
onset of hearing loss or even protect OHCs from degenera-
tion, this should be further investigated directly in vivo.
Another issue that deserves attention is the finding that
channel openers examined here do not only act on KCNQ4
channels within the inner ear but also strongly potentiate
M-currents mediated by KCNQ2, -3 and -5 subunits in many
central and peripheral neurons (Xiong et al., 2007; Lv et al.,
2010). Of note, ZnP alone showed the highest potency for
KCNQ4 as compared with other KCNQ isoforms (Xiong et al.,
2007). However, the various openers available to date have
different potencies towards KCNQ4 and also differ in their
potencies towards the different KCNQ isoforms (Schroder
et al., 2001; Tatulian et al., 2001; Xiong et al., 2007), suggest-
ing that it may be possible to develop openers with higher
specificity for KCNQ4.
Mechanism of current enhancement
It was shown previously that ZnP increases the open prob-
ability of KCNQ channels, rather than altering single channel
conductance (Xiong et al., 2007). This indicates that ZnP, and
most likely other KCNQ openers, are primarily modifiers of
channel gating, which is consistent with the shifted voltage-
dependence observed here and in previous studies (Schroder
et al., 2001; Tatulian et al., 2001; Xiong et al., 2007). DFNA2
mutations may abolish channel function via different mecha-
nisms: most obviously, mutations in the channel pore are
expected to impair ion permeation, rendering channels con-
stitutively non-functional independent of channel gating.
This is consistent with our observation that KCNQ openers
were completely ineffective in uncovering any channel activ-
ity in the pore mutants. For the mutation in the proximal
C-terminus, G321S, there is no obvious reason to expect an
impairment of ion permeation, as this region does not con-
tribute to the pore structure. It seems more likely that this
mutation disrupts channel gating, since in KCNQ channels,
the C-terminus mediates channel gating by various
physiological signals, including phosphatidylinositol(4,5)
bisphosphate (Hernandez et al., 2008; 2009), Ca2+-calmodulin
(Gamper et al., 2005) and phosphorylation (Li et al., 2004).
Consistent with this hypothesis, we found that the gating
modifiers, ZnP/Ret, partially restored channel activity in
G321S, but not in homomeric or heteromeric pore mutant
channels.
Recently, disruption of targeting to the plasma membrane
has been proposed as an alternative explanation for the dys-
function of DFNA2 mutants, including the pore mutations
and G321S (Mencia et al., 2008; Kim et al., 2011). Such a
mechanism would also be consistent with the lack of effect of
channel openers on the pore mutants. However, the ZnP/Ret-
induced currents through KCNQ4-G321S clearly show traf-
ficking of this mutant channel to the plasma membrane,
although we cannot exclude a reduction of surface
expression.
Pharmacological properties and the molecular
nature of IK,n
There is strong evidence indicating that the OHC current IK,n
is mediated by KCNQ4 channels (Marcotti and Kros, 1999;
Kharkovets et al., 2000; 2006; Holt et al., 2007; Oliver et al.,
2003). Nevertheless, the functional properties of IK,n differ
from those of heterologously expressed KCNQ4 channels in
various aspects. Most strikingly, the activation voltage of IK,n
is much more negative and the activation kinetics are faster
(Mammano and Ashmore, 1996; Marcotti and Kros, 1999).
Here we show that the differences extend to the pharmaco-
logical properties. Thus, current potentiation by retigabine,
ZnP, and a combination of both openers was much less pro-
nounced with IK,n than with heterologously expressed
KCNQ4. Similarly, the drug-induced hyperpolarizing shift in
the voltage of activation was smaller for the native channel.
The differential sensitivity to channel openers is particularly
pronounced for BMS-204352: this opener produced a 10-fold
potentiation of recombinant KCNQ4 at saturating voltages,
but was essentially ineffective on native IK,n.
The molecular basis of these differences has remained
elusive so far. An attractive hypothesis, however, is that IK,n
characteristics result from the presence of as yet unknown
accessory subunits within the native ion channel complex.
KCNE b-subunits are obvious candidates for such accessory
subunits, as they co-assemble with KCNQ a-subunits and are
determinants of biophysical and pharmacological channel
properties (McCrossan and Abbott, 2004). KCNE expression
has been detected in the cochlea and all KCNE isoforms
appear to co-assemble with KCNQ4 upon heterologous
expression (Strutz-Seebohm et al., 2006). However, none of
the KCNE1-5 isoforms alters the biophysical properties of
KCNQ4 currents in a manner consistent with the native
current, IK,n (Strutz-Seebohm et al., 2006). Another possibility
is that native IK,n channels may be heteromeric KCNQ3/
KCNQ4 channels (Kubisch et al., 1999). Among the KCNQ
channels, KCNQ3 is least sensitive to channel openers (Xiong
et al., 2007; 2008) and might decrease the sensitivity of
KCNQ4 in the heteromers. In OHCs, the expression of
KCNQ3 cannot be excluded unequivocally (Kubisch et al.,
1999; Jentsch, 2000; Kharkovets et al., 2006). Thus, we tested
the properties of heteromeric channels in CHO cells
co-transfected with KCNQ3 and KCNQ4. Voltage- depen-
dence and sensitivity towards channel openers of KCNQ3/4
heteromers were not different from homomeric KCNQ4
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channels, indicating that co-assembly with KCNQ3 in OHCs
cannot explain the unusual pharmacological and biophysical
properties of IK,n (Supporting Information Figure S5). Thus,
the molecular underpinnings of the native current remain
unknown.
Mechanistically, one explanation for the relative insensi-
tivity of IK,n might be that endogenous hair cell-specific modi-
fiers of gating increase open probability via the same
mechanism that is exploited by the synthetic channel
openers, thereby occluding additive effects. In fact, recombi-
nant KCNQ4 in the presence of ZnP/Ret closely resembles the
native current in terms of voltage-dependence and kinetics
(Supporting Information Figure S2). One prerequisite for the
dramatic current enhancement by channel openers is the low
open probability of KCNQ channels even at saturating volt-
ages (Li et al., 2005). For recombinant KCNQ4, ZnP was
shown to increase the open probability at 0 mV from 0.01 to
0.33 (Xiong et al., 2007). The similarity of IK,n with KCNQ4
currents potentiated by ZnP/Ret may indicate high basal
open probabilities of the native channels. For pharmacologi-
cal restoration of IK,n in DFNA2, a high endogenous open
probability may pose a fundamental obstacle, as it limits the
enhancement that can be reached. Therefore, it will be inter-
esting to see, if basal open probabilities of native channels
mediating IK,n are indeed higher than those of the correspond-
ing channel in an expression system.
In conclusion, we have shown that the dominant-
negative suppression of ion channel function underlying
hearing loss in DFNA2 can be overcome using synthetic
channel openers. Beyond hereditary deafness, KCNQ channel
openers may prove useful in forms of deafness that involve
hair cell loss, as we have recently shown that ZnP and reti-
gabine can also antagonize the suppression of IK,n by ototoxic
aminoglycoside antibiotics (Leitner et al., 2011).
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Supporting information
Additional Supporting Information may be found in the
online version of this article:
Figure S1 Chemical KCNQ openers augment heterologous
KCNQ4. (A–D) Dose-response relationships of CHO cells
expressing wt KCNQ4 for (A) retigabine (B) BMS-204352 (C)
flupirtine and (D) zinc pyrithione. Current amplitudes at
0 mV were normalized to control currents prior the applica-
tion of the KCNQ agonist, and were fitted to a Hill equation
to calculate the concentration at half-maximal effect (EC50)
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and the Hill coefficient (n). Note different potencies of
current augmentation of the substances. (E, F) Voltage-
dependence of heterologous KCNQ4 in presence of (E) 10 mM
BMS-204352 and (F) 10 mM flupirtine. Conductance-voltage
relations were derived from tail current recordings as shown
in Supporting Information Figure S2, and currents were nor-
malized to the maximum current and fitted by a two-state
Boltzmann function. Continuous lines indicate the Boltz-
mann fit to the averaged data. Fits to the current-voltage
relation of individual cells yielded (E) Vh under control
conditions of -19.6  1.9 mV, and in presence of 10 mM
BMS-204352 of -31.7  1.2 mV. Note that application of
BMS-204352 lowered k from -13.7  3.7 to -6.0  0.5 mV
(n = 7). (F) In presence of flupirtine Vh was shifted from
-17.2  1.2 mV to -23.2  1.2 mV (n = 11), without affecting
the slope. (G) Summarized time course of KCNQ4 current
potentiation at 0 mV by ZnP/Ret (10 mM both, n = 8).
Figure S2 ZnP/Ret produces IK,n-like KCNQ4 currents in
CHO cells. (A–C) Representative recordings of wt KCNQ4 in
CHO cells (A), K+ currents in OHCs (B) and wt KCNQ4
in presence of ZnP/Ret (10 mM both) (C). A and C show
recordings from the same cell. Voltage-protocols were as indi-
cated. (D) Current-voltage relationship for native IK,n in
OHCs and heterologous KCNQ4 in presence and absence of
ZnP/Ret. ZnP/Ret shifted KCNQ4 currents by -40 mV to Vh =
-64.0  2.5mV (n = 8), producing an IK,n-like voltage range of
activation (Vh = -75.7  1.3 mV, n = 24). Note that in pres-
ence of ZnP/Ret heterologous KCNQ4 currents showed
marked inactivation at voltages more depolarised than
+20 mV that was not further investigated in this study. Data
are reproduced for comparisons from Figures 1 and 7 in the
main text.
Figure S3 KCNQ4-F182L is fully functional and sensitive to
ZnP/Ret. (A, B) Representative currents of the same CHO cell
expressing KCNQ4-F182L. Voltage command as indicated,
scale bar corresponds to A and B. Dashed lines indicate zero
current. (C) Current-voltage relationship for F182L under
control conditions (black) and with ZnP/Ret (red) derived
from Boltzmann fits to the tail currents as recorded in (A, B).
Control F182L currents showed the same voltage-dependence
as wt KCNQ4 (F182L: Vh = -18.0  1.8 mV), and ZnP/Ret
shifted voltage-dependence as for wt (Vh = -62.9  4.7 mV;
n = 8). (D) KCNQ4-F182L current amplitudes at 0 mV in
presence and absence of the KCNQ channel opener. For
F182L ZnP/Ret-mediated current potentiation and sensitivity
to the KCNQ antagonist XE991 were similar as for wt KCNQ4.
Figure S4 KCNQ4 current amplitudes do not depend on the
DNA amount used for transfection. (A, B) Co-expression
experiments of wt and mutant KCNQ4 (1:1) required the
halving of the DNA concentration for each plasmid used for
transfection. Using equal DNA amounts in control experi-
ments did not affect homomeric wt KCNQ4 current ampli-
tudes. Thus reduction of current amplitudes by co-expressed
mutants was caused by dominant-negative suppression of wt
subunits (compare with Figure 5 in the main text). (A) Shows
a representative recording of a CHO cell expressing wt
KCNQ4 with half[DNA] used for transfection. (B) Current
amplitudes using half[DNA] were indistinguishable from
control cells using the normal amount of DNA (recordings
from the same batch of cells).
Figure S5 KCNQ4 homomeric channels and KCNQ3/
KCNQ4 heterotetramers show comparable sensitivity towards
chemical openers. (A) Retigabine (left panel, 2.5 mM) and ZnP
(right panel, 2.5 mM) robustly potentiated currents from CHO
cells transfected either with KCNQ4 alone or co-transfected
with KCNQ4 and KCNQ3. Values shown are current densities
at 0 mV. Note that control currents from co-transfected cells
are several folds larger than in KCNQ4-tranfected cells, indi-
cating coassembly of KCNQ3/KCNQ4 hetero-tetramers (cg.
Kubisch et al., 1999) (recordings from the same batch of
cells). The drug concentrations were chosen close to their
EC50 values (see Supporting Information Figure S1). (B)
Current potentiation by retigabine (left) and ZnP (right) was
comparable and statistically indistinguishable for KCNQ4
homomers and KCNQ3/4 heteromers. Values shown indicate
relative current increase at 0 mV calculated from the same set
of recordings shown in (A). (C) Current-voltage relationship
for KCNQ4 homomers and KCNQ3/4 heteromers. KCNQ4
homomeric channels (Vh = -21.7  0.8 mV) show the same
voltage-dependence as KCNQ3/4 (Vh = -23.3  1.3 mV;
recordings from the same batch of cells).
Please note: Wiley-Blackwell are not responsible for the
content or functionality of any supporting materials supplied
by the authors. Any queries (other than missing material)
should be directed to the corresponding author for the article.
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Probing the regulation of TASK potassium channels by
PI(4,5)P2 with switchable phosphoinositide phosphatases
Moritz Lindner1, Michael G. Leitner1, Christian R. Halaszovich1, Gerald R. V. Hammond2
and Dominik Oliver1
1Institute of Physiology and Pathophysiology, Department of Neurophysiology, Philipps University, Deutschhausstrasse 1-2, 35037 Marburg, Germany
2Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1PD, UK
Non-technical summary The electrical activity of nerve cells is produced by the flux of ions
through specialized membrane proteins called ion channels. Some ion channels can be regulated
by the signalling lipid PIP2, a component of the channels’ membrane environment. Here we
examine the relevance of PIP2 for the regulation of one specific channel type, termed TASK.Many
chemical transmitters in the brain change neural activity by shutting off TASK channels and it
has been suggested that this results from reduction of PIP2. By using novel techniques to alter
the concentration of PIP2 in living cells, we find that the activity of TASK is independent of PIP2.
Besides demonstrating that another signalling mechanismmust control the activity of nerve cells
via TASK inhibition, we delineate a general approach for clarifying the relevance of PIP2 in many
cell types and organs.
Abstract TASK channels are backgroundK+ channels that contribute to the resting conductance
in many neurons. A key feature of TASK channels is the reversible inhibition by Gq-coupled
receptors, thereby mediating the dynamic regulation of neuronal activity by modulatory trans-
mitters. The mechanism that mediates channel inhibition is not fully understood. While
it is clear that activation of Gαq is required, the immediate signal for channel closure
remains controversial. Experimental evidence pointed to either phospholipase C (PLC)-mediated
depletion of phosphatidylinositol-4,5-bisphosphate (PI(4,5)P2) as the cause for channel closure
or to a direct inhibitory interaction of active Gαq with the channel. Here, we address the role of
PI(4,5)P2 for G-protein-coupled receptor (GPCR)-mediated TASK inhibition by using recently
developed genetically encoded tools to alter phosphoinositide (PI) concentrations in the living
cell. When expressed in CHO cells, TASK-1- and TASK-3-mediated currents were not affected by
depletion of plasma membrane PI(4,5)P2 either via the voltage-activated phosphatase Ci-VSP or
via chemically triggered recruitment of a PI(4,5)P2-5′-phosphatase. Depletion of both PI(4,5)P2
and PI(4)P via membrane recruitment of a novel engineered dual-specificity phosphatase also
did not inhibit TASK currents. In contrast, each of these methods produced robust inhibition of
the bona fide PI(4,5)P2-dependent channel KCNQ4. Efficient depletion of PI(4,5)P2 and PI(4)P
was further confirmed with a fluorescent phosphoinositide sensor. Moreover, TASK channels
recovered normally from inhibition by co-expressed muscarinic M1 receptors when resynthesis
of PI(4,5)P2 was prevented by depletion of cellular ATP. These results demonstrate that TASK
channel activity is independent of phosphoinositide concentrations within the physiological
range. Consequently, Gq-mediated inhibition of TASK channels is not mediated by depletion of
PI(4,5)P2.
(Received 15 March 2011; accepted after revision 30 April 2011; first published online 3 May 2011)
Corresponding author D. Oliver: Institute of Physiology and Pathophysiology, Deutschhausstrasse 2, 35037 Marburg,
Germany. Email: oliverd@staff.uni-marburg.de
Abbreviations CHO, Chinese hamster ovary; Ci-VSP, Ciona intestinalis voltage-sensitive phosphatase;
GPCR, G-protein-coupled receptor; m1R, muscarinic m1 acetylcholine receptor; Oxo-M, oxotremorine-M;
PH, pleckstrin homology; PI, phosphoinositide; PI(4)P, phosphatidylinositol-4-phosphate; PI(4,5)P2,
phosphatidyl-inositol-4,5-bisphosphate; PLC, phospholipase C; TIRF, total internal reflection fluorescence.
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Introduction
TWIK-related acid sensitive potassium channels (TASK-1
and TASK-3) are members of the two-pore-domain
potassium channel (K2P) family (Duprat et al. 1997; Rajan
et al. 2000). They are constitutively open K+-selective
‘background’ channels that dominate the resting or ‘leak’
K+ conductance in many cells, thereby setting membrane
potential and basal electrical properties (reviewed in
Enyedi & Czirjak, 2010). TASK channels are broadly
expressed in diverse neuronal populations throughout the
central nervous system (Talley et al. 2001), but also in
many peripheral tissues, e.g. adrenal cortex (Czirjak et al.
2000) and heart (Putzke et al. 2007).
Both TASK-1 and TASK-3 channels are potently
inhibited by receptors that signal through the Gq/11
subgroup of G-proteins, including muscarinic acetyl-
choline receptors, metabotropic glutamate receptors and
angiotensin receptors (Enyedi & Czirjak, 2010). This
inhibition is rapid and reversible. It has been observed
in various native cell types and is readily reconstituted
in heterologous expression systems upon co-expression
of recombinant TASK with Gq-coupled receptors (e.g.
Czirjak et al. 2000; Millar et al. 2000; Chemin et al. 2003;
Chen et al. 2006). As TASK channels are open at resting
membrane potential, their inhibition generally results in
depolarization and increased excitability. A well-studied
example is the cerebellar granule neuron, where TASK
channels determine membrane potential and enable fast
action potential firing (Millar et al. 2000; Brickley et al.
2007). Activation of Gq-coupled muscarinic m3 acetyl-
choline receptors and group I metabotropic glutamate
receptors inhibit the TASK-mediated conductance (Boyd
et al. 2000; Chemin et al. 2003), consequently changing the
firing behaviour of the granule cell (Watkins & Mathie,
1996). In adrenal zona glomerulosa cells, secretion of
aldosterone is promoted by the depolarization that results
from inhibition of TASK-3 channels by angiotensin II via
Gq-coupled AT1 receptors (Czirjak et al. 2000; Enyedi &
Czirjak, 2010).
The molecular mechanism that leads to TASK channel
closure remains elusive (reviewed in Mathie, 2007;
Enyedi & Czirjak, 2010). While there is consensus that
activation of Gαq/11 is required (Chen et al. 2006),
two alternative Gq-dependent mechanisms have been
proposed to mediate channel inhibition.
First, channel closure may result from a direct inter-
action of activated Gαq with the channel protein. This
mechanism is supported, among other observations, by
inhibition of TASK by active Gαq even in a cell-free
(excised patch) system and by co-immunoprecipitation of
Gαqwith the channel protein (Chen et al. 2006).However,
this direct interaction awaits confirmation by independent
methods and the putative molecular interaction domains
have not yet been identified.
Alternatively, TASK inhibition may result from
depletion of PI(4,5)P2 by PLC activated downstream
of Gαq. Evidence for this model includes an activating
effect of PI(4,5)P2 applied to excised patches containing
TASK channels and channel inhibition by scavengers
of polyanionic lipids (Chemin et al. 2003; Lopes et al.
2005). Regulation of TASK channels by PI(4,5)P2 is
an attractive model, as activity of many ion channels
strictly depends on PI(4,5)P2 as a cofactor. In fact,
some channel types have been shown convincingly to be
controlled by PI(4,5)P2 dynamics (Suh & Hille, 2008).
Specifically, Gq-mediated inhibition of KCNQ (Kv7)
channels, which closely resembles inhibition of TASK by
the same receptors, is directly mediated by depletion of
PI(4,5)P2 (Suh & Hille, 2002; Zhang et al. 2003; Suh et al.
2006).
One pivotal experimental strategy to distinguish
between both mechanisms has been the use of the
PLC inhibitor U73122, because PLC acts downstream of
Gαq but upstream of PI(4,5)P2 concentration changes
(Horowitz et al. 2005). However, while occlusion of
receptor-mediated TASK channel inhibition by U73122
was found in some studies (Czirjak et al. 2001; Chemin
et al. 2003), U73122 was ineffective according to other
reports (Boyd et al. 2000; Chen et al. 2006). Thus, the
involvement of PLC is contentious.
In any case, if TASK inhibition results from
PLC-induced depletion of PI(4,5)P2, binding of this
phospholipid must be essential for maintaining channel
activity and, importantly, the channel’s affinity for
PI(4,5)P2 must be low enough to warrant disruption
of the interaction by reductions in the PI(4,5)P2
concentration that occur under physiological conditions,
i.e. receptor-induced activation of PLC. Following this
reasoning, we here employ an arsenal of newly developed
methods to alter the concentrations of endogenous
PI(4,5)P2 and related phosphoinositides in the living cell
whilemonitoring TASK channel activity. These genetically
encoded tools allowed for the acute depletion of PI(4,5)P2
without activating any of the multiple other signals
generated by the Gq-mediated pathway. Neither depletion
of PI(4,5)P2 and PI(4)P by various methods nor blocking
resynthesis of PI(4,5)P2 after receptor-induced depletion
by PLC interfered with TASK channel activity. In contrast,
all of these manoeuvres reliably down-regulated the bona
fide PI(4,5)P2-dependent channel, KCNQ4. Our results
thus provide clear evidence that TASK channel activity
does not require PI(4,5)P2. Consequently, inhibition by
GPCRs is not mediated by depletion of phosphoinositides
but by another signal within the complex Gq signalling
cascade.
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Methods
Molecular biology and heterologous expression
The following expression vectors were used: TASK-1
(NM 002246) and TASK-3 (NM 016601) both in
pcDNA3.1; KCNQ4 (NM 004700.2) in pEGFP-C1
(Clontech Laboratories, Mountain View, CA, USA);
PHPLCδ1-GFP (P51178; pEGFP-N1) or PHPLCδ1-YFP
(pcDNA3); Ci-VSP in pRFP-C1 (NP 001028998.1);
human m1R (NM 000738.2) in pSGHV0; Lyn11-FRB in
pC4RHE; and CF-Inp in pCFP-N1 (Suh et al. 2006).
Duplicate PH domains from Osh2p (NM 001180078,
residues 256–424) were fused in tandem at XhoI/EcoRI
and HindIII/KpnI sites in pEGFP-C1 (Clontech) with a
short VNSKL linker, as previously described (Balla et al.
2008).
Construction of pseudojanin and its mutants were
based around the mRFP-FKBP12 constructs previously
reported (Varnai et al. 2006). The constructs were built
using the pEGFP-C1 plasmid backbone (Clontech),
with mRFP replacing the EGFP and FKBP12 fused
to the 3′ end of the mRFP with a flexible linker
(SGLRSRSAAAGAGGAARAALG). Next, the cytosolic
catalytic fragment of S. cerevisiae Sac1p (NM 001179777,
residues 2–517) was fused with a flexible linker (SAGG
SAGGSAGGSAGGSAGGPRAQASRSLDA). Finally, after a
third flexible linker (GGTARGAAAGAGGAGR) residues
214–644 of the human INPP5E 5-phosphatase
(NM 019892) were inserted carrying a C641A mutation
to remove the prenylation site. Inactivating mutations
were then inserted into these phosphatase domains
by site-directed mutagenesis, and the resulting mutant
named for the activity they retain. Therefore, PJ-Sac
carries an inactivating point mutation of the conserved
DRVL motif of INPP5E (equivalent to D556A in the full
length INPP5E), and thus only Sac is active. Conversely,
PJ-5ptase carries an inactivating mutation in the
conservedCX5R(T/S)motif of the Sac domain (equivalent
to C392S in full-length Sac1p), thus only INPP5E
5-phosphatase domain is active. PJ-Dead carries both of
these mutations, and so has no phosphatase activity.
Chinese hamster ovary (CHO) cells were plated onto
glass-bottom dishes (WillCo Wells B. V., Amsterdam,
the Netherlands) for total internal reflection fluorescence
(TIRF) imaging or onto glass coverslips for electro-
physiology and confocal microscopy. Cells were trans-
fected with jetPEI transfection reagent (Polyplus Trans-
fection, Illkirch, France) according to the manufacturer’s
instructions. For co-expression of ion channels with
Ci-VSP-RFP, cells were selected for clear membrane
localization of RFP. For co-expression experiments
involving the rapamycin system (3 plasmids), cells were
selected for robust cyan fluorescent protein (CFP) or RFP
fluorescence, tagging the translocatable enzymes Inp54p
or PJ, respectively. Only those cells were included in
the analysis that showed translocation of CFP or RFP,
respectively, to the plasma membrane upon application
of rapamycin. This behaviour indicates successful
expression of both the membrane anchor (Lyn11-FRB)
and the translocatable fluorescence-tagged enzyme.
The presence of PLCd1-PH-GFP and Osh2x2-PH-GFP
for TIRF measurements was evidenced by the GFP
fluorescence. Successful co-expression of channels was
directly confirmed by the respective currents.
Electrophysiology
Whole-cell recordings were performed with an Axopatch
200B amplifier (Molecular Devices, Sunnyvale, CA, USA)
in voltage-clamp mode. Data were sampled with an
ITC-16 interface (Instrutech, HEKA, Lambrecht/Pfalz,
Germany) controlled by PatchMaster software (HEKA).
For experiments combining patch-clamp andfluorescence
imaging, an EPC10 amplifier (HEKA) was used. Currents
were low-pass filtered at 2 kHz and sampled at 5 kHz.
Patch pipettes were pulled from borosilicate or quartz
glass and had open pipette resistances of 1 to 3M when
filledwith pipette solution. Intracellular (pipette) solution
contained (mM): 135 KCl, 2.41 CaCl2, 3.5MgCl2, 5 Hepes,
5 EGTA, 2.5 Na2ATP and 0.1 Na2GTP, pH 7.3 (adjusted
with KOH). Free [Ca2+] of this solution was 100 nM, as
calculated with MaxChelator (maxchelator.stanford.edu).
Series resistance was <10M and was not compensated.
The extracellular solution was composed as follows
(mM): 144 NaCl, 5.8 KCl, 0.7 NaH2PO4, 5.6 glucose,
1.3 CaCl2, 0.9 MgCl2 and 10 Hepes, pH 7.4 (adjusted
with NaOH). Experiments were performed at room
temperature (∼22◦C).
Fluorescence imaging
TIRF imaging was performed as described elsewhere
(Halaszovich et al. 2009). In brief, a BX51WI upright
microscope (Olympus, Hamburg, Germany) equipped
with a TIRF condenser (numerical aperture of 1.45;
Olympus) and a 488 nm laser (20mW;Picarro, Sunnyvale,
CA, USA) was used. Fluorescence was imaged through
a LUMPlanFI/IR 40×/0.8 NA water immersion objective
(Olympus). Images were acquired with an IMAGO-QE
cooled CCD camera (TILL Photonics GmbH, Gra¨felfing,
Germany). Wide-field fluorescence illumination was
achieved with a monochromator (Polychrome IV, TILL
Photonics GmbH) coupled to the BX51WI microscope
through fibre optics. Green fluorescent protein (GFP)
fluorescence was excited at 488 nm. The laser shutter for
TIRF illumination, the monochromatic light source and
image acquisitionwere controlledbyTILLvisIONsoftware
(TILL Photonics GmbH).
Confocal imaging of membrane translocation of the
CF-Inp and RF–PJ constructs was performed with
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an upright LSM 710 Axio Examiner.Z1 microscope
equipped with a W-Plan/Apochromat 20×/1.0 DIC
M27 75mm water immersion objective (Carl Zeiss
GmbH, Jena, Germany). RFP was excited at 561 nm
with a diode-pumped solid-state laser (Carl Zeiss), and
fluorescence emission was sampled at 582–754 nm. CFP
was excited at 458 nmwith an argon laser (Carl Zeiss) and
emission was sampled at 454–581 nm.
Chemicals
Rapamycin was purchased as a solution in Me2SO (from
Merck KGaA, Darmstadt, Germany) and further diluted
in extracellular solution to a concentration of 5μM before
use. 10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone
(XE991; Tocris, Ellisville, USA) and oxotremorine-M
(Oxo-M;Tocris)wereprepared as 10mMstock solutions in
H2O, and diluted with extracellular solution to their final
concentration of 10μM. Chemicals were delivered locally
to the cells with a gravity-fed, custom-built application
system.
Data analysis
Electrophysiological data were analysed using IgorPro
(Wavemetrics, Lake Oswego, OR, USA) and imaging
data were analysed with TILLvisION and IgorPro.
Regions of interest (ROI) were defined to include the
majority of a single cell’s footprint. To avoid movement
artifacts the margins of the cell were excluded from
analysis. Normalized F/F0 traces were calculated from
the TIRF signal intensity F , averaged from the ROI,
and the initial fluorescence intensity F0 obtained before
application of agonists or depolarization of the cell.
Where appropriate, traces were corrected for bleaching
according to a monoexponential fit to the signal
decay during the pre-application interval. Fluorescence
intensities were background-corrected. Time constants
were obtained from monoexponential fits. All data are
given as mean± standard error of the mean (SEM), with
n indicating the number of individual cells analysed.
Statistical analysis was performed byANOVA test followed
by a two-tailed Dunett t test. Significance was assigned for
P < 0.05.
Results
Inhibition of TASK channels by Gq-coupled muscarinic
receptor
WhenTASK-1orTASK-3 channelswere co-expressedwith
the Gq-coupled muscarinic m1 acetylcholine receptor
(m1R) in CHO cells, application of themuscarinic agonist
Oxo-M resulted in rapid and nearly complete inhibition of
TASK-mediated currents (Fig. 1A andB). Afterwashout of
Oxo-M, the current recovered to about 70% (69.1± 7.0%
for TASK-1 and 70.3± 3.0% for TASK-3) within 4min.
It is well established that Gq-triggered activation of
PLCß can result in a pronounced decrease of the PI(4,5)P2
concentration in the plasma membrane (e.g. Horowitz
et al. 2005) Receptor-mediated PI(4,5)P2 dynamics have
been implicated in the regulation of numerous ion
channels (Suh & Hille, 2008). Thus, it appeared that
channel deactivation due to loss of PI(4,5)P2 might be an
attractive and straightforward mechanism explaining the
inhibition of TASK currents by the Gq-coupled receptors,
as suggested previously (Chemin et al. 2003; Lopes et al.
2005).
We tested for the putative PI(4,5)P2 depletion in
CHO cells using two distinct PI(4,5)P2 biosensors,
the GFP-fused pleckstrin homology (PH) domain of
PLCd1 (PHPLCδ1-GFP (Stauffer et al. 1998) as an optical
probe for PI(4,5)P2, and the voltage-gated potassium
channel KCNQ4 (Kv7.4). PHPLCδ1-GFP specifically binds
to PI(4,5)P2 and has been used widely as a genetically
encoded ‘translocation biosensor’ for PI(4,5)P2. The
degree of its membrane association directly reports on
the concentration of PI(4,5)P2 (Varnai & Balla, 2006).
Here, we used live-cell TIRF microscopy to monitor
membrane association of PHPLCδ1-GFP (Halaszovich et al.
2009). In cells co-expressing m1R and PHPLCδ1-GFP,
TIRF fluorescence strongly decreased during activation
of m1R, indicating dissociation of the sensor from
the membrane, and thus robust depletion of PI(4,5)P2
(Fig. 1E). Upon washout of the receptor agonist, the
TIRF signal recovered, demonstrating reversibility of
PI(4,5)P2 depletion due to resynthesis of PI(4,5)P2. It
has been shown unequivocally that inhibition of KCNQ
(Kv7) potassium channels by many Gq-coupled receptors
results from Gq/PLC-mediated depletion of PI(4,5)P2
(Suh & Hille, 2002; Zhang et al. 2003; Suh et al. 2006;
Hernandez et al. 2009). In our experimental setting,
homomeric KCNQ4 channels were also strongly inhibited
by activation of m1R (Fig. 1C and D), confirming
depletion of PI(4,5)P2. Characteristics of inhibition
resembled the inhibition observed with TASK channels:
KCNQ4-mediated currents decreased by 88.0± 5.5%
within a few seconds and recoveredwith a time course that
matched recovery of TASK-mediated currents (Fig. 1C).
However, the onset of inhibition of TASK-1 and TASK-3
occurred consistently faster than inhibitionofKCNQ4and
PHPLCδ1-GFP dissociation (Fig. 1E).
TASK channel activity is resistant to depletion of
PI(4,5)P2
To scrutinize the suggested role of PI(4,5)P2 concentration
changes in receptor-mediated TASK channel inhibition,
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we used different molecular tools for the selective
depletion of phosphoinositides in the intact cell.
First, we used the voltage-sensitive phosphoinositide
phosphatase Ci-VSP (Murata et al. 2005; Murata
& Okamura, 2007), a membrane-resident PI(4,5)
P2-5-phosphatase, that is rapidly and reversibly activated
by strong depolarization of the membrane potential.
Upon activation, Ci-VSP efficiently removes PI(4,5)P2
from the plasma membrane by dephosphorylation to
PI(4)P (Halaszovich et al. 2009; Falkenburger et al. 2010).
Figure 1. Receptor-mediated inhibition of TASK channels and concomitant depletion of PI(4,5)P2
A, averaged time course of TASK currents upon activation of muscarinic m1 receptors. Data were obtained from
CHO cells co-transfected with m1R and either TASK-1 (n = 6) or TASK-3 (n = 12). Application of the muscarinic
agonist oxo-M (10 μM, 60 s) inhibited currents to 17.0 ± 2.4% for TASK-1 and 9.7 ± 2.4% for TASK-3. Cells were
clamped at –60 mV and currents were measured in response to voltage ramps every 2 s. Traces show currents
at +50 mV, normalized to current amplitude prior to application for each cell before averaging. B, representative
recordings for the experiments summarized in A. Current traces in response to the voltage ramp shown were
obtained from a cell co-expressing m1R and TASK-3. Dashed line indicates zero current level. C, muscarinic
inhibition of KCNQ4 channels measured from CHO cells co-transfected with m1R and KCNQ4 (n = 11). Currents
obtained at 0 mV using the voltage step protocol shown in D at 5 s intervals (holding potential, 0 mV) were
normalized to the current amplitude prior to application of Oxo-M for each cell before averaging. D, representative
recordings and voltage protocol for the experiments summarized in C. E, TIRF recordings from CHO cells expressing
m1R and PHPLCδ1-GFP (n = 17 cells from 3 independent experiments). Application of 10 μM Oxo-M triggered a
strong and reversible decrease in TIRF, indicative of translocation of the GFP-fused sensor from the membrane
to the cytosol. Insets show epifluorescence (upper) and TIRF image (lower panel) of a representative cell before
and after application of Oxo-M. Scale bar, 10 μm. F, average time constants of the onset of muscarinic current
inhibition and of translocation of PHPLCδ1-GFP. Time constants were obtained from monoexponential fits to the
data shown in (A–E). Asterisks indicate significantly faster time constants of TASK-1 and TASK-3 compared to
KCNQ4 (P ≤ 0.05).
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As shown in Fig. 2A, TASK channels were completely
insensitive to the activation of co-expressed Ci-VSP. After
50 s of depolarization to +80mV, TASK-1 and TASK-3
current amplitudes were 102.0± 3.2% and 107.9± 5.8%,
respectively, of current amplitude before activation of
Ci-VSP. In contrast, KCNQ4 currents were strongly
inhibited by the same voltage protocol when co-expressed
with Ci-VSP (residual current, 32.3± 5.8%; Fig. 2A).
This indicated efficient depletion of PI(4,5)P2 by Ci-VSP,
which was further confirmed by strong translocation
of the fluorescent PI(4,5)P2 probe PHPLCδ1-GFP upon
depolarization (Fig. 2D).
We next applied an independent approach that
was developed recently to acutely modify PI(4,5)P2
concentrations (Suh et al. 2006; Varnai et al. 2006). Here,
PI(4,5)P2 is depleted by chemically triggered recruitment
of a yeast polyphosphoinositide-5-phosphatase, Inp54p,
that specifically dephosphorylates PI(4,5)P2 at the 5′
position. Thismethod is based on the hetero-dimerization
of the FRB (FKBP/rapamycin binding) domain from
mTOR and the FKBP (FK506 binding protein) in the
presence of rapamycin. FRB is anchored to the plasma
membrane by fusion to a membrane targeting motif from
Lyn (Lyn11-FRB) and Inp54p is fused to CFP-tagged FKBP
(CF-Inp) (Suh et al. 2006). Consequently dimerization
induced by the addition of rapamycin results in massive
and rapid translocation of Inp54p to the membrane
and thus consumption of PI(4,5)P2. Recruitment can
be monitored conveniently as the translocation of CFP
fluorescence from the cytosol to the membrane (Fig. 3A,
inset).
As shown in Fig. 3A, currents mediated by TASK-1 or
TASK-3 were not affected by application of rapamycin
to cells co-expressing either channel with Lyn11-FRB and
CF-Inp. For all recordings, efficient recruitment of Inp54p
was verified by monitoring the translocation of CFP
fluorescence to the membrane (insets). As before, we
tested for depletion of PI(4,5)P2 by rapamycin-triggered
Figure 2. TASK currents are insensitive to depletion of PI(4,5)P2 by Ci-VSP
A, representative whole-cell currents from CHO cells co-transfected with TASK-3 and Ci-VSP. Currents were
recorded in response to brief voltage ramps from a holding potential of –80mV (a). Holding potential was then
depolarised to +80 mV for 40 s to activate Ci-VSP (b), followed by repolarisation to –80 mV (c). Scale bars,
0.5 nA and 100 ms. B, currents from cells co-transfected with KCNQ4 and Ci-VSP obtained with the same holding
potential protocol as in A. Currents were evoked by brief intermittent voltage steps (–80 to 0 mV) as indicated.
Scale bars, 0.1 nA and 200 ms. C, mean time course of currents obtained from experiments as in A and B from
cells co-transfected with Ci-VSP and either TASK-1, TASK-3 or KCNQ4. The shaded area indicates depolarisation
to +80 mV from an initial holding potential of –80 mV. Depolarisation induced rapid inhibition of KCNQ4 currents
(to 34.1 ± 5.8% of initial current at the end of the depolarizing period; n = 12) but not of TASK-1 (102.0 ± 3.2%,
n = 6) and TASK-3 (107.9 ± 5.8%, n = 7). Monoexponential fits to the recovery of KCNQ4 currents yielded time
constants of 14.6 ± 2.2 s. D, mean TIRF intensities from voltage-clamped cells expressing Ci-VSP and PHPLCδ1-GFP
obtained as in Fig. 1E (n = 12). Depolarization as in C induced fast and reversible translocation of the PI(4,5)P2
probe. Monoexponential fits to the re-association of the PH domain yielded time constants of 10.2 ± 0.8 s.
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translocation of Inp54p using the sensors KCNQ4 and
PHPLCδ1-YFP. KCNQ4-mediated currents were robustly
and rapidly suppressedby applicationof rapamycin to cells
co-expressing KCNQ4, Lyn11-FRB and CF-Inp (Fig. 3B).
Rapamycin applied to cells transfected with the channel
alone failed to affect current amplitude, confirming
that channel inhibition resulted from recruitment of
Inp54p to the membrane. Additionally, dissociation
of PHPLCδ1-YFP from the membrane upon addition
of rapamycin (Fig. 3C) demonstrated efficient depletion
of PI(4,5)P2 by recruitment of Inp54p.
Taken together, TASK channels remained fully active
despite strong decrease in the concentration of membrane
PI(4,5)P2 in intact cells.
Combined depletion of PI(4,5)P2 and PI(4)P does not
affect TASK activity
Our experimental manipulation of PI(4,5)P2 levels
differed from receptor-mediated PI(4,5)P2 depletion.
The phosphatases used here stoichiometrically converted
PI(4,5)P2 to PI(4)P, probably keeping the over-
all phosphoinositide concentration in the membrane
constant. In contrast, activation of PLC depletes both
PI(4,5)P2 and PI(4)P (Willars et al. 1998; Horowitz et al.
2005) without generating a structurally similar lipid. Since
these two phosphoinositides constitute the majority of all
phosphoinositides in the plasmamembrane (Willars et al.
1998; Nasuhoglu et al. 2002), activation of Gq-coupled
receptors triggers bulk depletion of phosphoinositides.
If TASK channels are activated by phosphoinositides
with no or little specificity, the PI(4)P produced by
Ci-VSP and Inp54p might be sufficient to sustain channel
activity. We therefore sought to fully deplete both
PI(4,5)P2 and PI(4)P to closely recapitulate the changes
in phosphoinositide concentrations during Gq/PLC
activation, but without activating the various other
cellularmessengers involved inGq signalling.We therefore
used a modified heterodimerization approach, where
an engineered dual-specificity phosphatase, pseudo-
janin (PJ), replaced Inp54p. As shown schematically
in Fig. 4A, pseudojanin was engineered in analogy to
the native dual-specificity phosphoinositide phosphatase
synaptojanin (Mani et al. 2007) and consists of
two functionally distinct phosphoinositide phosphatase
domains separated by a linker region. The N-terminus
of PJ consists of the yeast 4′-phosphatase Sac while the
C-terminus harbours a human 5-phosphatase (INPP5E).
To allow for rapamycin-drivenmembrane recruitment, PJ
was fused to FKBP and mRFP (RF–PJ).
In cells co-transfected with RF–PJ and Lyn11-FRB,
application of rapamycin triggered efficient recruitment
of PJ to the plasma membrane (Fig. 4A). The
Figure 3. PI(4,5)P2 depletion by chemically triggered
recruitment of Inp54p fails to suppress TASK currents
A, normalized current amplitudes measured from cells co-expressing
CF-Inp, Lyn11-FRB and either TASK-1 or TASK-3. Currents were
unaffected by application of rapamycin. Current amplitudes 2 min
after application of rapamycin were 89.9 ± 4.1% (n = 5) and
89.6 ± 2.5% (n = 6) for TASK-1 and TASK-3, respectively.
Translocation of CF-Inp to the membrane was verified for each
experiment as shown in the representative confocal images before
(left) and after (right) application of rapamycin. Scale bar, 10 μm. B,
KCNQ4-mediated current in cells co-expressing CF-Inp and Lyn11-FRB
was robustly suppressed upon application of rapamycin (n = 5).
When the translocatable phosphatase was omitted (Lyn11-FRB only),
currents were not affected by rapamycin, confirming current
inhibition by depletion of PI(4,5)P2. Residual currents were blocked
by the KCNQ channel inhibitor, XE991. Voltage protocols used were
as described in Fig. 1. C, TIRF recordings from cells co-transfected
with PHPLCδ1-YFP, CF-Inp and Lyn11-FRB. Application of rapamycin
decreased TIRF intensity, indicating dissociation of PHPLCδ1-GFP from
the membrane (n = 15 cells from 4 independent experiments).
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resulting changes in phosphoinositide concentrations
were examined by TIRF imaging of the PI(4,5)P2 sensor,
PHPLCδ1-GFP, and a probe for PI(4)P, PHOSH2×2-GFP
(Roy & Levine, 2004). The latter is a GFP-fused tandem
construct of two identical PH domains from yeast
OSH2p and has been shown to bind to the plasma
membrane in a PI(4)P-dependent manner (Balla et al.
2008). PHPLCδ1-GFPdissociated from themembrane upon
Figure 4. TASK-3 currents are insensitive to combined
depletion of PI(4,5)P2 and PI(4)P by pseudojanin
A, schematic representation of the pseudojanin membrane
targeting construct (RF–PJ) and its recruitment to the plasma
membrane by rapamycin. Confocal images of RF–PJ before (top)
and after addition of 5 μM rapamycin (bottom) show efficient
translocation of PJ. Scale bar, 10 μm. B, TIRF recordings were
performed on cells co-transfected with PHPLCδ1-GFP, Lyn11-FRB,
and either of the RF–PJ variants indicated. Dissociation of
PHPLCδ1-GFP from the membrane upon application of rapamycin
(shaded) was only observed with intact INPP5E 5-phosphatase
domain. (n = 9 cells/5 independent experiments, 5/3, 10/4 and
21/8, for PJ, PJ-Sac, PJ-5ptase and PJ-Dead, respectively). C, TIRF
recordings from cells co-transfected with PHOSH2×2-GFP,
Lyn11-FRB and either of the RF–PJ variants indicated. Dissociation
of PHOSH2×2-GFP from the membrane required functional Sac1
and INPP5E phosphatase domains (n = 14 cells /8 independent
experiments, 11/5, 15/5 and 14/21, for PJ, PJ-Sac, PJ-5ptase and
PJ-Dead, respectively). D, whole-cell voltage-clamp recordings
from cells co-transfected with Lyn11-FRB, fully intact PJ and
either TASK-3 or KCNQ4. While KCNQ currents were robustly
inhibited by recruitment of PJ (residual currents, 30.6 ± 7.8%,
n = 6), TASK currents were not affected (residual currents,
97.4 ± 3.9%, n = 7). Voltage protocols as shown in Fig. 1.
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recruitment of PJ (Fig. 4B and C). Dissociation was also
observed when the Sac1 domain was inactivated by a
point mutation in its catalytic centre, but not when the
INPP5E phosphatase or both phophatase domains were
inactivated by mutation. Thus, recruitment of PJ leads
to depletion of PI(4,5)P2 via its 5′-phoshatase domain.
Similarly, recruitment of PJ resulted in dissociation of
PHOSH2×2-GFP (Fig. 4C) from themembrane. In contrast
to PHPLCδ1, mutational inactivation of either phosphatase
domain abolished this dissociation. This indicates that
PHOSH2×2 can bind to PI(4,5)P2 or PI(4)P and that
the presence of only one of both phosphoinositides
is sufficient for membrane localisation of this probe.
However, this finding also provides clear evidence for
depletion of PI(4)P by PJ recruitment. Taken together,
TIRF imaging using both fluorescent probes demonstrates
that rapamycin-triggered recruitment of PJ robustly and
rapidly depletes both PI(4,5)P2 and PI(4)P.
We went on to examine the effects of phosphoinositide
depletion by PJ on TASK channels in cells co-expressing
TASK-3 with RF–PJ and Lyn11-FRB. As shown in
Fig. 4D, application of rapamycin had no effect on
TASK currents (remaining current, 97.4± 3.9%), despite
successful membrane recruitment of PJ, as confirmed
by association of RFP fluorescence with the plasma
membrane for each recording. To independently confirm
the proper activity of PJ under whole-cell patch-clamp,
we also examined the effect of PJ recruitment on KCNQ4
channels. In contrast to TASK, KCNQ4-mediated currents
were strongly suppressed to 30.6± 7.8% by PJ when sub-
jected to the same experimental protocol (Fig. 4D). In
conclusion, combined depletion of the most abundant
phosphoinositides in the plasmamembrane is insufficient
to inhibit TASK channel activity.
Recovery from receptor-induced inhibition does not
require resynthesis of PI(4,5)P2
Finally, we probed for involvement of phosphoinositides
in TASK channel regulation by interfering with the
resynthesis of PI(4,5)P2 after activation of Gq/PLC.
If channel inhibition was due to PLC-mediated
PI(4,5)P2 depletion, current recovery must depend
on replenishment of PI(4,5)P2. Resynthesis occurs via
sequential phosphorylation of phosphatidylinositol and
PI(4)P and therefore involves ATP hydrolysis (Horowitz
et al. 2005). The ATP requirement for recovery has pre-
viously been used as a criterion for defining involvement
of PI(4,5)P2 in the regulation of KCNQ channels (Suh &
Hille, 2002).
We examined the recovery of TASK currents from
inhibition by co-expressed m1R. ATP was omitted from
the pipette solution and replaced by the non-hydrolysable
analogue AMP-PCP, which fully prevents resynthesis
of PI(4,5)P2 as reported previously (Suh & Hille,
2002; Halaszovich et al. 2009). As shown in Fig. 5A,
TASK3 currents recovered completely after withdrawal
of the muscarinic agonist. The time course of recovery
was not significantly different from control recordings
obtained with 2.5 mM MgATP in the patch pipette
(Fig. 5B). In contrast, recovery of KCNQ4 channels
fromm1R-mediated inhibition was completely abrogated
by ATP removal as reported previously for KCNQ2/3
heteromeric channels (Suh & Hille, 2002). This finding
confirmed that resynthesis was fully prevented and trans-
ient activation of PLC resulted in persistent depletion of
PI(4,5)P2.
In conclusion, our results demonstrate that TASK
channels re-open despite maximal depletion of
phosphoinositides by PLC. Consequently, channel activity
Figure 5. ATP is not required for recovery of TASK-3 currents
A, recovery of TASK-3 and KCNQ4 currents after removal of intracellular ATP. CHO cells co-expressing either
TASK-3 or KCNQ4 with m1R were patch-clamped with a pipette solution containing no ATP and 3 mM AMP-PCP.
Recordings were started after 4 min of dialysis with the pipette solution (TASK-3, n = 5; KCNQ4, n = 6). Voltage
protocols as shown in Fig. 1. B, average time constants for recovery from muscarinic inhibition of TASK-3 were
similar in the presence of 2.5 mM MgATP (data shown in Fig. 1C) or 3 mM AMP-PCP in the patch pipette. Time
constants were derived from monoexponential fits to the current recovery for individual cells.
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does not require PI(4,5)P2 or other phosphoinositides,
indicating that m1R-mediated current inhibition is not
mediated by reduction of the concentrations of PI(4,5)P2
or PI(4)P.
Discussion
PI(4,5)P2 is dispensable for activity of TASK channels
We used various methods to deplete the endogenous
PI(4,5)P2 pool in living cells and consistently found no
change in currents mediated by TASK-1 and TASK-3.
These finding clearly demonstrate that TASK channel
activity does not depend on the concentration of this
phosphoinositide species in the plasma membrane.
Since this conclusion critically relies on the assumption
that Ci-VSP and rapamycin-triggered recruitment of
Inp54p efficiently degrade the PI(4,5)P2 content of the
membrane, it is worth considering the degree of PI(4,5)P2
depletion achieved with these methods. We used two
different sensors to follow the PI(4,5)P2 concentration in
our experimental setting: a fluorescent PI(4,5)P2 probe
that has been used extensively (PHPLCδ1-GFP; (Varnai
& Balla, 2006) and a PI(4,5)P2-dependent ion channel,
KCNQ4. Inhibition of KCNQ4 currents upon recruitment
of Inp54p and PJ was faster than the dissociation of
PLCδ1-PH-GFP (Figs 3 and 4) and current recovery was
slower after activation of m1R or Ci-VSP (Figs 1 and 2).
This difference may be explained by a lower apparent
affinity of KCNQ4 for PI(4,5)P2 when compared to the
fluorescent sensor. In fact, less activation of Ci-VSP,
and consequently a lower degree of PI(4,5)2 depletion,
is needed to fully inhibit KCNQ4 channels than to
displace PLCδ1-PH-GFP from the plasma membrane (A.
Rjasanow, C. R. Halaszovich and D. Oliver, unpublished
results). Notwithstanding, translocation of PHPLCδ1-GFP
from the membrane and inhibition of KCNQ4 channels
during activation of Ci-VSP and membrane recruitment
of the phosphatase quantitatively matched the responses
following activation of m1R. Therefore, the degree of
PI(4,5)P2 depletion achieved with the genetically encoded
tools was similar to the PLC-mediated depletion during
receptor stimulation.
In agreement with our observations, recent
work showed that channel inhibition by Ci-VSP
and rapamycin-triggered phosphatase recruitment
is remarkably consistent with the sensitivity
to receptor-mediated PLC activation for other
PI(4,5)P2-regulated channels including voltage-gated
calciumandpotassium channels (Falkenburger et al. 2010;
Suh et al. 2010). Moreover, even Kir2.1 inward rectifier
K+ channels, which are characterized by particularly
high affinity for PI(4,5)P2 (Du et al. 2004), are strongly
inhibited by Ci-VSP (Murata & Okamura, 2007; A.
Rjasanow and D. Oliver, unpublished results). These
considerations clearly show that the genetically encoded
tools used here are well suited to gauge the sensitivity of
channels to PLC-mediated depletion of PI(4,5)P2.
We further note that inhibition of TASK channels
by m1R activation occurred consistently faster than
inhibition of KCNQ4. The latter channel has a
comparatively low affinity to PI(4,5)P2, and is therefore
highly sensitive to PLC activation (Hernandez et al. 2009).
Thus, if depletion of PI(4,5)P2 was causing loss of TASK
channel activity due to a direct PI(4,5)P2–channel inter-
action, the affinity of TASK channels for PI(4,5)P2 would
be predicted to be even lower compared to KCNQ4
and TASK would be highly sensitive to activation of
the phosphatases used in our experiments. This was not
the case. We therefore conclude that TASK channels are
resistant to depletion of PI(4,5)P2 within a physiological
range of concentrations.
It was previously shown that application of PI(4,5)P2 to
excised membrane patches can enhance TASK-mediated
currents (Chemin et al. 2003; Lopes et al. 2005). This is
seemingly in contradiction to our results and has been
taken to suggest a role of PI(4,5)P2 in the regulation of
these channels.However, it shouldbenoted thatour results
do not necessarily exclude that a reduction of PI(4,5)P2 to
levels below those reached under physiological conditions
(by PLC or phosphatases) may lead to channel closure.
In other words, it remains possible that TASK channels
bind PI(4,5)P2 with a very high affinity, whereby PI(4,5)P2
would be a permissive cofactor but not a physiological
regulator of TASK (Gamper & Shapiro, 2007). Such a
role of PI(4,5)P2 may be consistent with the partial
block of TASK-mediated currents byPI(4,5)P2-scavenging
polycations such as poly-lysine and neomycin observed
previously (Chemin et al. 2003; Lopes et al. 2005).
Alternatively, artificially high levels of PI(4,5)P2, as may
be reached by application to excised patches, may enhance
TASK currents. In any case, our experiments exclude that
inhibition of TASK channels by Gq-coupled receptors
results from PLC-mediated depletion of PI(4,5)P2.
A role for other phosphoinositides?
Although resistance to Ci-VSP and Inp54p unequivocally
show that PI(4,5)P2 depletion is not sufficient
for channel down-regulation, it remained possible
that other phosphoinositides might be involved in
receptor-mediated inhibition of TASK. Specifically, PI(4)P
might be relevant since it is present at similar
concentrations as PI(4,5)P2 in the resting plasma
membrane and is also depleted during receptor-induced
activation of PLC (Willars et al. 1998; Horowitz
et al. 2005). If TASK channels had a non-selective
dependence on phosphoinositides, similar to some
inward rectifier K+ (Kir) channels (Rohacs et al.
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1999; Tucker & Baukrowitz, 2008), then activation of
PI(4,5)P2-5-phosphatases might not suffice for channel
deactivationdespite strongdepletionofPI(4,5)P2. Inother
words, the differential sensitivity of TASK to PLC versus
phosphatases might result from the different changes in
the overall concentration of phosphoinositides according
to the different enzymatic activities.
To examine such a possible role of combined depletion
of PI(4,5)P2 and PI(4)P in receptor-induced TASK
inhibition, we used PJ, a novel engineered dual-specificity
phosphatase for dephosphorylation of PI(4,5)P2 and
PI(4)P. Recruitment of PJ to the membrane efficiently
depleted both phosphoinositides as indicated by specific
fluorescent sensors. However, the complete insensitivity of
TASK to this manoeuvre indicated that neither PI(4,5)P2
nor PI(4)P concentrations contribute to regulation of
TASK channels by PLC. This conclusion is further
strongly supported by the full reactivation of TASK
channels from receptor-induced inhibition observed after
substitution of ATP by the non-hydrolysable analogue
AMP-PCP.Under this condition, resynthesis of PI(4)P and
PI(4,5)P2 is abrogated, resulting in persistent depletion
of both phosphoinositides after activation of Gq-coupled
receptors.
A TASK-associated pool of PI(4,5)P2 inaccessible to
exogenous phosphatases?
It has been suggested that the plasma membrane
may harbour functionally distinct pools of PI(4,5)P2
(Wang et al. 2004; Vasudevan et al. 2009). Such pools
may correspond to PI(4,5)P2 localized to spatially
separated membrane domains, such as lipid rafts or
caveolae versus non-raft membranes (Johnson et al.
2008; Cui et al. 2010), although such local domains
are difficult to reconcile with the fast diffusion of
phosphoinositides as determined in native plasma
membranes (Hilgemann, 2007). Experimental findings
suggested that localized PI(4,5)P2 pools resulting from
restricted diffusion may determine regulation of ion
channels by PI(4,5)P2 in cardiomyocytes (Cho et al.
2005). The efficient inhibition of KCNQ2/3 heteromeric
channels by Gq-coupled muscarinic receptors in HEK
cells required co-localization of channels and receptors
to detergent-resistant membrane fractions (Oldfield et al.
2009). In principle, the observed differential action of
receptor-activated PLC and recombinant phosphatases
could be compatible with PI(4,5)P2-mediated regulation
of TASK channels, if the channels interactedwith a distinct
‘private’ pool of PI(4,5)P2 that is depleted by endogenous
PLC but is inaccessible to the phosphatase constructs used
in this study. However, any membrane pool of PI(4,5)P2
must remain exhausted after depletion by PLC when
replenishment of PI(4,5)P2 is blocked. Therefore, such a
possibility is clearly ruled out by our finding of full current
recovery in the absence of intracellular ATP.
In summary, our results obtained upon depletion
of PI(4,5)P2 and PI(4)P by exogenous phosphatases
and inhibition of their resynthesis after depletion by
endogenous PLC rule out a requirement of these
phosphoinositides for TASK channel activity. Specifically,
we conclude that the inhibition of TASK channels by
Gq-coupled receptors is not mediated by depletion of
phosphoinositides.
Possible mechanisms for Gq/PCR-mediated TASK
channel inhibition
Since depletion of PI(4,5)P2 can be ruled out as the signal
that mediates channel closure downstream of Gq/PCR
activation, which other mechanisms of channel inhibition
remain? In principle, several other intermediates within
the Gq-mediated signalling cascade may interact with
TASK channels to induce channel closure.
The currently most complete evidence suggests that
a direct interaction of activated Gαq protein (Gαq∗)
can deactivate TASK channels (Chen et al. 2006). This
scenario is supported by elegant experiments including
the demonstration of channel activation by purified Gαq∗
in excised patches and co-immunoprecipitation of Gαq∗
with TASK channels (Chen et al. 2006). However, it
should be noted that previous studies demonstrated the
suppressionofGqPCR-mediatedTASKchannel inhibition
by the PLC inhibitor U73122 (Czirjak et al. 2001; Chemin
et al. 2003), suggesting at least a contribution of signals
downstream of PLC activation. Among these signals,
channel phosphorylation by PKC has been ruled out,
since elimination of candidate phosphorylation sites did
not impedeGq/PCR-dependent channel inhibition (Talley
& Bayliss, 2002; Veale et al. 2007). This conclusion is
supported by our current results showing that inhibition
is unaffected by removal of the intracellular ATP required
for phosphorylation.
Given the high physiological relevance of Gq/PCR-
mediated inhibition of TASK-1 and TASK-3, further work
is needed to unequivocally identify the mechanism of
channel regulation.
Methods for probing the phosphoinositide regulation
of ion channels
The combined methods used here provide a toolbox for
probing the physiological relevance of phosphoinositides
and their concentration dynamics for the regulation of
ion channels. Many ion channels have been shown to
be affected by PI(4,5)P2 (Suh & Hille, 2008). However,
in many cases the proposal of a functional role for
PI(4,5)P2 is solely based on the application of exogenous
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phosphoinositides to excised membrane patches. In
addition to TASK channels, examples for the alteration
of channel behaviour by exogenous PI(4,5)P2 include
TREK channels as additional members within the K2P
channel family (Chemin et al. 2005), voltage-gated
K+ (Kv) channels (Oliver et al. 2004), various TRP
channels (Rohacs & Nilius, 2007) and HCN channels
(Zolles et al. 2006), among others. As shown here, such
sensitivity to applied phosphoinositides may not always
provide strong evidence for a role in the regulation of
channels under physiological conditions. Furthermore,
pharmacological tools for alterations of phosphoinositide
concentrations are poorly developed, and a control for
the effectiveness of the intended changes is usually not
performed. Thus, genetically encoded tools for the acute
manipulation of endogenous phosphoinositide pools
combined with fluorescence-based sensors for control of
thesemanipulations shouldhelp substantially in obtaining
a clearer picture of the genuine roles of PI(4,5)P2 in
ion channel regulation. Moreover, these methods are not
limited to the analysis of ion channels but may be used
to address the role of phosphoinositides in other cellular
processes as well.
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The recently discovered voltage-sensitive phosphatases
(VSPs) hydrolyze phosphoinositides upon depolarization of the
membrane potential, thus representing a novel principle for the
transduction of electrical activity into biochemical signals.
Here, we demonstrate the possibility to confer voltage sensitiv-
ity to cytosolic enzymes. By fusing the tumor suppressor PTEN
to the voltage sensor of the prototypic VSP from Ciona intesti-
nalis, Ci-VSP, we generated chimeric proteins that are voltage-
sensitive and display PTEN-like enzymatic activity in a strictly
depolarization-dependent manner in vivo. Functional coupling
of the exogenous enzymatic activity to the voltage sensor is
mediated by a phospholipid-binding motif at the interface
between voltage sensor and catalytic domains. Our findings
reveal that the main domains of VSPs and related phosphoino-
sitide phosphatases are intrinsically modular and define struc-
tural requirements for coupling of enzymatic activity to a volt-
age sensor domain. A key feature of this prototype of novel
engineered voltage-sensitive enzymes, termed Ci-VSPTEN, is
the novel ability to switch enzymatic activity of PTEN rapidly
and reversibly. We demonstrate that experimental control of
Ci-VSPTENcanbeobtained either by electrophysiological tech-
niques or more general techniques, using potassium-induced
depolarization of intact cells. Thus, Ci-VSPTEN provides a
novel approach for studying the complex mechanism of activa-
tion, cellular control, and pharmacology of this important
tumor suppressor. Moreover, by inducing temporally precise
perturbation of phosphoinositide concentrations, Ci-VSPTEN
will be useful for probing the role and specificity of these mes-
sengers in many cellular processes and to analyze the timing of
phosphoinositide signaling.
Many cellular processes, ranging from secretion of hormones
and neurotransmitters to gene transcription, can be triggered
by rapid changes in membrane potential. The canonical princi-
ple for transduction of membrane potential changes into intra-
cellular signals involves Ca2 influx by activation of voltage-
gated channels, resulting in an increase of the intracellular
Ca2 concentration, which in turn acts via downstream Ca2-
sensitive proteins as effectors (1–3). The recent discovery of
voltage-sensitive phosphatases (VSPs)4 (4, 5) has broadened
this view fundamentally. In response to depolarization of the
membrane potential, the prototypic VSP fromCiona intestina-
lis, Ci-VSP (5, 6), degrades both phosphatidylinositol 4,5-bis-
phosphate (PI(4,5)P2) and phosphatidylinositol 3,4,5-trisphos-
phate (PI(3,4,5)P3) by removing the phosphate group in
position 5 of the inositol ring (5–8). These phosphoinositides
are signaling molecules with pivotal roles in the regulation of
various cellular processes such as cell proliferation and differ-
entiation (9, 10), ion channel activity (11), synaptic exocytosis
and endocytosis (12, 13), and neural development (9). Thus,
VSPs constitute a novel mechanism of coupling of intracellular
pathways to electrical activity at the plasma membrane,
although their physiological role remains elusive.
VSPs are homologues of the tumor suppressor PTEN (phos-
phatase and tensin homolog deleted from chromosome 10) (14,
15), a key regulator of phosphoinositide signaling pathways.
PTEN is a cytosolic 3-phosphoinositide phosphatase, acting as
an antagonist of theAkt/PI3Kpathway. Loss-of-functionmuta-
tions of PTEN are frequently found in human cancer, ranking
this protein as one of the most important tumor suppressors
known presently (16). Regulation of PTEN activity is highly
complex, but in contrast to VSPs, it is independent of mem-
brane potential because PTEN is a cytosolic protein. Because
the membrane lipid PI(3,4,5)P3 is the main substrate of PTEN,
binding to the plasmamembrane is a prerequisite for enzymatic
activity. Targeting to the plasmamembrane is mediated by two
distinct domains located in theN andC termini (17–20). The C
terminus harbors a C2 domain that binds phosphatidylserine;
its binding affinity is regulated by phosphorylation (19, 21). The
N terminus constitutes a phosphoinositide-binding motif
(PBM) that recruits PTEN to the membrane by specifically
binding to PI(4,5)P2, the main catalytic product of PTEN (17,
22). Moreover, binding of the PBM to PI(4,5)P2 allosterically
activates PTEN (17, 22). Thus, the activity of PTEN relies not
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only on the recognition of its substrate but also on binding to
the membrane and on a membrane-delimited allosteric inter-
action with PI(4,5)P2, which acts as an activating ligand. This
complexity poses substantial challenges for further detailed
examination of the mechanism of activation, enzymatic mech-
anism, and regulation of PTEN and of itsmultiple cellular func-
tions (23). A robust method for experimental control of PTEN
activity, analogous to the voltage control of the VSPs, might
therefore greatly facilitate such examination.
In VSPs, voltage sensitivity is conferred by a voltage-sensing
domain (VSD) located in the N terminus, which, in turn, con-
trols the activity of the catalytic domain (CD) locatedwithin the
C terminus (see Fig. 1A). Both domains are fully functional
when expressed individually (5, 24). The modular nature of
both domains suggested that the VSD initiates the catalytic
activity by operating a molecular switch intrinsic to the CD.
The N terminus of the CD of Ci-VSP also contains a PBM
highly homologous to the PBM of PTEN (see Fig. 1B), which is
critical for depolarization-triggered activity. In fact, it has been
proposed that the mechanism of activation of the Ci-VSP
involves binding of the PBM to the membrane (8, 24); accord-
ingly, voltage sensitivity relies on the control of this binding
step by the VSD. Thus, activation of VSPs resembles the PBM-
mediated activation of PTEN. Moreover, the CD of Ci-VSP
shares substantial sequence conservation with PTEN (8, 25). A
structural homology model for the CD of Ci-VSP (see Fig. 1C)
based upon the crystal structure of PTEN as a template (26)
confirmed a high degree of structural similarity between Ci-
VSP and PTEN, including an architecture consisting of a phos-
phatase domain (PD) and a C2 domain. These considerations
suggested that it may be possible to impose voltage control
upon PTEN if it was connected properly to a VSD. Following
this idea, we here describe the successful generation and char-
acterization of engineered voltage-activated enzymes (VEnz),
by conferring voltage sensitivity upon the cytoplasmic signaling
enzyme PTEN.
EXPERIMENTAL PROCEDURES
Generation of Ci-VSPTEN Chimera and Mutagenesis—Ci-
VSPTEN chimeras were built by swapping the DNA fragments
encoding the codons 240–576 (Ci-VSPTEN0), 255–576 (Ci-
VSPTEN16), and 260–576 (Ci-VSPTEN21) of Ci-VSP by the
DNA fragments encoding the codons 1–403 (Ci-VSPTEN0),
16–403 (Ci-VSPTEN16), and 21–403 (Ci-VSPTEN21) of the
mouse PTEN cDNA.5 For this, we employed a PCR-based
primer extension strategy. Briefly, the PTEN DNA fragments
were generated by PCR-amplification from a Sport6 plasmid
containing the full-length PTEN cDNA. The 5 ends of the
sense and antisense primers used for these PCR were comple-
mentary to the 5 and 3 regions immediately flanking the
sequence to swap in the Ci-VSP cDNA. The obtained PCR
products were purified and used as extended primers for a sec-
ond PCR reaction using a standard QuikChange mutagenesis
protocol (Stratagene). TheDNAtemplate used for these second
PCR was a pBSTA plasmid encoding the Ci-VSP cDNA under
the T7 promoter. For expression in CHO and opossum kidney
(OK) cells, Ci-VSPTEN chimeras were subcloned from pBSTA
into pRFP-C1. Ci-VSPTEN mutants were generated by stand-
ard site-directedmutagenesis and verified by sequencing. Sens-
ing current recordings and voltage clamp fluorometry, were
performed with Ci-VSPTEN containing the additional muta-
tion C363S, equivalent to the catalytically inactive mutant
C124S in PTEN.
Expression in Xenopus Oocytes—The DNA was linearized
with NotI and transcribed using T7 RNA polymerase. 50 nl of
0.5–1 g/l RNA was injected per oocyte, followed by incuba-
tion at 18 °C in a solution containing 100 mM NaCl, 2 mM KCl,
1 mM MgCl2, 1.8 mM CaCl2, 2 mM sodium pyruvate, 50 M
EDTA, and 10 mM HEPES, pH 7.5 (27).
Sensing Currents and Voltage Clamp Fluorometry—Sensing
currents were measured 2–4 days after injection with the cut-
open oocyte voltage clamp technique (28) as described by Vil-
lalba-Galea et al. (27). Currents were measured in response to
voltage steps (400 ms, 10-s interval) from a holding potential of
80 mV without leak subtraction during acquisition. Capaci-
tance transient currents were compensated analogically using
the amplifier compensation circuit. The external recording
solutions contained 120 mM NMG-MeSO3 (methanesulfon-
ate), 10 mM HEPES, and 2 mM CaCl2, pH 7.4, whereas internal
solutions contained 120mMNMG-MeSO3, 10mMHEPES, and
2 mM EGTA, pH 7.4. Labeling of oocytes with tetramethylrho-
damine-5-maleimide and fluorometry were done as described
previously (29). Briefly, tetramethylrhodamine-5-maleimide
fluorescence was measured through a BX51WI microscope
(Olympus) equipped with a LUMPlanFl 40 water immersion
objective (numerical aperture, 0.80) and an appropriate filter
set. Fluorescence intensity was monitored with a PhotoMax-
201-PIN photodiode controlled by a PhotoMax 200 amplifier
(Dagan). Electrophysiological and fluorescence data were fil-
tered at 2–5 kHz and sampled at 5–20 kHz and recorded and
analyzed with the acquisition system and programs described
previously (27).
Expression in CHO and OK Cells—CHO and OK cells were
grown as described (7, 30), plated onto glass-bottomed dishes
(WillCoWells B. V., Amsterdam, The Netherlands) or glass cov-
erslips, respectively, and transfected using jetPEI (CHO cells;
Polyplus Transfection, Illkirch, France) or Lipofectamine 2000
(OK cells; Invitrogen). Experiments were done 24–48 h post-
transfectionon cells selected for expressionofmRFP-Ci-VSPTEN
and the presence of corresponding sensing currents. Vectors used
for transfectionwere as follows: PLC1-PH-pEGFP-N1 (GenBank
accession no. P51178); Akt1-PH-pEGFP-N1 (GenBank accession
no. AAL55732.1); Btk-PH-pEGFP (GenBank accession no.
AAC51347.1); OSBP-PH-pEGFP-N1 (GenBank accession no.
NP_002547.1); TAPP1-PH-FUGW (GenBank accession no. NP_
067635); bovine phosphatidylinositol 3-kinase p110 (constitu-
tivelyactivemutantK227E;GenBankaccessionno.NP_776999.1);
and hTASK-3-pcDNA3.1 (GenBank accession no. NP_057685).
Combined Patch Clamp and TIRF Microscopy—CHO cells
werewhole-cell voltage clampedwith an EPC-10 amplifier con-
5 PTEN fromboth human andmouse displays 96% identity in their nucleotide
sequence, while only differing in a single amino acid in the distal region of
theC terminus, particularly a Serine in position 398, insteadof a Threonine,
as in human. To our knowledge, there is no evidence showing any differ-
ence between the activities of these two enzymes.
Voltage-controlled PTEN Activity
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trolled by PatchMaster software (HEKA, Lambrecht, Ger-
many). Sensing currents were isolated using a P/-10 protocol.
Patch pipettes were pulled from a quartz glass to an open
pipette resistance of 1.5–4.0 M when filled with intracellular
solution: 135 mM KCl, 2.5 mM MgCl2, 2.41 mM CaCl2, 5 mM
EGTA, 5 mM HEPES, and 3 mM Na2ATP, pH 7.3 (with KOH).
For perforated patch measurements Nystatin (100 g/ml) was
added. The extracellular solution contained the following: 144
mM NaCl, 5.8 mM KCl, 0.7 mM NaH2PO4, 5.6 mM glucose, 1.3
mM CaCl2, 0.9 mM MgCl2, and 10 mM HEPES, pH 7.4 (with
NaOH). For depolarization by K, cells were initially kept in
standard extracellular solution, anddepolarizationwas induced
by transient application of 150 mM K (150 mM KCl, 5.6 mM
glucose, 1.3 mM CaCl2, 0.9 mM MgCl2, and 10 mM HEPES, pH
7.4). Total internal reflection fluorescence (TIRF) imaging was
done as described previously (7). Briefly, a BX51WI upright
microscope (Olympus) equipped with a TIRF condenser
(numerical aperture, 1.45; Olympus) and a 488-nm laser (20
milliwatt; Picarro, Sunnyvale, CA) was used. Fluorescence was
imaged through a LUMPlanFI/IR 40/0.8 numerical aperture
water-immersion objective. Images were acquired with a TILL-
Imago QE cooled CCD camera (TILL Photonics, Gra¨felfing,
Germany) controlled by TILLvision software (TILL Photonics).
Imaging data were analyzed using TILLvisION and IgorPro
(Wavemetrics, Lake Oswego, OR). Regions of interest encom-
passed the footprint of a single cell excluding cell margins to
avoid movement artifacts. F/F0 traces were calculated from the
background-corrected TIRF signal intensity F, averaged over
the region of interest and the initial fluorescence intensity F0
during the baseline interval. F/F0 traces were corrected for
bleaching according to monoexponential fits to the baseline
interval.
Confocal Imaging—OKcellswere co-transfectedwithmRFP-
Ci-VSPTEN16, Akt-PH-GFP, p110(K227E), and the TASK3
potassium channel. Cells were transiently depolarized by appli-
cation of 150 mM K. Confocal imaging was performed with a
Zeiss Examiner upright microscope equipped with a LSM710
scan head (Carl Zeiss AG, Jena, Germany) and a W-Plan-Apo-
chromat 20/1.0 DICM27 75 mm (Carl Zeiss AG). Laser lines
used were 561 nm for mRFP and 488 nm for GFP, detection
wavelength ranges were 582–754 and 493–582 nm, respec-
tively. Time series recordings were taken in the GFP channel.
Fluorescence (F) was averaged from regions of interest placed
in cytosolic regions of individual cells and normalized to the
baseline fluorescence (F0), prior to stimulation.
All experiments were performed at room temperature. Data
are given as means S.E.
RESULTS
Designing Chimeras between Ci-VSP and PTEN—A chimera,
hereafter named Ci-VSPTEN16, was built by replacing the CD
of Ci-VSP with full-length PTEN (Fig. 1D). Because the PBM is
critically involved in mediating activation both in Ci-VSP and
PTEN, we particularly focused our attention on the motif link-
ing PTEN to theVSD in the chimeras. Previous functional anal-
ysis showed that, in Ci-VSP, theVSD seems to control the bind-
ing of the PBM to the membrane, and this process is critically
dependent on arginines 253 and 254. In fact, mutation of these
arginines eliminates coupling between electrical and catalytic
activity (8, 24) even if the charges are conserved (8). In addition,
arginines 245 and 246 are also critical for coupling since neu-
tralization of these residues renders coupling inefficient (8).
Despite overall similarity, the PBMof PTEN lacks the arginines
equivalent to 245 and 246 ofCi-VSP, displaying nonet charge at
the corresponding position (Fig. 1B). To account for potential
relevance of these residues for coupling of PTEN to theVSD,we
replaced the DNA sequence coding from amino acid 17 of the
PBM from Ci-VSP (including Arg245/246), with the coding
sequence of PTENcontributing themore distal part of the PBM
(Ci-VSPTEN16; see Fig. 1, B and D).
In addition to positions Arg245/246, there are further differ-
ences in the sequences of the PBMs from Ci-VSP and PTEN
(see Fig. 1B), which may be relevant for coupling between VSD
and PD. In fact, some of these amino acids are known to have a
critical impact on the function of PTEN (18, 20, 31). To account
for a potential impact of these residues on electrochemical cou-
pling, we designed two additional chimeras containing either
the full-length PBM (i.e. 21 residues) of Ci-VSP (termed Ci-
VSPTEN21) or the full PBM of PTEN without contribution
from the PBM of Ci-VSP (Ci-VSPTEN0) (see Fig. 1D).
Ci-VSPTEN16DisplaysVoltage-activatedEnzymaticActivity—
Enzymatic activity of Ci-VSPTEN16 was assessed in living cells
by imaging genetically encoded fluorescent phosphoinositide
probes, following paradigms established previously for Ci-VSP
VSD
VSD PBM
VSD PB
Ci-VSPTEN 0
Ci-VSPTEN 16
Ci-VSPTEN 21
PTENCi-VSP(CD)
PBM PD C2VSD
CD
Ci-VSP
PTEN
 
 

 
A
B
C
D
FIGURE 1.Design of chimeras between Ci-VSP and PTEN. A, comparison of
the domain organization of Ci-VSP and PTEN. P, PDZ-binding motif. B, high
sequence identity between the PBMs of Ci-VSP and PTEN. Numbers refer to
the amino acid positions in Ci-VSP and PTEN, respectively. C, structural simi-
larity between the catalytic domains of Ci-VSP and PTEN predicted by struc-
tural homologymodeling of the CD of Ci-VSP (left panel) based on the crystal
structure of PTEN (26), generated with ESyPred3D (48). PD and C2 domains
are displayed in blue and green, respectively. Partially rendered PBMs are
shown in red, with arginines 253 and 254 in Ci-VSP and arginines 14 and 15 in
PTEN emphasized as stickmodels. Cysteines 363 (in Ci-VSP) and 124 (in PTEN)
in the catalytic core are displayed as yellow stick models. D, design of Ci-
VSPTEN chimeras. PTEN replaces the CD of Ci-VSP with different variants of
the PBM (see text).
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(7). Briefly, membrane association of these probes reports the
abundance of the specifically recognized lipid.Membrane asso-
ciation was determined by TIRF imaging of cells under whole-
cell voltage clamp.
Upon depolarization (to 80 mV), cells co-expressing Ci-
VSPTEN16 and the probe Akt-PH-GFP, specific for PI(3,4,5)P3
and PI(3,4)P2, displayed an unambiguous decrease in mem-
brane-associated fluorescence intensity (Fig. 2, B and C). This
observation showed that the concentration of PI(3,4,5)P3
and/or PI(3,4)P2 decreased during depolarization, indicating
that Ci-VSPTEN16 has depolarization-triggered enzymatic
activity. Following repolarization, the membrane-associated
fluorescence recovered, indicating resynthesis of PI(3,4,5)P3
and/or PI(3,4)P2 (Fig. 2C). Activation of Ci-VSPTEN16 was
rapidly reversible, as fluorescence decrease was observed only
during depolarization and ceased upon repolarization to 60
mV, as demonstrated using double-pulse protocols (Fig. 2D).
Similar results were obtained with Ci-VSPTEN21 but not with
the catalytically inactive mutant Ci-VSPTEN16-C363S (this
mutation is equivalent to C124S in PTEN) (Fig. 2C), confirming
that the fluorescence decrease was caused by enzymatic activity
of the PTEN domain of the chimeras.
The decrease in Akt-PH-GFP TIRF fluorescence obtained
with Ci-VSPTEN16 after 60 s of depolarization (80 mV) was
to 46.8  7.2% of the initial signal (n  5). Because a signal
decrease to 40% reports the full translocation of an initially
fully membrane-resident probe (7), this finding indicates that
Ci-VSPTEN16 can completely deplete the pool of PI(3,4,5)P3
and PI(3,4)P2 in the plasma membrane.
Ci-VSPTEN16 Preserves PTENSubstrate Selectivity—Having
found that Ci-VSPTEN16 is both active and voltage-depen-
dent, we next examined the catalytic specificity of this chimera
using other phosphoinositide-specific probes (Fig. 2A). When
co-expressedwithBtk-PH-GFPorTAPP1-PH-GFP (32), which
FIGURE 2. Ci-VSPTEN displays voltage-activated lipid phosphatase activity. A, schematic representation of the enzymatic activity of PTEN, a 3-phospha-
tase that converts PI(3,4,5)P3 into PI(4,5)P2 and PI(3,4)P2 into PI(4)P. GFP-fused sensor domains used in this study to detect concentration changes of the
putative substrates and products of Ci-VSPTEN chimeras are indicated (green). B, TIRF images of a living CHO cell coexpressing the PI(3,4,5)P2/PI(3,4)P2 sensor
Akt-PH-GFP andCi-VSPTEN16 togetherwith constitutively active PI3K p110K227E (PI3K). Imageswere acquired before (left) and after 30 s of depolarization to
80 mV (right) in whole-cell configuration. Depolarization-induced loss of fluorescence results from reduced membrane association of Akt-PH and indicates
depletion of 3-phosphoinositides. C, depolarization-induced translocation of Akt-PH as in B is followed by slow recovery, indicating resynthesis of 3-phos-
phoinositides by PI3K (recordings obtained with perforated patch configuration). The gray area indicates depolarization from60 to80mV. D, normalized
TIRF intensities in response to repetitive depolarization obtained as in B. Cells coexpressed Akt-PH-GFP, PI3K, and the Ci-VSPTEN chimeras indicated (n 10, 3,
and 7 cells, for Ci-VSPTEN16, Ci-VSPTEN21, and Ci-VSPTEN16-C363S, respectively). E–H, depolarization-triggered changes inmembrane association of fluores-
centprobes that specifically bindvariousphosphoinositides,measuredas inD. Cells expressedCi-VSPTEN16 togetherwithPI3Kandeither Btk-PH-GFP (n16),
TAPP1-PH-GFP (n 5), PLC1-PH-GFP (n 6), or OSBP-PH-GFP (n 6). Error bars indicate S.E.
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specifically bind PI(3,4,5)P3 and PI(3,4)P2, respectively,
Ci-VSPTEN16 evoked a decrease in membrane fluorescence
upon depolarization (Fig. 2, E and F). Thus Ci-VSPTEN16
dephosphorylates both PI(3,4,5)P3 and PI(3,4)P2, consistent
with the enzymatic activity of PTEN (Fig. 2A). Conversely,
membrane fluorescence from the PI(4,5)P2-specific probe,
PLC1-PH-GFP (33), increased during depolarization (Fig.
2G). This result indicated production of PI(4,5)P2 from
PI(3,4,5)P3 and confirmed that Ci-VSPTEN16 behaves as a
3-phosphatase. Membrane association of PLC1-PH-GFP
recovered rapidly following deactivation of Ci-VSPTEN,
which most likely reflects rapid turnover of PI(4,5)P2 (7, 34)
and indicates that the PI(4,5)P2 concentration is regulated
independent of the PI(3,4,5)P3 pool depleted by Ci-VSPTEN.
Despite dephosphorylation of PI(3,4)P2, membrane fluores-
cence of the PI(4)P specific probe OSBP-PH-GFP (35)
seemed unaffected by depolarization (Fig. 2H), indicating
the lack of substantial changes of the PI(4)P concentration
by Ci-VSPTEN16 activation. However, this is expected,
because the basal PI(3,4)P2 content of the membrane is typ-
ically 1000-fold lower than its PI(4)P content (36). Based on
these observations, we conclude that Ci-VSPTEN16 retains
the enzymatic specificity of PTEN.
Role of PBM in Coupling Exogenous Enzymatic Activity to
Voltage Sensor—To understand the coupling of catalytic
activity to membrane potential, we next characterized the
behavior of the VSD. Thus, we measured sensing currents
from the chimeras carrying the mutation C363S expressed in
Xenopus oocytes. Sensing currents are mainly produced by
the movement of charged residues within the putative fourth
trans-membrane segment (S4) of the VSD (5). The net sens-
ing charge movement versus potential relationship (Q-V
curve) revealed that both Ci-VSPTEN16 and -21 display
voltage dependences similar to Ci-VSP (Fig. 3A). However, a
shift to negative potentials was observed for Ci-VSPTEN0.
In addition, Ci-VSPTEN0 displayed much slower OFF-sens-
ing currents than Ci-VSPTEN16 and Ci-VSPTEN21 (Fig. 3,
B and C). We further examined the movement of the S4
segment using voltage clamp fluorometry. Tetramethylrho-
damine-5-maleimide was attached covalently to a cysteine
replacing glycine 214 in the extracellular end of this seg-
ment, such that S4 movements result in fluorescence inten-
sity changes (27, 37). Ci-VSP (Fig. 3E) and Ci-VSPTEN0 (Fig.
3D) displayed voltage-dependent fluorescence changes with
strikingly different kinetics during repolarization: consistent
FIGURE 3. Effect of the PBM on the voltage sensor dynamics. A, voltage dependence of the sensing currents of the three Ci-VSPTEN chimeras were
measured from Xenopus oocytes (27), using the catalytically inactive mutant C363S (equivalent to C124S in PTEN). Normalized Q-V curves were derived
from the OFF sensing currents at 90 mV following a 400-ms step to the potentials indicated. The gray curve shows the voltage dependence of
Ci-VSP-C363S recorded under the same conditions (27). Fits of a two-state Boltzmann distribution to the data (continuous red lines) yielded potentials
at half-maximal charge transfer of7 0.2 mV (n 4),67 0.4 mV (n 3), and69 0.3 mV (n 4), with charges of 2.0 0.03 e0, 1.2 0.02 e0 and
1.1  0.01 e0, for Ci-VSPTEN0, Ci-VSPTEN16, and Ci-VSPTEN21, respectively. B, OFF sensing currents of Ci-VSPTEN chimeras measured at 90 mV
following a 400-ms test pulse to 0 mV for Ci-VSPTEN0 and 100 mV for Ci-VSPTEN16 and Ci-VSPTEN21. Current scale bars, 50 nA, 250 nA, and 100 nA,
respectively. C, Weighted mean time constants of tail-sensing currents recorded as in A are shown for the nearly saturating region of the Q-V curves
(Q/Qmax	 0.75; n 5) for Ci-VSPTEN (black), Ci-VSPTEN16 (red), and Ci-VSPTEN21 (blue). D and E, sensing currents and changes in fluorescence intensity
(
F/F0) from tetramethylrhodamine-5-maleimide-labeled Ci-VSPTEN0-G214C-C363S (D) and Ci-VSP-G214C-C363S (E) in response to depolarizing volt-
age steps (120 to 140 mV).
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with sensing currents (upper panels), fluorescence signals
(lower panels) were much slower for Ci-VSPTEN0.
Ci-VSPTEN0 Displays High Basal Activity—Despite an
intact catalytic domain, Ci-VSPTEN0 produced no changes in
membrane-associated fluorescence of Akt-PH-GFP during
depolarization (data not shown). This might be a consequence
of a strong negative shift in the voltage dependence of enzy-
matic activity in parallel with the voltage sensor behavior (Fig.
3A). Such a shift may render Ci-VSPTEN0 active at resting
potential and thereby preclude additional depletion of
PI(3,4,5)P3 and PI(3,4)P2 upon depolarization. However, we did
not succeed in detecting depolarization-induced enzymatic
activity even after prolonged hyperpolarization to abolish any
activity present at resting membrane potential. We therefore
tested for basal activity of Ci-VSPTEN0 under conditions of
experimentally increased substrate concentration. To this end,
cells were treated with H2O2, which is known to strongly
increase the plasma membrane concentration of PI(3,4)P2 (32,
38). The H2O2-triggered pathway leading to the PI(3,4)P2
increase is not well understood but appears to involve the dys-
regulation of endogenous enzymes that otherwise control
PI(3,4)P2 levels, likely including inactivation of PTEN (32). It
should be noted that H2O2 also inactivates PTEN, and conse-
quentlyCi-VSPTEN0, by formation of a disulfide bondbetween
Cys71 and catalytic Cys124, corresponding to Cys310 and Cys363
in the chimera (39). However, this inactivation is readily
reversed in the presence of DTT (39). When H2O2 was applied
to cells expressing Ci-VSPTEN0 and the PI(3,4)P2 sensor
TAPP1-PH, accumulation of PI(3,4)P2 was readily detected as
an increase in membrane association of TAPP-PH-GFP (Fig.
4A). Subsequent application of DTT to reverse oxidative inac-
tivation induced a rapid decrease of membrane fluorescence in
cells expressing Ci-VSPTEN0, indicating consumption of
PI(3,4)P2. In contrast, in cells expressing the inactive mutant
Ci-VSPTEN0-C363S, recovery of PI(3,4)P2 after H2O2 treat-
ment was delayed and occurred much more slowly (Fig. 4A).
Time constants obtained frommonoexponential fits to the flu-
orescence decay upon application of DTT quantitatively con-
firmed the faster depletion of PI(3,4)P2 with wild-type Ci-
VSPTEN0 (Fig. 4B).
In conclusion, the fast removal of PI(3,4)P2 upon treatment
with DTT provides direct evidence for enzymatic activity of
Ci-VSPTEN0 under basal conditions, i.e. at resting membrane
potential. Additionally, the increase of PI(3,4)P2 during H2O2
application was slightly stronger and faster in cells expressing
Ci-VSPTEN0. This findingmight be explained by a lower initial
concentration of PI(3,4)P2, which is again consistent with basal
activity of Ci-VSPTEN0.
Mutations in PBM Abolished Ci-VSPTEN16 Activity—Both
the effect of the PBM on the VSD movement (Fig. 3) and the
differential enzymatic activity of Ci-VSPTEN16 versus
Ci-VSPTEN0 are consistent with a pivotal role of the PBM in
electrochemically coupling the exogenous enzymatic activity to
the VSD movement. We directly tested this suggestion by
introducing mutations that have been shown previously to
affect the activity of PTEN, namely of Arg14/15 of the PBM (15,
17). The corresponding amino acids (Arg253/254) were also
shown to be critical for electrochemical coupling of Ci-VSP (8,
24). Conversion of arginines Arg14/Arg15 of the PBM to ala-
nines or lysines completely abolished voltage-activated enzy-
matic activity of Ci-VSPTEN16 (Fig. 5), despite functionality of
the VSD as confirmed by sensing currents (data not shown).
This demonstrates functional uncoupling of the CD from the
VSD, confirming the essential role of the PBM for activation of
exogenous catalytic domains by a VSD.
Activation of Ci-VSPTEN16 in Intact Cells without Electro-
physiological Instrumentation—So far, we have shown that Ci-
VSPTEN allows the activation of PTEN enzymatic activity and
the depletion of both PI(3,4,5)P3 and PI(3,4)P2 when used with
electrophysiological single-cell techniques. Obviously, meth-
ods for controlling enzymatic activity with more general meth-
ods that can also be used on cell populations would substan-
tially increase the range of potential applications.
We therefore explored K-induced depolarization as a
means to activate Ci-VSPTEN16. Thus, we transiently depo-
larized the membrane potential by application of high extra-
cellular K concentration to otherwise undisturbed cells
coexpressing Ci-VSPTEN16 and Akt-PH-GFP. K-induced
depolarization triggered rapid depletion of both PI(3,4,5)P3 and
PI(3,4)P2 as reported by translocation of Akt-PH-GFP from the
FIGURE 4. Basal PI-3-phosphatase activity of Ci-VSPTEN0 at resting
membrane potential. A, membrane association of the PI(3,4)P2 probe
TAPP1-PH-YFP in cells either coexpressingCi-VSPTEN0 (n 47 cells fromnine
independent experiments) or Ci-VSPTEN0 with the inactivating mutation
C363S (n  35 cells from 10 experiments) was imaged by TIRF microscopy.
H2O2 (1mM)was applied for 15min, followed by application of DTT (5mM) for
15min as indicated. B, average time constants obtained frommonoexponen-
tial fits to the signal recovery upon application of DTT from the same experi-
ments shown in A. Error bars indicate S.E.
FIGURE 5. Binding of the PBM is essential for phosphatase activation by
the VSD. Mutations that interfere with membrane binding of the PBM
(R253A/R254A and R253K/R254K) abolish the depolarization-induced activa-
tion of enzymatic activity of Ci-VSPTEN16 as monitored by measuring mem-
brane association of Akt-PH-GFP (n  7 cells for each mutant). Experiments
were done as described in the legend to Fig. 2, and data for Ci-VSPTEN16 are
fromFig. 2D for comparison. The gray area indicates depolarization from60
to80 mV.
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membrane into the cytosol measured either by TIRF (Fig. 6A)
or confocal microscopy (Fig. 6, B and C). Upon lowering the
extracellular concentration of K back to the initial condition,
Akt-PH-GFP reassociated to the membrane, indicating resyn-
thesis of PI(3,4,5)P3 and PI(3,4)P2. These results show that Ci-
VSPTEN can be activated precisely and in a readily reversible
manner by simply altering the extracellular concentration of
K.
DISCUSSION
The recently discoveredVSPs constitute a novel principle for
the transduction of cellular electrical activity into intracellular
biochemical signals, which differs fundamentally from the
canonical principle for such transduction, i.e. influx of Ca2
mediated by voltage-gated channels. Here, we explore molecu-
lar details of this novel principle and show that at least one
exogenous enzyme can be operated by a voltage sensor domain.
Specifically, fusing the VSD of Ci-VSP to PTEN, a key cytosolic
modulator of intracellular signaling, yielded chimeric proteins
that renders strictly voltage-dependent PTEN-like activity. To
our knowledge, both Ci-VSPTEN16 and -21 represent the first
example of conferring voltage control to a cytoplasmic enzyme,
and they constitute the first generation of engineered VEnz.
Potential Applications for Engineered VEnz—We note that
dramatically improving experimental control over PTEN activ-
ity provides a novel paradigm for the study of this important
signaling enzyme. Stringent control of activity will enable
addressing details of the enzymatic mechanism, cellular regu-
lation, disease-causing mutations, and pharmacology of PTEN.
Beyond analysis of PTEN operation, voltage-controlled
enzymes such as Ci-VSPTEN provide novel tools for analyzing
cellular signaling. By inducing rapid phosphoinositide concen-
trations changes, Ci-VSPTEN can be used to probe the role and
specificity of these messengers in many cellular processes and
to analyze the timing of phosphoinositide signaling. Various
methods have beenusedpreviously to address the roles of phos-
phoinositides in the control of cellular function. For example,
overexpression and knockdown of enzymes involved in phos-
phoinositide synthesis or homeostasis have been used widely
(40–42). Many fundamental cellular processes occurring at a
variety of time scales are affected by phosphoinositides, includ-
ing protein targeting, cell differentiation, and transcription.
Therefore, with the above-mentionedmethods, it may often be
difficult to unequivocally define the direct role of these lipid
messengers for the process under observation.Moreover, com-
pensatory mechanisms may complicate the actual changes of
phosphoinositide concentrations resulting from long term
manipulation of synthesis or degradation (43). To overcome
these problems, methods for triggered recruitment of enzymes
and signaling molecules to the plasma membrane by rapamy-
cin-induced dimerization have been developed (43, 44). Such
recruitment has been used to induce rapid, albeit irreversible,
alterations of phosphoinositide concentrations during experi-
mental observation (43, 44).
Voltage-controlled activation of enzymes, as introduced
here, takes this approach one step further by rapidly switching
enzymatic activity “on” and “off.” Thus, the precisely timed and
reversible control of enzyme activation on a time scale of milli-
seconds provides a powerful tool for addressing temporal char-
acteristics of signaling processes. Unlike the rapamycin-based
approach, reversibility of activation allows the graded titration
of phosphoinositide concentrations in the living cell (Fig. 2D)
(7).Moreover, the recovery of phosphoinositide concentrations
following a step-like perturbation (Fig. 2C) can yield unique
insights into synthesis, homeostasis, and regulation of these
messengers (7, 34). In analogy to Ci-VSPTEN, we envisage that
fusion of different enzymatic domains to a VSD could provide
novel tools for the temporally precise interference with diverse
signaling pathways in the living cell, allowing for the experi-
mental manipulation of cellular signaling networks beyond the
level possible with the current cell biological or biochemical
techniques.
Which enzymes or enzymatic domains may be amenable to
functional coupling to VSDs? Here, we show that membrane
binding of the PBM is critical for the activation of the exoge-
nous enzymatic domain. The strong impact of the PBM on
voltage sensor movement indicates that the VSD activates the
exogenous enzyme by controlling themembrane binding of the
PBM (see below), resembling electrochemical coupling in
FIGURE 6. Experimental control of Ci-VSPTEN activity in intact cells with-
out useof electrophysiological instrumentation.A, reversible dissociation
of Akt-PH from the plasma membrane upon K-induced depolarization
observedwithCi-VSPTEN16 (n30 cells from five independent experiments)
but not with the catalytically inactive Ci-VSPTEN16-C363S (n 29 cells, from
five independent experiments), measured by TIRF microscopy. CHO cells
were cotransfected with Ci-VSPTEN16, Akt-PH-GFP, PI3K, and the potassium
channel TASK3.B, confocal imagesofOKcells showreversible translocationof
Akt-PH from the plasmamembrane to the cytosol upon K-induced depolar-
ization.OK cellswere cotransfected asdescribed inA.C, averaged time course
of K-induced translocation of Akt-PH-GFP obtained from experiments as
described in B (n 19 cells from two independent experiments).
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native VSPs (8, 24). Although it has been shown that binding of
the PBM to PI(4,5)P2 increases the -helicity of PTEN (22), it
remains unknown whether activation occurs by the reorienta-
tion of the PD toward its membrane-resident substrate or by
direct interaction of the PBM with the catalytic site. Although
further work is needed to distinguish between these mecha-
nisms, the latter model would suggest that generation of VEnz
may be limited to CDs whose intrinsic activation mechanism
involves a PBM-like motif. Such candidates may include, with-
out being limited to, additional PTEN-related proteins, namely
TPTE (45), TPIP (46), and PLIP (47). In vitro, these molecules
may possess phosphoinositide phosphatase activities with dis-
tinct substrate specificities (46, 47). Generation of VEnz chi-
merawith these proteinsmay substantially help to address their
function in intact cells, which has been largely unexplored.
Mechanism of Coupling in Engineered VEnz—The loss of
electrically triggered enzymatic activity observed with PBM
mutants (Fig. 5) clearly demonstrates that electrochemical cou-
pling in Ci-VSPTEN16 involves the PBM. Howmight the PBM
mediate the interaction of VSD and PD? For PTEN, it has been
shown that the PBM mediates both membrane binding and
activation of catalytic activity (17, 19, 20). Likewise, work on
Ci-VSP suggested that binding of the PBM to the plasmamem-
brane is involved in coupling and that VSD movement modu-
lates the PBM binding to control enzymatic activity (8, 24).
Thus, sensor movement following depolarization is thought to
promote membrane binding of the PBM and thereby activate
the PBM. According to this model, the membrane binding of
the PBMwill reciprocally affect voltage sensormovement. Spe-
cifically, binding of the PBM upon depolarization will restrict
subsequent voltage sensormovement upon repolarization, thus
slowing down OFF sensing currents (8, 24).
Our present results with Ci-VSPTEN chimeras are consis-
tent with this idea. Thus, mutations in the PBMmost probably
abrogate electrochemical coupling by interfering with mem-
brane binding, similar to previous results obtainedwith Ci-VSP
(8). We further observed that the full PBM from PTEN drasti-
cally slowed down voltage sensor return to the resting state
upon repolarization, when compared with both of the other
chimeras. According to the model outlined above, this obser-
vation suggests distinct membrane binding affinities of the dif-
ferent chimeric PBMs, with the full PBM of PTEN (i.e.
Ci-VSPTEN0) exhibiting the strongest binding.
Following this idea, the proposed distinctmembrane binding
affinities may point to a specific interaction between the differ-
ent PDs and their associated PBM. Thus, we note that the chi-
meric PBMs of Ci-VSPTEN16 and 21 yielded the fastest OFF-
sensing currents, which may indicate that their bound
conformation is less stable compared with native PBMs of Ci-
VSP or Ci-VSPTEN0 associated with their original PDs (Fig. 3
and Ref. 8). These combined observations suggest that for opti-
mal membrane binding, the PBM must match the catalytic
domain with which they couple. In this view, the PBM in Ci-
VSP serves as an adapter for the binding between the mem-
brane and the CD. Combinatorial exchange of PBMs in VSP
chimeras designed to operate as Ci-VSPTEN should help in
directly addressing such specific interaction of PBM and PD.
One caveat to this model comes from its failure to fully
explain the apparent lack of control of the VSD over the CD in
Ci-VSPTEN0. The basal activity at negative potentials may
either indicate that PTEN is constitutively active at all poten-
tials (i.e. uncoupled from the VSD) or that the activation range
is also shifted to negative potentials, as found for the sensing
current. Both scenarios are not mutually exclusive and may be
consistent with a highermembrane binding affinity of the PBM
of PTEN. For the first case, it is plausible that the control of the
VSD can be overridden by a strong interaction between the
membrane and the PBM. For the second case, the shift in volt-
age dependence may prevent the sensor from adopting a con-
formation in which the PBM cannot bind (as in the case of
Ci-VSPTEN16, -21 and other VSPs at negative potentials),
resulting in high basal activity.
Furthermore, it should be noted that the observed shift in the
voltage dependence of Ci-VSPTEN0 might be explained by an
alternative scenario, in which the PBM influences the profile of
the focused electrical field across the voltage sensor. In this
case, the PBMcould increase the sensitivity of theVSD to depo-
larization and therefore self-promote the activation of the cat-
alytic activity, rendering a high basal activity. To distinguish
between these different possibilities, further work is required,
which is beyond the scope of the current study.
In Ci-VSP, cationic residues Arg245, Arg246, Arg253, and
Arg254 within the PBM are involved in electrochemical cou-
pling, presumably by contributing to binding to negatively
charged phospholipids in the membrane (8, 24). It is therefore
remarkable that the PBM from PTEN, although lacking the
positive charge at residue pair 245–246 (R245K-R246E; see Fig.
1B), produced slowed OFF-sensing currents and enhanced
enzymatic activity at resting potentials, both consistent with
enhanced membrane binding according to the coupling mech-
anism proposed above. This finding supports the idea that the
PBM binds to membrane lipids in a stereo-specific manner
rather than simply by electrostatic interaction with the mem-
brane (8). This conclusion also is consistent with the elimina-
tion of electrochemical coupling by isocoulombic substitution
of Arg253 and Arg254 to Lys (Fig. 5). Further detailed analysis of
the role of individual residues within the PBM for membrane
binding is required to fully resolve this issue.
In conclusion, we have been able to engineer a series of chi-
meric proteins conferring voltage sensitivity to the tumor sup-
pressor PTEN in vivo. Thiswork supports the idea that the PBM
is a key element in the activation of VSP. In a broader view, this
study constitutes a proof-of-concept to a novel approach for
controlling enzymatic activity using VSDs.
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7 Appendix 
7.1 Table of Figures 
Figure 1: The organ of Corti in the inner ear mediates the transduction of sound......................-2- 
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